erythromycin has been researched along with zithromax in 711 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (3.52) | 18.7374 |
| 1990's | 316 (44.44) | 18.2507 |
| 2000's | 177 (24.89) | 29.6817 |
| 2010's | 155 (21.80) | 24.3611 |
| 2020's | 38 (5.34) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, CM; Froshauer, SA; Hayashi, SF; Hecker, SJ; Jaynes, BH; Jefson, MR; Kamicker, BJ; Lipinski, CA; Lundy, KM; McFarland, JW; Reese, CP; Vu, CB | 1 |
| Agouridas, C; Auger, JM; Benedetti, Y; Bonnefoy, A; Bretin, F; Chantot, JF; D'Ambrières, SG; Denis, A; Dussarat, A; Fromentin, C; Lachaud, S; Laurin, P; Le Martret, O; Loyau, V; Tessot, N | 1 |
| Alder, J; Chu, DT; Clark, RF; Ewing, P; Flamm, RK; Ma, Z; Mitten, M; Nilius, AM; Or, YS; Wang, S | 1 |
| Alder, J; Brazzale, A; Cao, Z; Chu, DT; Clark, RF; Ewing, P; Flamm, R; Griesgraber, G; Li, L; Ma, Z; Meulbroek, J; Mitten, M; Nemoto, PA; Nilius, AM; Or, YS; Phan, LT; Plattner, JJ; Rupp, MJ; Shortridge, VD; Wang, S; Yong, H; Zhang, S; Zhang, X; Zhong, P | 1 |
| Asaka, T; Kameo, K; Kashimura, M; Morimoto, S; Nishida, A; Sato, M; Sugiyama, H; Suzuki, K; Tanikawa, T | 1 |
| Asakura, E; Hasegawa, T; Kitaichi, K; Miyoshi, M; Nadai, M; Nakayama, H; Shimizu, A; Sugie, M; Takagi, K; Zhao, YL | 1 |
| Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Dunne, MW; Fidock, DA; Nkrumah, LJ; Sacchettini, JC; Sidhu, AB; Sun, Q | 1 |
| Cai, Y; Fang, W; Ruan, J; Wang, Z; Zhao, Z; Zhou, D; Zou, J | 1 |
| Chan, YY; Chua, KL; Ong, YM | 1 |
| Klugman, KP; Low, DE; Smith, AM; Wolter, N | 1 |
| Kasahara, K; Kita, E; Mikasa, K; Mizuno, F; Nishi, K; Yasuda, Y | 1 |
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Ardanuy, C; Bouza, E; Calatayud, L; Cercenado, E; Fenoll, A; Liñares, J; Martín, R; Pallares, R | 1 |
| Binet, R; Maurelli, AT | 1 |
| Appelbaum, PC; Kim, G; Parsek, MR; Shrout, JD; Starner, TD | 1 |
| Chiba, N; Hasegawa, K; Iwata, S; Matsubara, K; Morozumi, M; Nakayama, E; Sunakawa, K; Takayanagi, R; Ubukata, K | 1 |
| Bailey, M; Chettiath, T; Mankin, AS | 1 |
| Brémont, S; Courvalin, P; Damier-Piolle, L; Lambert, T; Magnet, S | 1 |
| Danese, P; DeVito, J; Franceschi, F; Lawrence, L; Sutcliffe, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Achard, A; Guérin-Faublée, V; Leclercq, R; Pichereau, V; Villers, C | 1 |
| Apajalahti, J; Fox, J; Frimodt-Møller, N; Hansen, F; Loidl, G; Nagai, J; Siikanen, O; Takano, M; Vaara, M; Vaara, T | 1 |
| Crabb, DM; Duffy, LB; Waites, KB | 1 |
| Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
| Bohnert, JA; Fähnrich, E; Kern, WV; Schuster, S; Wehmeier, C | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Jiang, LJ; Or, YS; Wang, M | 1 |
| Blackman Northwood, J; Coley, MD; Cossins, LR; Creti, R; Del Grosso, M; Farrell, DJ; Pantosti, A | 1 |
| Beeton, ML; Chalker, VJ; Kotecha, S; Maxwell, NC; Spiller, OB | 1 |
| Li, W; Liu, Y; Wang, M; Xu, X; Ye, X; Zhang, H; Zhu, D | 2 |
| Chen, X; Han, X; Hou, A; Li, G; Li, J; Ma, S; Mi, Z; Qin, L; Shi, D; Wei, T; Xin, D | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Kamal, N; Shafer, WM | 1 |
| Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, KM; McGhee, P; Nagai, K | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
| Cai, L; Gilbert, GL; Kong, F; Oftadeh, S; Xiao, M; Xu, X; Zhou, F | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Shakya, T; Wright, GD | 1 |
| Liu, Y; Sun, FJ; Wang, Q; Xia, PY; Xie, LL; Xiong, LR | 1 |
| Eshaghurshan, CS; Grinwis, ME; Parkins, MD; Rabin, HR; Sibley, CD; Surette, MG | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Cao, J; Ju, Y; Ma, R; Ma, S; Xian, R; Zhang, L | 1 |
| Gunell, M; Hakanen, AJ; Huovinen, P; Jalava, J; Kotilainen, P; Siitonen, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Guo, H; He, X; Hu, H; Hu, X; Lu, Y; Luo, M; Pan, Y; Qiu, G; Wu, Z; Xiao, Y; Yang, J; Zhou, D | 1 |
| Chisholm, SA; Dave, J; Ison, CA | 1 |
| Bohnert, JA; Karamian, B; Nikaido, H | 1 |
| Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Baldelli, R; Cevenini, R; D'Antuono, A; Delucca, F; Di Francesco, A; Donati, M; Moroni, A; Shurdhi, A | 1 |
| Allen, VG; Farrell, DJ; Lo, S; Low, DE; Melano, RG; Perusini, SJ; Rebbapragada, A; Tan, J; Tijet, N; Towns, L | 1 |
| Cui, W; Jiao, B; Ju, Y; Liu, L; Ma, C; Ma, R; Ma, S; Ma, X; Meng, Y; Qi, Y; Shen, X; Wang, H; Zhang, L; Zheng, M | 1 |
| Boothroyd, JC; Choi, JY; Fu, H; Harvey, C; Khosla, C; Lee, Y; Ravindran, S; Roush, WR | 1 |
| Cao, J; Cong, C; Hu, Y; Li, X; Liu, C; Ma, S; Wang, H | 1 |
| Cao, J; Fang, Y; Liu, C; Ma, S; Ma, X; Wang, J; Wang, R; Zhang, L | 1 |
| Bhateja, P; Chakrabarti, A; Das, B; Dullu, J; Hajare, AK; Jadhav, JS; Kumar, R; Pandya, M; Ramkumar, G; Rathy, S; Surase, YB; Venkataramanan, R | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Li, X; Ma, S; Wang, Y; Yan, M | 1 |
| Chai, X; Hu, H; Meng, Q; Wang, B; Wu, Q; Yu, S; Zhang, L; Zhao, Q; Zou, Y | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Gan, M; Guan, Y; Hu, X; Shang, X; Tan, Y; Wang, Y; Wu, C; Xiao, C; Yang, Z; You, X; Zhou, H | 1 |
| Beaumont, K; Di, L; Maurer, TS; Smith, DA | 1 |
| Di Giorgio, A; Duca, M; Tran, TP; Vo, DD | 1 |
| Calderón, F; Fernández-Álvaro, E; Hong, WD; Nixon, GL; O'Neill, PM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Silver, LL | 1 |
| Barreca, ML; Cannalire, R; Cecchetti, V; Couto, I; Felicetti, T; Machado, D; Manfroni, G; Massari, S; Sabatini, S; Santos Costa, S; Tabarrini, O; Viveiros, M | 1 |
| Blanco, MJ; Edmondson, Q; Furukawa, A; Handford, MJ; Hewitt, WM; Kelly, CN; Klein, VG; Lokey, RS; Ly, AM; Naylor, MR; Noland, RP; Pye, CR; Ramos, DP; Schwochert, J; Townsend, CE; Turmon, AC | 1 |
| Batta, G; Bychkova, EN; Erdei, R; Isakova, EB; Korolev, AM; Mirchink, EP; Osterman, IA; Szücs, Z; Tevyashova, AN | 1 |
| Andrade, RB; Buttaro, B; Daher, SS; Freundlich, JS; Jin, X; Patel, J | 1 |
| Bertrand, D; Fernandes, P; Pereira, D; Watkins, PB | 1 |
| Engel, JN | 1 |
| Friedel, HA; McTavish, D; Peters, DH | 1 |
| Farmer, S; Hancock, RE; Li, ZS | 1 |
| Neu, HC | 2 |
| Danziger, LH; Piscitelli, SC; Rodvold, KA | 1 |
| Johnson, RC; Luger, SW; Massarotti, EM; Messner, RP; Rahn, DW; Steere, AC; Wong, JB | 1 |
| Araujo, FG; Lin, T; Remington, JS | 1 |
| Kirchner, JT | 1 |
| McDonald, PJ; Pruul, H | 3 |
| Brown, BA; De Rosas, V; Onyi, GO; Wallace, RJ | 1 |
| Cvrlje, M; Dokić, S; Kobrehel, G; Kolacny-Babić, L; Kucisec-Iepes, N; Lazarevski, G | 1 |
| Baquero, F; Landínez, R; Liñares, J; Loza, E; Martín, R; Martínez-Beltrán, J | 1 |
| Gaydos, CA; Quinn, TC; Welsh, LE | 1 |
| Bahal, N; Nahata, MC | 1 |
| Drew, RH; Gallis, HA | 1 |
| Davila, D; Djokić, S; Kolacny-Babić, L; Tambić, T | 1 |
| Havlichek, DH; Stein, GE | 1 |
| Tunkel, AR; Whitman, MS | 1 |
| Biollaz, J; Chatton, JY; Chave, JP; Dayer, P; Glauser, MP; Munafo, A | 1 |
| Almadany, R; Chau, F; Derouin, F; Pocidalo, JJ; Rouveix, B | 1 |
| Azoulay-Dupuis, E; Bergogne-Bérézin, E; Pocidalo, JJ; Vallée, E | 1 |
| Asin, HR; Branger, T; Hoepelman, AI; Ligtvoet, E; Mertens, JC; van Barneveld, PW; Visser, MR | 1 |
| Hammerschlag, MR; Qumei, KK; Roblin, PM | 1 |
| Hedderich, J; Heim, P; Paulsen, P; Peters, O; Simon, C | 1 |
| Dalu, ZA; Hopkins, SJ; Johnson, RB; Jones, RB; Martin, DH; McCarty, J; Mroczkowski, TF | 1 |
| Stott, GA | 1 |
| Baillet, J; Bruaire, JP; Cohen, G; Ducroix, JP; Eb, F; Orfila, J; Smail, A | 1 |
| Gingras, BA; Jensen, JB | 2 |
| Chin, NX; Gu, JW; Neu, HC | 1 |
| Laufen, H; Riedel, KD; Wildfeuer, A; Zimmermann, T | 1 |
| Alaluusua, S; Asikainen, S; Jousimies-Somer, H; Pajukanta, R; Saarela, M | 1 |
| Bonnet, M; Van der Auwera, P | 2 |
| Cynamon, MH; Klemens, SP | 1 |
| Amsden, GW; Ballow, CH | 1 |
| Peltier, K | 1 |
| Molinari, G; Paglia, P; Schito, GC | 1 |
| de Vries, A; Nawrocki, RP; Ossewaarde, JM; Plantema, FH; Rieffe, M; van Loon, AM | 1 |
| Anestad, G; Halsos, A; Hansen, E; Johansen, A; Moseng, D; Nilsen, A; Størvold, G; Tørud, E | 1 |
| Chrysos, G; Fraser, HY; Hardie, JM; Maskell, JP; Sefton, AM; Shain, H; Williams, JD | 1 |
| Furuya, N; Goto, S; Hirakata, Y; Ohno, A; Tateda, K; Yamaguchi, K | 1 |
| Herbert, CM; Jones, AB | 1 |
| Carper, HT; Frank, MO; Mandell, GL; Sullivan, GW | 1 |
| Kunz, S; O'Reilly, T; Sande, E; Sande, MA; Täuber, MG; Zak, O | 1 |
| Bergan, T; Jørgensen, NP; Olszewski, W; Zhang, Y | 1 |
| Cioce, C; Facchini, M; Pestalozza, G | 1 |
| Lode, H; Schaberg, T | 1 |
| Cimperman, J; Ruzic, E; Strle, F | 1 |
| Chiodo, F; Jannuzzi, C; Longo, L; Manfredi, R; Mantero, E; Pavesio, D; Pecco, P; Schiavone, R; Tempesta, A | 1 |
| Adam, D | 1 |
| Currie, B; Farthing, C; Rendel, M; Seidlin, M | 1 |
| Rehg, JE | 1 |
| Johnson, RB | 1 |
| Araujo, FG; Huskinson-Mark, J; Remington, JS | 1 |
| Gelber, RH; Murray, LP; Siu, P; Tsang, M | 1 |
| Felmingham, D; Leakey, A; Ridgway, GL; Robbins, MJ; Sanghrajka, M | 1 |
| Balmes, P; Clerc, G; Dupont, B; Labram, C; Pariente, R; Poirier, R | 1 |
| Duthu, GS; Ferraina, RA; Mullins, MA; Shepard, RM | 1 |
| Araujo, FG; Remington, JS; Shepard, RM | 1 |
| Moellering, RC | 1 |
| Stamm, WE | 1 |
| Hooton, TM | 1 |
| Casiano, RR | 1 |
| Dark, D | 1 |
| Mallory, SB | 1 |
| Hopkins, S | 2 |
| Ballow, CH; Schentag, JJ | 1 |
| Azoulay-Dupuis, E; Bedos, JP; Muffat-Joly, M; Pocidalo, JJ; Vallée, E | 1 |
| Amacher, DE; Retsema, JA; Schomaker, SJ | 1 |
| Gikas, A; Grosset, J; Perronne, C; Pocidalo, JJ; Truffot-Pernot, C; Vilde, JL | 1 |
| Araujo, FG; Remington, JS | 1 |
| Davila, D; Kolacny-Babić, L; Plavsić, F | 1 |
| Chang, N; Taylor, DE | 1 |
| Barry, AL; Fuchs, PC | 2 |
| Lode, H | 1 |
| Williams, JD | 1 |
| Pechère, JC | 2 |
| Brennan, LA; Girard, AE; Retsema, JA | 1 |
| Brennan, LA; Cimochowski, CR; Faiella, JA; Girard, AE; Retsema, JA | 1 |
| Antrobus, JH; Coates, P; Daniel, R; Houston, AC; Taylor, T | 1 |
| Chan, KH; Foulds, G; Johnson, JT; Johnson, RB; Shepard, RM | 1 |
| Karma, P; Penttilä, M; Pukander, J | 1 |
| De Souza, A; Jones, JA; Morgan, WE; Morris, DL | 1 |
| Harrison, JD; Jones, JA; Morris, DL | 1 |
| Krohn, K | 1 |
| Kinasewitz, G; Wood, RG | 1 |
| Car, V; Gunjaca, M; Majerus-Misic, L; Petricevic, I; Schönwald, S; Skerk, V | 1 |
| Kiani, R | 1 |
| Armstrong, D; Brown, IN; Brown, S; Dale, JW; Edwards, FF; Felder, MS; Ollar, RA | 1 |
| Taylor-Robinson, D; Tuffrey, M; Woods, C | 1 |
| Bermudez, LE; Inderlied, C; Young, LS | 1 |
| Kirst, HA | 1 |
| Bolan, R; Inderlied, CB; Kolonoski, P; Wiviott, L; Wu, M; Young, LS | 1 |
| Cox, C; Foulds, G; Johnson, R; Madsen, P; Shepard, R | 1 |
| Foulds, G; Gerber, N; Henry, EB; Hilligoss, DM | 1 |
| Edelstein, MA; Edelstein, PH | 1 |
| Navashin, SM; Nikitin, AV | 1 |
| Capobianco, JO; Goldman, RC | 2 |
| Børsum, T; Dannevig, L; Melby, K; Størvold, G | 1 |
| Aragón, J; López-López, G; Pascual, A; Perea, EJ | 1 |
| Andrews, JM; Ashby, JP; Baldwin, DR; Honeybourne, D; Wise, R | 1 |
| Bébéar, C; Renaudin, H | 1 |
| Debbia, EA; Molinari, G; Paglia, P; Schito, GC | 1 |
| Gorby, GL; McGee, ZA | 1 |
| Burette, A; Glupczynski, Y | 1 |
| Milatovic, D | 1 |
| Brunham, R; Chubb, H; Ronald, A; Slaney, L | 1 |
| Baskerville, A; Featherstone, AS; Fitzgeorge, RB | 1 |
| Johnson, RB; Olafsson, JH; Ryan, RW; Steingrimsson, O; Thorarinsson, H; Tilton, RC | 1 |
| Parrish, EA; Stamm, LV | 1 |
| Lassus, A | 1 |
| Car, V; Gosev, M; Gunjaca, M; Kolacny-Babić, L; Schönwald, S | 1 |
| Acar, JF; Goldstein, FW; Kitzis, MD; Miégi, M | 1 |
| Maskell, JP; Sefton, AM; Williams, JD | 1 |
| Acar, JF; Coutrot, A; Emirian, MF; Goldstein, FW | 1 |
| Metchock, B | 1 |
| Girard, D; Johnson, RC; Kodner, C; Russell, M | 1 |
| Fiese, EF; Steffen, SH | 1 |
| Falkner, FC; Shepard, RM | 1 |
| Girard, AE; Girard, D; Retsema, JA | 1 |
| Bianchi, A; Chappey, B; Pérol, Y; Scieux, C; Vassias, I | 1 |
| Foulds, G; Johnson, RB; Shepard, RM | 1 |
| Girard, AE; Girard, D; Milisen, WB; Retsema, JA | 1 |
| Baker-Zander, SA; Fohn, MJ; Lukehart, SA | 1 |
| Doran, CC; Fesik, SW; Goldman, RC | 1 |
| Chastang, C; Derouin, F | 1 |
| Bollet, C; de Micco, P; Gevaudan, MJ; Gulian, G; Mallet, MN; Tissot-Dupont, H | 1 |
| Briffod, J; Brion, JP; Le Noc, P; Micoud, M; Sedallian, A | 1 |
| Gladue, RP; Snider, ME | 1 |
| Lach, P; Laufen, H; Wildfeuer, A | 1 |
| Andrews, JM; Cooper, MA; Nye, K; Wise, R | 1 |
| Anderson, M; Borovoy, R; Brennan, L; Bright, G; Girard, A; Manousos, M; Mason, R; Retsema, J; Schelkly, W | 1 |
| Inderlied, CB; Kolonoski, PT; Wu, M; Young, LS | 1 |
| Bright, GM; Gladue, RP; Isaacson, RE; Newborg, MF | 1 |
| Wise, R | 1 |
| Davies, BI; Gubbelmans, R; Maesen, FP | 1 |
| Ravdin, JI; Skilogiannis, J | 1 |
| Barry, AL; Gavan, TL; Thornsberry, C | 1 |
| Gross, B; Preac-Mursic, V; Schierz, G; Süss, E; Wilske, B | 1 |
| Eichhorn, A; Hoppe, JE | 1 |
| Haferkamp, O; Laufen, H; Müller-Wening, D; Wildfeuer, A | 1 |
| Cimochowski, CR; English, AR; Faiella, JA; Girard, AE; Girard, D; Gootz, TD; Haskell, SL; Retsema, JA | 1 |
| Chang, HR; Pechère, JC | 1 |
| Dunkin, KT; Howard, AJ; Jones, S | 1 |
| Barry, AL; Jones, RN; Thornsberry, C | 1 |
| Araujo, FG; Guptill, DR; Remington, JS | 1 |
| Crokaert, F; Glupczynski, Y; Lismont, MJ; van der Linden, MP; Yourassowsky, E | 1 |
| Hallander, HO; Rylander, M | 1 |
| Chan, KH; Doyle, WJ; Kardatzke, DR; Swarts, JD; Tanpowpong, K | 1 |
| Chin, NX; Labthavikul, P; Neu, HC; Saha, G | 1 |
| Carević, O; Djokić, S | 1 |
| Bermudez, LE; Young, LS | 1 |
| Barry, AL; Jones, RN | 1 |
| Felmingham, D; Jones, K; Ridgway, G | 1 |
| Aronoff, SC; Jacobs, MR; Laurent, C | 1 |
| Kappus, EW; Quinn, TC; Walsh, M | 1 |
| Abruzzo, GK; Bartizal, K; Flattery, AM; Gill, CJ; Jackson, J; Kong, L; Kropp, H; Shankaran, K; Smith, JG; Wilkening, R | 1 |
| Hahn, DL | 1 |
| Mouton, RP; Sloos, JH; Van Asselt, GJ; Van Boven, CP; Van de Klundert, JA | 1 |
| Cavallo, JD; Chevalier, B; Crenn, Y; Meyran, M; Plotton, N | 1 |
| Blussé van Oud Alblas, A; Boekhout, M; Bohte, R; Hermans, J; Lobatto, S; Nauta, EH; van den Broek, PJ; van't Wout, JW | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 2 |
| Delia, S; Iona, E; Mascellino, MT; Mastroianni, CM; Ponzo, R | 1 |
| Amacher, DE; Ellis, JH; Holden, HE; Joyce, AJ; Muehlbauer, PA; Ray, VA; Turner, GN; Wahrenburg, MG | 1 |
| Raulston, JE | 1 |
| Hirakata, Y; Ishii, Y; Matsumoto, T; Ohno, A; Tateda, K; Yamaguchi, K | 1 |
| Gemmell, CG; Ramadan, MA; Shibl, AM; Tawfik, AF | 1 |
| Champney, WS; Chittum, HS | 1 |
| Dmitrieva, LA; Filatova, NA; Kalinin, AI; Kuznetsov, EA; Tsarev, VN | 1 |
| Jacques-Palaz, K; Murray, BE; Rakita, RM | 1 |
| Beauchamp, D; Blais, J; Chamberland, S | 1 |
| Katosova, LK; Sereda, EV; Tatochenko, VK | 1 |
| Mashkilleĭson, AL | 1 |
| Goodman, NL; McCraney, SA; Rapp, RP; Shaddick, DJ | 1 |
| Doern, GV; Erwin, ME; Gerlach, EH; Hindler, J; Jones, RN | 1 |
| Idänpään-Heikkilä, JJ; Mattila, MJ; Vanakoski, J | 1 |
| Bush, MR; Rosa, C | 1 |
| Dorrell, L; Fulton, B; Ong, EL | 1 |
| Irifune, K; Ishida, K; Kaku, M; Mizukane, R; Suyama, N; Takemura, H; Tanaka, H; Tomono, K; Usui, T; Yoshida, R | 1 |
| Asmolovskiĭ, VM; Kuleshov, SE; Strachunskiĭ, LS; Tikhonov, VG | 1 |
| Kiseleva, NM; Shubin, SV; Soldatova, SI; Zgababova, ER | 1 |
| Brettle, RP; Leen, CL; Wynn, RF | 1 |
| Arullendran, P; Bailey, RL; Mabey, DC; Whittle, HC | 1 |
| Kosunen, TU; Rautelin, H; Renkonen, OV | 1 |
| Bustos, R; Herrera, N; Marinkovic, K; Prado, V; Romero, J | 1 |
| Edelstein, MA; Edelstein, PH; Stamler, DA | 1 |
| Furuya, N; Hirakata, Y; Ishida, K; Ishii, Y; Kaku, M; Koga, H; Kohno, S; Mizukane, R; Yamaguchi, K | 1 |
| Blais, J; Chamberland, S; Garneau, V | 1 |
| Barbour, AG; Dever, LL; Jorgensen, JH | 1 |
| Fass, RJ | 1 |
| Donowitz, GR; Earnhardt, KI | 1 |
| Holdcroft, C | 1 |
| Appelbaum, PC; Spangler, SK | 1 |
| Choong, J; Davis, CH; Knight, ST; Wyrick, PB | 1 |
| Fouda, HG; Gadgil, SD; Gardner, MJ; Hilligoss, DM; Koranyi, KI; Nahata, MC | 1 |
| Vaara, M | 1 |
| Carnimeo, NS; Foschino, MP; Miragliotta, G; Morandini, G; Perduca, M; Zannini, G | 1 |
| Armstrong, D; Bernard, EM; Brown, ST; Edwards, FF; Tong, W | 1 |
| Butler, T; Girard, AE | 1 |
| Hammerschlag, MR | 2 |
| Laufen, H; Reisert, I; Wildfeuer, A | 1 |
| Cameron, DJ | 1 |
| Eliopoulos, GM; Ferraro, MJ; Malanoski, GJ; Moellering, RC | 1 |
| Aras, Z; Brown, PR; Dumornay, W; Gelling, M; Golden, NH; Hammerschlag, MR; Neuhoff, S; Oh, MK; Roblin, PM; Sturdevant, M | 1 |
| Barth, GD; Melski, JW; Mitchell, PD; Reed, KD | 1 |
| Ikerd, TR; Koletar, SL | 1 |
| Gordillo, ME; Murray, BE; Singh, KV | 1 |
| Pichichero, ME; Rodewald, LE | 1 |
| Flynn, PM; Hughes, WT; Pui, CH; Santana, VM; Shenep, JL; Vargas, SL | 1 |
| Ellis, W; Fayer, R | 1 |
| Guzmán, CA; Molinari, G; Pesce, A; Schito, GC | 1 |
| Mansoor, GA; Ornt, DB; Panner, BJ | 1 |
| Desbos, A; Guillaumond, B; Harf, R; Leclercq, M; Panteix, G; Perrin-Fayolle, M; Sapin, V | 1 |
| Martin, A; Milgram, E; Pérez-Gutiérrez, F; Prosperi, J; Rodriguez-Solares, A | 1 |
| Chisari, G; Gismondo, MR; Lo Bue, AM; Nicoletti, G; Sammartino, R | 1 |
| Aguirre-Avalos, G; Amaya-Tapia, G; Andrade-Villanueva, J; Esparza-Ahumada, S; Morfín-Otero, R; Peredo-González, G; Rodríguez-Noriega, E | 1 |
| Müller, O | 1 |
| Hoepelman, AI; Neve, AJ; Rozenberg-Arska, M; Sips, AP; van Barneveld, PW; van Helmond, JL; Verhoef, J; Zwinkels, M | 1 |
| Bradbury, F | 1 |
| Myburgh, J; Nagel, GJ; Petschel, E | 1 |
| Bergeron, JM; Girard, D; Milisen, WB; Retsema, JA | 1 |
| Baskerville, A; Fitzgeorge, RB; Lever, S | 1 |
| Happonen, HP; Lauharanta, J; Mustonen, MT; Saarinen, K | 1 |
| Balechandran, T; Lister, PJ; Ridgway, GL; Robinson, AJ | 1 |
| Waugh, MA | 1 |
| Cimochowski, CR; Faiella, JA; Girard, AE | 1 |
| Foulds, G; Johnson, RB | 1 |
| Bergeron, JM; Girard, AE; Girard, D; Milisen, WB; Retsema, JA | 1 |
| Laufen, H; Leitold, M; Wildfeuer, A; Zimmermann, T | 1 |
| Carlà, V; Crispo, A; Fallani, S; Mazzei, T; Novelli, A; Periti, P; Surrenti, C; Surrenti, E | 1 |
| Daniel, RR | 1 |
| el Hoshy, Z; Mohs, E; Rivas, E; Rodriguez-Solares, A | 1 |
| Schaad, UB | 1 |
| Hamill, J | 1 |
| Weippl, G | 1 |
| Cevenini, R; Morandotti, G; Rumpianesi, F; Satta, G; Sperning, R | 1 |
| Dokić, S; Kelnerić, Z; Kobrehel, G; Lazarevski, G | 1 |
| Cluzel, R; Philippon, A; Soussy, CJ | 1 |
| Lagrange, PH | 1 |
| Pocidalo, JJ; Veber, B | 1 |
| Bistoni, F; Campanelli, C; Mosci, P; Orefici, G; Tissi, L; von Hunolstein, C | 1 |
| Gomberg, MA; Kutin, SA; Mashkilleyson, AL; Mashkilleyson, N | 1 |
| Laufen, H; Leitold, M; Scharpf, F; Wildfeuer, A; Yeates, RA; Zimmermann, T | 1 |
| Lagrange, PH; Pépin, LF; Reinert, P; Ripoll, L | 1 |
| Abeck, D; Ballard, RC | 1 |
| Gaydos, C; Quinn, TC; Welsh, L | 1 |
| Barrett, MS; Jones, RN; Mehaffey, PC; Putnam, SD | 1 |
| Cellesi, C; Chigiotti, S; Corbisiero, R; Mencarelli, M; Rossolini, GM; Zanchi, A | 1 |
| Appelbaum, PC; Ednie, LM; Jacobs, MR; Visalli, MA | 1 |
| Massa, M; Sutcliffe, J; Wondrack, L; Yang, BV | 1 |
| Fujita, J; Hojo, S; Kawanishi, K; Negayama, K; Takahara, J; Xu, G; Yamaji, Y; Yuube, K | 1 |
| Tuominen, RK; Vainio, PJ; Viluksela, M | 1 |
| Furuya, N; Ishii, Y; Matsumoto, T; Matsunaga, T; Miyazaki, S; Nagashima, M; Ohno, A; Tateda, K; Yamaguchi, K | 1 |
| Citron, DM; Claros, MC; Goldstein, EJ; Hunt Gerardo, S | 1 |
| Abdel-Rahman, SM; Nahata, MC; Wintermeyer, SM | 1 |
| Kapell, K; Meyer, P; Segreti, J | 1 |
| Fomina, IP; Iudin, SM; Smirnova, LB | 1 |
| Anderson, R; Feldman, C; Theron, AJ | 1 |
| Branley, J; Gottlieb, T; Wolfson, C | 1 |
| Berg-Candolfi, M; Candolfi, E | 1 |
| Fietta, A; Gialdroni Grassi, G; Merlini, C | 1 |
| Klein, JO | 1 |
| McCracken, GH | 1 |
| Tarlow, MJ | 1 |
| Currie, BJ; Gratten, M; Laming, AC; Leach, AJ; Mathews, JD; Mayo, M; Shelby-James, TM | 1 |
| Gossens, MM; Kimpen, JL; Roord, JJ; Wolf, BH | 1 |
| Andrews, JM; Boswell, F; Brenwald, NP; Wise, R | 1 |
| Sugihara, E | 1 |
| McMillan, A; Moyes, A; Young, H | 1 |
| Hoppe, JE; Tschirner, T | 1 |
| Handsfield, HH | 1 |
| Barry, AL; Brown, SD; Fuchs, PC | 3 |
| Brandt, CM; Miro, JM; Patel, R; Rouse, MS; Steckelberg, JM; Wilson, WR | 1 |
| Appelbaum, PC; Jacobs, MR; Visalli, MA | 2 |
| Appelbaum, PC; Ednie, LM; Jacobs, MR | 2 |
| Hammerschlag, MR; Kutlin, A; Roblin, PM | 1 |
| Chen, C; Danziger, LH; Martin, SJ; Pendland, SL; Schreckenberger, PC | 1 |
| Chekhova, NO; Dmitrieva, LA; Filatova, NA; Romanov, AE; Tsarev, VN | 1 |
| Iino, S; Iwasawa, H; Nakashio, S; Shimada, J | 1 |
| Freidank, H | 1 |
| Laufen, H; Schumacher, T; Yeates, RA; Zimmermann, T | 1 |
| Sadovnikova, SF; Selina, EV | 1 |
| Adair, CD; Ernest, JM; Gunter, M; McElroy, G; Stovall, TG; Veille, JC | 1 |
| den Hollander, JG; Espersen, F; Frimodt-Møller, N; Fuursted, K; Knudsen, JD; Mouton, JW; Verbrugh, HA | 1 |
| Arnold, B; Stout, JE; Yu, VL | 1 |
| Giger, O; Mortensen, JE; Rodgers, GL | 1 |
| Bryskier, A; Hoppe, JE | 1 |
| Campa, M; Favini, P; Malizia, T; Marchetti, F; Pizzarelli, G; Senesi, S; Tejada, M | 1 |
| Bouvier d'Yvoire, MJ; Dresco, IA; Tulkens, PM | 1 |
| Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV | 1 |
| Appelbaum, PC; Jacobs, MR; Lin, G; Spangler, SK | 1 |
| Inoue, K; Matsuo, H; Sakamoto, Y; Sakata, K; Shibazaki, M; Tanaka, K | 1 |
| Kobayashi, H; Kobayashi, O; Ota, M; Watanabe, H | 1 |
| Hammerschlag, MR; Roblin, PM | 1 |
| Ali, Y; Lopez, G; Ruggeirio, RM; Shahem, S; Wehbeh, HA | 1 |
| Barg, N | 1 |
| Counihan, M; Duan, SX; Durol, AL; Graf, JA; Greenblatt, DJ; Harmatz, JS; Mertzanis, P; Shader, RI; von Moltke, LL; Wright, CE | 1 |
| Katosova, LK; Platonova, MM; Sereda, EV | 1 |
| Campbell, M; Cassell, GH; Hammerschlag, MR; Harris, JA; Kolokathis, A | 1 |
| Burdine, R; Champney, WS | 1 |
| Berry, V; Knott, SJ; Thorburn, CE; Woodnutt, G | 1 |
| Agouridas, C; Denis, A | 1 |
| Esposito, S; Principi, N | 1 |
| Abramo, T; Ahmed, A; Carubelli, C; Leinonen, M; McCoig, C; McCracken, GH; Muniz, L; Trujillo, M; Wubbel, L | 1 |
| Brasseur, R; Mingeot-Leclercq, MP; Montenez, JP; Piret, J; Tulkens, PM; Van Bambeke, F | 1 |
| Sefton, AM | 1 |
| Calderaro, F; Califano, C; Cazzola, M; Centanni, S; Di Perna, F; Salzillo, A; Vinciguerra, A | 1 |
| Alvarez-Elcoro, S; Enzler, MJ | 1 |
| Hill, SL; Johnson, MM; Piddock, LJ | 1 |
| Appelbaum, PC; Credito, KL; Ednie, LM; Jacobs, MR | 1 |
| Blumenschein, K; Howard, KB; Rapp, RP | 1 |
| Cizman, M; Orazem, A; Paragi, M; Pokorn, M; Seme, K | 1 |
| Moore, PA | 1 |
| Furuta, T; Yoshida, H | 1 |
| Frimpong, EK; Honda, T; Voravuthikunchai, SP; Yoh, M | 1 |
| Debbia, EA | 1 |
| Carnuccio, R; D'Acquisto, F; Di Rosa, M; Ialenti, A; Ianaro, A; Iuvone, T; Maffia, P; Rombolà, L; Sautebin, L | 1 |
| Puri, SK; Singh, N | 1 |
| Potts, JM; Rackley, RR; Ward, AM | 1 |
| Goss, TF; Najib, MM; Stein, GE | 1 |
| Donders, GG | 1 |
| Bates, J; File, TM; Grayston, JT; Indorf, A; Phillips, J; Sarosi, GA; Summersgill, J; Tan, J; Vergis, EN; YU, VL | 1 |
| Ekblad, U; Heikkinen, T; Laine, K; Neuvonen, PJ | 1 |
| Westphal, JF | 1 |
| See, S | 1 |
| Castaño, E; Castrejón, MM; de Atencio, I; de Morales, I; McCracken, GH; Muñiz, L; Olsen, K; Sáez-Llorens, X; Vallarino, D; Wubbel, L | 1 |
| Borthagaray, G; Lee, EH; Shafer, WM; Veal, W; Zarantonelli, L | 1 |
| Dan, M; Rosenberg, S; Samra, Z; Soffer, Y | 1 |
| Hasegawa, T; Iinuma, Y; Kawamura-Sato, K; Ohta, M; Yamashino, T | 1 |
| Almer, L; Beyer, J; Bui, MH; Flamm, RK; Hensey-Rudloff, D; Ma, Z; Nilius, AM; Or, YS | 1 |
| Courtoy, PJ; Leys, K; Mingeot-Leclercq, MP; Tulkens, PM; Tyteca, D; Van Bambeke, F; Van Der Smissen, P | 1 |
| Bouvet, A; Broc, V; Merad, B; Rostane, H; Schlegel, L | 1 |
| Adali, MK; Karasalihoglu, AR; Koten, M; Uzun, C; Yagiz, R; Yorulmaz, F | 1 |
| Rubinstein, E | 1 |
| Appelbaum, PC; Bryskier, A; Davies, TA; Ednie, LM; Jacobs, MR; Nagai, K; Palavecino, E | 1 |
| Gaillat, J | 1 |
| Andrasevic, AT; Appelbaum, PC; Davies, TA; Drukalska, L; Hoellman, DB; Hryniewicz, W; Hupkova, H; Jacobs, MR; Kelly, LM; Kolman, J; Miciuleviciene, J; Nagai, K; Pana, M; Setchanova, L; Thege, MK; Trupl, J; Urbaskova, P | 1 |
| Rollins, G | 1 |
| Ishii, Y; Kobayashi, T; Matsumoto, T; Miyazaki, S; Tateda, K; Yamaguchi, K | 1 |
| Armbruster, C; Daxecker, H; El-Menyawi, I; Griesmacher, A; Müller, MM; Raab, M; Robibaro, B; Vorbach, H | 1 |
| Gaylor, AS; Reilly, JC | 1 |
| Faulkner, S; Harness, JA; Muirhead, GJ; Taubel, J | 1 |
| Bathgate, T; King, A; Phillips, I | 1 |
| Champney, WS; Miller, M | 1 |
| Danziger, LH; Jung, R; Pendland, SL | 1 |
| de Cienfuegos, GA; Escobar, M; Ortega, E | 1 |
| Anatoliotaki, M; Anatoliotakis, N; Apostolakou, H; Kontoyiannis, DP; Maraki, S; Margioris, AN; Samonis, G; Tselentis, Y | 1 |
| Blondeau, JM | 1 |
| Sugiyama, Y | 1 |
| Bryden, L; Liu, G; Martin, I; Ng, LK | 1 |
| Leclercq, R; Malbruny, B; Picard, B; Prunier, AL; Tandé, D | 1 |
| Kanai, H; Maizumi, N; Tamura, Y; Tsutsui, T | 1 |
| Kim, MK; Nicolau, DP; Nightingale, CH; Tessier, PR; Xuan, D; Ye, M; Zhou, W | 1 |
| Biertz, J; Breithardt, G; Bruns, HJ; Eckardt, L; Fabritz, L; Fleischer, D; Haverkamp, W; Kirchhof, P; Milberg, P; Ramtin, S; Reinsch, N | 1 |
| Srugo, I; Steinberg, JM | 1 |
| Forrest, A; Gudgel, LD; Niederman, MS; Paladino, JA | 1 |
| Amsden, GW; Hauben, M | 1 |
| Eiros, JM; Mayo, A; Pastor, E | 1 |
| Bennish, ML; Bogaerts, J; Khan, WA; Rahman, A; Saha, D; Salam, MA | 1 |
| Castro-Rodriguez, JA; Girardi, G; Kogan, R; Martínez, MA; Payá, E; Puppo, H; Quevedo, I; Rubilar, L | 1 |
| Cabria, F; Esteban, J; Fernández-Roblas, R; Gadea, I; Rollan, E; Santos-O'Connor, FG; Soriano, F; Torres, MV | 1 |
| Al-Belasy, FA; Hairam, AR | 1 |
| Katouno, Y; Kobayashi, Y; Sugita, K; Uchida, H | 1 |
| Bartels, H; Franceschi, F; Hansen, HA; Harms, JM; Schlünzen, F; Yonath, A; Zarivach, R | 1 |
| Abe, S; Inoue, S; Nakamura, H; Otake, K; Sada, M; Takeda, H | 1 |
| Castaldo, RS; Celli, BR; Gomez, F; Hanrahan, JP; LaVallee, N; Souhrada, J | 1 |
| Hockman, M; Huebner, RE; Klugman, KP; Wasas, AD | 1 |
| Ito, K; Itoh, T; Kanamitsu, S; Ogihara, K | 1 |
| Bidet, P; Bingen, E; Brahimi, N; Deforche, D; Doit, C; Geslin, P; Loukil, C | 1 |
| Bhattacharya, MK; Bhattacharya, SK; Dutta, D; Ramamurthy, T; Sarkar, D; Singharoy, A | 1 |
| Schöni, MH | 1 |
| Amundson, DE; Conlin, AM; Crum, NF; Earhart, KC; Gray, GC; Lamb, CR; Olson, PE; Robinson, TJ; Ryan, MA; Wallace, MR | 1 |
| Fujiki, Y; Iyobe, S; Okubo, T; Sagai, H | 1 |
| Aizawa, H; Hirota, N; Kido, Y; Koyanagi, T; Nagafuchi, M; Niizeki, T; Ono, N; Rikimaru, T; Sugihara, E; Yamada, K | 1 |
| Ghahramani, P; Kleinermans, D; Layton, G; Nichols, D; Purkins, L; Wood, N | 1 |
| Inoue, K; Kumakura, S; Tsutsui, T; Uchida, M | 1 |
| Abu-Elyazeed, R; Clemens, JD; El-Gendy, A; Frenck, RW; Pittner, BT; Putnam, SD; Rao, MR; Riddle, MS; Savarino, SJ; Taha, NN; Wierzba, TF | 1 |
| Algarra, I; Alvarez De Cienfuegos, G; Escobar, MA; Gaforio, JJ; Ortega, E | 1 |
| Baysallar, M; Doğanci, L; Gür, D; Senses, Z | 1 |
| Asakura, E; Baba, K; Hasegawa, T; Kitaichi, K; Nadai, M; Sugie, M; Takagi, K; Torita, S; Zhao, YL | 1 |
| Bromhead, C; Brown, S; Lawton, B; MacDonald, J; Rose, S; Shepherd, J | 1 |
| Gregory, AR; Laubach, H; Schatz, S | 1 |
| Buxbaum, A; Gattringer, R; Georgopoulos, A; Graninger, W; Lagler, H; Sauermann, R; Stich, K | 1 |
| Feldman, SR; Fleischer, AB; McCarty, MA; McHugh, RC; Osborne, BE; Rice, A; Rohrback, JM; Sangha, ND; Utterback, R | 1 |
| Appelbaum, PC; Bozdogan, B; Clark, CL; Credito, KL; Ednie, LM; Jacobs, MR; Kelly, LM; Kosowska, K; Lin, G; Matic, V; McGhee, P; Pankuch, GA; Smith, K | 1 |
| Appelbaum, PC; Clark, C; Credito, K; Dewasse, B; Hoellman, D; Jacobs, MR; Kosowska, K; Lin, G; McGhee, P; Pankuch, GA | 1 |
| Caniça, M; Dias, R | 2 |
| Harindra, V; Mani, R; Tobin, JM | 1 |
| Amsden, GW | 1 |
| Candolfi, E; Christmann, D; Molet, B; Ranque, S | 1 |
| Altunaiji, S; Curtis, N; Kukuruzovic, R; Massie, J | 2 |
| Guchev, IA; Ivanitsa, GV; Klochkov, OI; Pervov, IuA; Rosman, SV; Shturmina, SM | 1 |
| Azuma, A | 1 |
| Asche, C; Halpern, MT; Lavin, B; Mandell, LA; Nieman, R; Sarocco, PW; Schmier, JK; Snyder, LM | 1 |
| García Vázquez, E; Marcos, MA; Martínez, JA; Mensa, J; Ortega, M; Puig, J; Torres, A | 1 |
| Armstrong, EP; Malone, DC; Ramachandran, S; Skrepnek, GH | 1 |
| Akagawa, KS; Cho, A; Harigaya, Y; Nagai, K; Nagamitsu, T; Omura, S; Otoguro, K; Sugawara, A; Sunazuka, T; Yoshida, K | 1 |
| Blaha, G; Moore, PB; Steitz, TA; Tu, D | 1 |
| Arafah, M; El-Medany, A; Mahgoub, A; Moursi, M; Mustafa, A | 1 |
| Bosnar, M; Eraković, V; Kelnerić, Z; Munić, V; Parnham, MJ | 1 |
| Fairgrieve, WT; Masada, CL; McAuley, WC; Myers, MS; Peterson, ME; Strom, MS | 1 |
| Balthazar, JT; Rouquette-Loughlin, CE; Shafer, WM | 1 |
| Burt, H; Galetin, A; Gibbons, L; Houston, JB | 1 |
| Allaouchiche, B; Benatir, F; Floccard, B; Gaillac, N; Levrat, A; Meunier, P; Ould, T | 1 |
| Boyd, D; Hoban, DJ; Mulvey, M; Wierzbowski, AK; Zhanel, GG | 1 |
| Fecik, RA; Nguyen, PL; Venkatraman, L | 1 |
| Moran, J; Murphy, TV; Tiwari, T | 1 |
| Palmer, NO | 1 |
| Bauer, HM; Baxter, R; Bolan, G; Chow, J; Guerry, S; Packel, L; Rahangdale, L; Rhew, M | 1 |
| Hsueh, PR; Shyr, JM; Wu, JJ | 1 |
| Cofré Guerra, J | 1 |
| Bébéar, C; Bébéar, CM; Charron, A; Pereyre, S; Renaudin, H | 1 |
| Gagliotti, C; Milandri, M; Moro, ML; Nobilio, L | 1 |
| Fairgrieve, WT; Masada, CL; McAuley, WC; McDowell, GC; Peterson, ME; Strom, MS | 1 |
| Amer, A; Fischer, H | 1 |
| Bos, JC; Prins, JM; Schultsz, C; Speelman, P; Vandenbroucke-Grauls, CM | 1 |
| Ji, SG; Liu, CL; Zhang, B; Zhou, P | 1 |
| Alacam, R; Colakoglu, S; Hascelik, G | 1 |
| Høgh, B; Pontoppidan, PE | 1 |
| Egawa, S; Endo, K; Hosobe, T; Kiyota, H; Kobayashi, I; Onodera, S; Suzuki, H; Takahashi, T | 1 |
| Boswinkel, M; Sloet van Oldruitenborgh-Oosterbaan, MM | 1 |
| Halling, SM; Jensen, AE | 1 |
| Dupont, LJ; Geudens, N; Schoofs, K; Smeets, S; Van Raemdonck, DE; Vanaudenaerde, BM; Verleden, GM; Wuyts, WA | 1 |
| Chhatwal, GS; Kaplan, EL; Rohde, M | 1 |
| Konthiang, P; Nakornchai, S | 1 |
| Derendorf, H; Rand, KH; Schmidt, S; Suvanakoot, U; Treyaprasert, W | 1 |
| Ito, S; Murakami, H; Nasu, R; Ohtani, H; Sawada, Y; Tsujimoto, M | 1 |
| Blasi, F; de Caprariis, PJ; Feldman, C; Garbino, J; Hoepelman, IM; Hogan, P; Tamm, M; Todisco, T | 1 |
| Giguère, S; Lee, EA; Suarez-Mier, G | 1 |
| Aoki, A; Inoue, M; Iyobe, S; Kobayashi, T; Nakada, Y; Okitsu, N; Sagai, H; Toriya, M; Yano, H | 1 |
| Adelman, MH; Chiou, CC; Klugman, KP; Lavin, B; Paladino, JA; Patel, M; Schentag, JJ; Wilton, GJ; Yu, VL | 1 |
| Athanasiou, S; Falagas, ME; Iavazzo, C; Pitsouni, E | 1 |
| Gao, S; Guo, Q; Huang, J; Liu, F; Xu, Y | 1 |
| Hjortdahl, P; Hussein, F; Kristiansen, IS; Romoren, M; Steen, TW; Sundby, J; Velauthapillai, M | 1 |
| Carberry, FJ | 1 |
| Bell, B; Dorfman, MS; Jamison, T; Stroman, DW; Wagner, RS | 1 |
| Jerse, AE; Shafer, WM; Warner, DM | 1 |
| Chen, TH; Huang, CH; Lin, LH; Lu, YJ; Shen, CM | 1 |
| Deinhard, RK; Harrell, LW; Nguyen, OT; Rhodes, LD; Roberts, MC; White, TM | 1 |
| Ara, T; Fujii, T; Imamura, Y; Tamura, A; Wang, PL | 1 |
| John, T; Shah, AA | 1 |
| Bennett, PM; Enne, VI; Keelan, P; Liu, J | 1 |
| Kang, SH; Kim, HC | 1 |
| Arbogast, PG; Cooper, WO; Dudley, JA; Dyer, SM; Gideon, PS; Hall, KS; Hernandez-Diaz, S; Kaltenbach, LA; Ray, WA | 1 |
| Allizond, V; Andreotti, S; Banche, G; Barbui, A; Carlone, NA; Cuffini, AM; Gaido, E; Li Vigni, N; Malabaila, A; Mandras, N; Roana, J; Savoia, D; Scalas, D; Tullio, V | 1 |
| Collier, B; Devasia, RA; Jones, TF; Schaffner, W | 1 |
| Horner, P | 2 |
| Alexander, RE; Grogan, DM | 1 |
| Coulter, WA; Elborn, JS; Goldsmith, CE; Maeda, Y; Mason, C; Matsuda, M; McCalmont, M; Millar, BC; Moore, JE; Rendall, J; Tazumi, A | 1 |
| Avolio, M; Camporese, A; De Rosa, R; Modolo, ML; Stano, P | 1 |
| Gomes, T; Juurlink, DN; Mamdani, MM | 1 |
| Davis, CB; Dawson, PA; Garver, E; Han, C; Haywood, J; Lan, T; Rao, A | 1 |
| Finley, R; Glass, SK; McEwen, SA; Pearl, DL | 1 |
| Salkovic-Petrisic, M; Trkulja, V; Vukelic, D | 1 |
| He, F; Jiang, R; Liu, Z; Ma, C; Ma, S; Song, H | 1 |
| Eckert, S; Keenan, JD; Rutar, T | 1 |
| Castanheira, M; Jones, RN; Woosley, LN | 1 |
| Bērziņa, D; Drukaļska, L; Gardovska, D; Miklasevics, E; Pugacova, N; Zavadska, D | 1 |
| Duncan, J; Fry, NK; George, RC; Harrison, TG; Vaghji, L | 1 |
| Tang, D; Ying, L | 1 |
| Giguère, S; Javsicas, LH; Womble, AY | 1 |
| Blaha, G; Bulkley, D; Innis, CA; Steitz, TA | 1 |
| Gomes, T; Horn, JR; Juurlink, DN; Mamdani, MM; Wright, AJ | 1 |
| Anić-Milić, T; Bogdan, M; Bosnar, M; Culić, O; Eraković Haber, V; Marjanović, N; Michielin, F; Parnham, MJ; Popović-Grle, S; Willé, DR | 1 |
| Keelan, JA; Kemp, MW; Li, S; Musk, GC; Newnham, JP; Nitsos, I; Saito, M; Timmins, M; Yaegashi, N | 1 |
| Gannon, M; Underhill, M; Wellik, KE | 1 |
| Dan, M; Rosenberg, S; Samra, Z | 1 |
| Bilonick, RA; Kowalski, RP; Ling, Y; Mah, FS; Romanowski, EG; Shanks, RM; Wingard, JB | 1 |
| Ashley, EA; Lubell, Y; Turner, P; White, NJ | 1 |
| Gao, W; Shen, AD; Yang, YH; Yao, KH; Yu, SJ; Zhou, L | 1 |
| Asahi, Y; Azakami, H; Ebisu, S; Izutani, N; Maezono, H; Noiri, Y; Yamaguchi, M; Yamamoto, R | 1 |
| Wang, CP; Xu, XL; Zeng, XH; Zhou, M; Zhou, Y | 1 |
| Walkey, AJ; Wiener, RS | 1 |
| Ager, A; Alihodžić, S; Bukvić Krajačić, M; Ellis, WY; Fajdetić, A; Hutinec, A; Ivezić-Schönfeld, Z; Jelić, D; Landek, G; Mesić, M; Milhous, WK; Ohrt, C; Padovan, J; Perić, M; Rupčić, R; Smith, KS; Spaventi, R; Ziher, D | 1 |
| Chini, P; Hou, W; McDonald, R; Moshiree, B; Toskes, PP; Waseem, S | 1 |
| Itakura, S; Kamiya, S; Kouyama, T; Nagase, T; Omura, S; Sunazuka, T; Takizawa, H; Yamauchi, Y | 1 |
| Noto, MJ; Wheeler, AP | 1 |
| Alihodžić, S; Bencetić Mihaljević, V; Bosnar, M; Bošnjak, B; Brajša, K; Culić, O; Eraković Haber, V; Glojnarić, I; Hrvačić, B; Jelić, D; Kapić, S; Koštrun, S; Kragol, G; Marušić Ištuk, Z; Padovan, J; Spaventi, R; Tavčar, B; Verbanac, D; Vujasinović, I | 1 |
| Arriola, CS; Bernal, M; Calampa, C; Camiña, M; Casapia, M; Chuquiray, N; Gregory, M; Guevara, J; Hall, E; Jones, F; Kasper, M; Lopez, M; Maves, R; Meza, R; Patiño, L; Perez, J; Pollett, S; Rocha, C; Rosenbaum, M; Salazar-Lindo, E; Tilley, D; Valencia, A; Zerpa, R | 1 |
| Kong, L; Leeming, AH; Weisman, LE | 1 |
| Chang, AB; Gavranich, JB; Gillies, MB; Mulholland, S | 1 |
| Ashour, S; Bayram, R | 1 |
| Du Plessis, LH; Kotzé, AF; Maritz, MM; van Niekerk, AC | 1 |
| Blondeau, JM; Drlica, K; Metzler, K | 1 |
| Broad, J; Sanger, GJ | 1 |
| Goodman, CD; Gramajo, H; Labadie, GR; McFadden, GI; Peirú, S; Rodríguez, E; Useglio, M | 1 |
| Hernández-Díaz, S; Lin, KJ; Louik, C; Mitchell, AA; Yau, WP | 1 |
| Decramer, M; Laekeman, G; Simoens, S | 1 |
| Elborn, JS; Tunney, MM | 1 |
| Abraham, WM; Baker, WR; Clarke, TC; Davies, CM; Garland, AL; Liu, J; Phillips, G; Sabater, JR; Stutts, MJ; Tan, CD; Tarran, R; Wilbert, S; Wright, CD; Yeung, A | 1 |
| Abe, A; Che, XF; Gotoh, A; Inazu, M; Kawaguchi, T; Komatsu, S; Miyazawa, K; Moriya, S; Tomoda, A | 1 |
| Bailey, DG; Fleet, J; Gandhi, S; Garg, AX; Gomes, T; Hwang, YJ; Juurlink, DN; Mamdani, M; Patel, AM; Shariff, S | 1 |
| Donaldson, GC; James, GD; Nazareth, I; Petersen, I; Wedzicha, JA | 1 |
| Berghaus, LJ; Giguère, S; Guldbech, K | 1 |
| Herath, SC; Poole, P | 1 |
| Criner, GJ; Ramos, FL | 1 |
| Abenhaim, HA; Gangal, M; Xiao, C | 1 |
| Heriot, WJ; Mack, HG; Stawell, R | 1 |
| Alechaga, E; Boleda, MR; Galceran, MT; Moyano, E; Ventura, F | 1 |
| Gordon, SS; Haas, DM; Pierson, RC | 1 |
| Hofmann, T; Scheuch, G; Siekmeier, R | 1 |
| Burkin, M; Galvidis, I; Lapa, G | 1 |
| Del Mar, CB; Eriksson, L; Farley, R; Spurling, GK | 1 |
| Bilton, D; Elborn, JS; Haworth, CS | 1 |
| Ge, L; He, S; Huang, A; Jin, Y | 1 |
| Chang, AB; Gardiner, SJ; Gavranich, JB | 1 |
| Chen, S; Chen, X; Cheng, A; Jia, R; Liu, M; Luo, H; Sun, K; Wang, L; Wang, M; Yang, Q; Zhou, W; Zhu, D | 1 |
| He, Q; Li, Y; Liu, X; Wang, Z; Zhang, B | 1 |
| Maruyama, F; Masuda, M; Nonaka, L; Suzuki, S | 1 |
| Berndt, A; Liebler-Tenorio, E; Lohr, M; Ostermann, C; Prohl, A; Reinhold, P; Rothe, M; Sachse, K; Schroedl, W; Schubert, E | 1 |
| Kasai, A; Nishiyama, H; Ogihara, S; Saito, R; Tanimichi, Y; Yamada, K | 1 |
| Apfalter, P; den Heijer, CD; George, A; Hoffmann, K; Maier, M | 1 |
| Chai, Z; Gong, W; Gu, X; Guan, Z; Li, K; Lu, H; Yan, L; Zhou, P | 1 |
| Eybagi, S; Kazerouni, NP; Naserzadeh, P; Pourahmad, J; Salimi, A; Seydi, E | 1 |
| Angrisano, F; Baum, J; Beeson, JG; Crabb, BS; de Jong, NW; Gilson, PR; Goodman, CD; Langer, C; McFadden, GI; Sleebs, BE; Weiss, GE; Wilson, DW | 1 |
| Gumbart, JC; Pavlova, A | 1 |
| Muralidharan, V; Striepen, B | 1 |
| Chazan, B; Colodner, R; Edelstein, H; Gal, V; Kennes, Y; Raz, R | 1 |
| Shimizu, T; Suzaki, H | 1 |
| Bérard, A; Nordeng, H; Sheehy, O; Zhao, JP | 1 |
| Caspi, M; Firsow, A; Greif, H; Kariv, R; Megido, D; Moshkovitz, I; Munitz, A; Pasmanik-Chor, M; Rajkumar, R; Rosenberg, DW; Rosin-Arbesfeld, R; Skalka, N | 1 |
| Che, XF; Handa, H; Hiramoto, M; Itoi, T; Kazama, H; Kokuba, H; Miyazawa, K; Moriya, S; Mukai, S; Ōmura, S; Sakamoto, S; Sugawara, A; Sunazuka, T; Yokoyama, T | 1 |
| Hong, J; Liu, E; Liu, H; Lu, Q | 1 |
| Dixon, SN; Garg, AX; Hackam, DG; Jandoc, R; McArthur, E; Nash, DM; Trac, MH | 1 |
| Li, C; Li, X; Liu, G; Wang, M; Wang, Z; Zhou, L | 1 |
| Renaud, J; Sabourin, L; Sumarah, M; Topp, E | 1 |
| Cao, L; Chen, X; Du, D; Liu, J; Zheng, Z | 1 |
| Alcaraz, I; Caumes, E; Dupin, N; Janier, M; Maatouk, I; Timsit, FJ | 1 |
| Crabb, DM; Duffy, LB; Jensen, JS; Liu, Y; Paukner, S; Waites, KB | 1 |
| Chastang, J; Descours, G; Doublet, P; Etienne, J; Forey, F; Ginevra, C; Jacotin, N; Jarraud, S; Kay, E; Lina, G | 1 |
| Descours, G; Doublet, P; Gilbert, C; Ginevra, C; Jarraud, S; Massip, C | 1 |
| Altman, RB; Fohner, AE; Klein, TE; Sparreboom, A | 1 |
| Giguère, S | 1 |
| Andrzejewska, M; Klawe, JJ; Spica, D; Szczepanska, B | 1 |
| Gumbart, JC; Oyelere, AK; Parks, JM; Pavlova, A | 1 |
| Gomes, T; Huang, A; Juurlink, DN; Macdonald, EM; Mamdani, MM; Quinn, KL | 1 |
| Adir, Y; Lavon, O; Schneer, S; Shteinberg, M | 1 |
| Appiagyei, A; Finneran, MM; Mertz, H; Templin, M | 1 |
| Ban, C; Han, B; Hu, Y; Li, W; Zhang, J | 1 |
| Gergova, RT; Mitov, IG; Muhtarova, AA | 1 |
| Atkinson, CT; Kunde, DA; Tristram, SG | 1 |
| Berghaus, LJ; Giguère, S; Willingham-Lane, JM | 1 |
| Grillo-Ardila, CF; Huerfano, C; Romero, L | 1 |
| Fabiánová, K; Jakubů, V; Urbášková, P; Zavadilová, J | 1 |
| Abulreesh, HH; Ahmad, I; Khan, JA; Qais, FA; Rathore, RS | 1 |
| Chalmers, JD; Crossingham, I; Evans, DJ; Felix, LM; Kelly, C; Milan, SJ; Relph, N; Spencer, S | 1 |
| Ahmed, S; Ahmed, T; Chisti, MJ; Faruque, ASG; Korpe, P | 1 |
| Berkley, JA; Williams, PCM | 1 |
| Alyabieva, NM; Katosova, LK; Khokhlova, TA; Lazareva, AV; Ponomarenko, OA | 1 |
| Lyon, C; Nashelsky, J; Radi, R; Staff, T | 1 |
| Aktan, B; Ersoy, B; Kilic, K; Sakat, MS; Sipal, S | 1 |
| Broutet, N; Lincetto, O; Santesso, N; Schünemann, H; Wi, T; Zikic, A | 1 |
| Azuma, A; Kamio, K | 1 |
| Ashrafi Tamai, I; Mahmoodi, P; Mohammadzadeh, A; Zahraei Salehi, T | 1 |
| Buhimschi, CS; Finneran, MM; Smith, DD | 1 |
| Bahar, MA; Hak, E; Kocks, JWH; Wang, Y; Wilffert, B; Zijp, TR | 1 |
| Wang, J; Yang, C | 1 |
| Barr, BS; Carter, CN; Cohen, ND; Elam, J; Erol, E; Giguère, S; Huber, L; Locke, SJ; Phillips, ED; Slovis, NM; Smith, JL | 1 |
| Herath, SC; Maisey, S; Normansell, R; Poole, P | 1 |
| Cabrera, MZ; de Morais, MA; Mendonça, AA | 1 |
| Burga, R; Colston, JM; François, R; Kosek, MN; Paredes-Olortegui, M; Peñataro-Yori, P; Pisanic, N; Schiaffino, F | 1 |
| Li, G; Ling, YJ; Min, FM; Pan, JH; Wang, L; Xie, YP; Ye, HZ; Yuan, C | 1 |
| Bracht, JR; Nelson, MM; Waldron, CL | 1 |
| Droitcourt, C; Dupire, G; Hughes, C; Le Cleach, L | 1 |
| Bachilova, S; Berghella, V; Heidari, P; Hoffman, MK; Navathe, R; Roman, A; Schoen, CN; Smith, S; Tepper, J; Visintainer, P; Ward, A | 1 |
| Gong, J; Guan, X; He, L; Li, J; Liu, J; Liu, L; Meng, F; Zhang, J; Zhao, F | 1 |
| Clark, CM; Mergenhagen, KA; Russo, TA; Skelly, MK; Wattengel, BA | 1 |
| Ben Abdelmoumen Mardassi, B; Ben Allaya, A; Boujemaa, S; Mardassi, H; Mlik, B | 1 |
| Jin, Y; Wang, J; Xu, Y; Zhou, J; Zhou, Z | 1 |
| Carter, C; Cruz Penn, MJ; Erol, E; Fortner, J; Locke, S; Saied, A; Smith, J | 1 |
| Katsukawa, C; Kawahara, R; Kawasaki, Y; Kawatsu, K; Yamaguchi, T | 1 |
| Ackhter, MM; Ahmed, T; Alam, T; Chisti, MJ; Dash, S; Golam Faruque, AS; Khan, SH; Parvin, I; Rahman, MW; Sarmin, M; Shahid, ASMSB; Shahrin, L; Shahunja, KM | 1 |
| Boroumand, B; Hajimirzaei, N; Judi-Chelan, R; Khalili, NP; Pourhosseini, A; Safari, F; Tavakoli, F | 1 |
| Martingano, D; Mitrofanova, A; Singh, S | 1 |
| Broderick, D; Clooney, L; Drew, RJ; Eogan, M; Fitzgibbon, A; McCallion, N | 1 |
| Pejčić, AV | 2 |
| Dotters-Katz, S | 1 |
| Akeda, Y; Arakawa, Y; Miyamoto, K; Onda, M; Shoji, M; Terada, K; Tomono, K; Tsuchiya, T; Yamabe, K | 1 |
| Ahmad, Z; Akhtar, A; Arshad, MS; Ayaz, MM; Chang, MW; Kucuk, I; Maniruzzaman, M; Zafar, S; Zahra, AT; Zaman, H | 1 |
| Li, J; Tang, W; Wang, W | 1 |
| Franciosi, JP; Gomez-Suarez, RA; Mougey, EB; Saunders, M | 1 |
| Fang, LL; Han, LP; Xiao, HY | 1 |
| Kopkin, RH; Seaman, RD; Turrentine, MA | 1 |
| Hao, L; Jiang, L; Li, H; Nan, K; Tian, Y; Wang, C; Wang, F; Zhang, L | 1 |
| Berglund, F; Ebmeyer, S; Johnning, A; Kieffer, N; Kristiansson, E; Larsson, DGJ; Lund, D; Parras-Moltó, M | 1 |
| Burr, LD; Choo, JM; Lingman, S; Martin, M; Papanicolas, LE; Richard, A; Rogers, GB; Schreiber, V; Taylor, SL | 1 |
| Chen, Q; Fan, X; Guo, YL; Li, Q; Lv, XT; Zhao, C | 1 |
| Alharbi, L; Alkhamisi, R; Alradadi, R; Ashy, N; Eljaaly, K | 1 |
| Adel, K; Alaeddine, R; Amor, M; De Feo, V; Emira, N; Jamal, SA; Kaïss, A; Mejdi, S; Mohd, A; Mousa, A; Siwar, G | 1 |
| Arun, S; Chakraborty, P; Gaonkar, O; Neppolian, B; Xin, L; Zhang, G | 1 |
| Catherine Stanton, I; Hayes, A; Hugo Gaze, W; Kaye Murray, A; May Murray, L; Snape, J; Zhang, L | 1 |
| Cummins, E; Monahan, C; Morris, D; Nag, R | 1 |
| Abdelaal, II; Abdelbadie, AS; Abdelfattah, LE; Aboshama, RA; Abulhasan, MH; Anan, MA | 1 |
| Erol, H; Kaplan, YC; Karadas, B; Keskin-Arslan, E; Temiz, T; Uysal, N | 1 |
| Azizian, K; Fu, J; Kouhsari, E; Lu, Z; Tadi, DA | 1 |
| Chibwe, M; Nnadozie, CF; Odume, ON | 1 |
| Anusha, M; George Priya Doss, C; Prashantha, CN; Tejaswini, V; Udhaya Kumar, S; Vasudevan, K | 1 |
| Çolak, ÇY; Delik, E; Eroğlu, B; Özçelik, AT; Tefon Öztürk, BE | 1 |
| Bahule, L; Barrett, KE; Benson, CA; Bila, CG; Hlashwayo, DF; Noormahomed, EV; Schooley, RT; Sigaúque, B | 1 |
| Jiang, B; Jing, XL; Li, GA; Li, SS; Ling, WC; Sui, SS; Sun, CY; Wang, YL | 1 |
| Burkin, MA; Bychkova, EN; Galvidis, IA; Melekhin, AO; Tevyashova, AN | 1 |
| Binkowska, JM; Bogaert, D; Condliffe, AM; Darton, TC; Hardman, SJ; Rigby, AS; Shackley, FM; Ugonna, K | 1 |
95 review(s) available for erythromycin and zithromax
| Article | Year |
|---|---|
Antimalarial Chemotherapy: Natural Product Inspired Development of Preclinical and Clinical Candidates with Diverse Mechanisms of Action.
Topics: Antimalarials; Biological Products; Chemistry, Pharmaceutical; Humans; Malaria; Molecular Structure | 2016 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A Gestalt approach to Gram-negative entry.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Microbial Sensitivity Tests; Structure-Activity Relationship | 2016 |
Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
Topics: Animals; Azithromycin; Bacterial Infections; Biological Availability; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intestinal Absorption; Microbial Sensitivity Tests; Respiratory Tract Infections; Sexually Transmitted Diseases; Tissue Distribution | 1992 |
Clarithromycin and azithromycin: new macrolide antibiotics.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Drug Interactions; Drug Labeling; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria | 1992 |
The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Drug Interactions; Erythromycin; Humans; Macrolides; Roxithromycin | 1992 |
Azithromycin--spectrum of activity, pharmacokinetics, and clinical applications.
Topics: Azithromycin; Drug Interactions; Erythromycin; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Respiratory Tract Infections; Sexually Transmitted Diseases; Skin Diseases, Infectious | 1992 |
The new macrolide antibiotics. Azithromycin and clarithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Protocols; Clinical Trials as Topic; Drug Resistance, Microbial; Erythromycin; Humans; Respiratory Tract Infections; Sexually Transmitted Diseases; Skin Diseases, Infectious; Therapeutic Equivalency | 1992 |
Azithromycin and clarithromycin: overview and comparison with erythromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Mycobacterium Infections, Nontuberculous; Respiratory Tract Infections; Sexually Transmitted Diseases; Skin Diseases, Infectious | 1992 |
New macrolide antibiotics: clarithromycin and azithromycin.
Topics: Azithromycin; Clarithromycin; Erythromycin; Humans; Respiratory Tract Infections; Skin Diseases, Infectious | 1992 |
Azithromycin: the first azalide antibiotic.
Topics: Azithromycin; Bacterial Infections; Clinical Trials as Topic; Drug Costs; Drug Interactions; Drug Resistance, Microbial; Erythromycin; Humans; Intestinal Absorption | 1992 |
The new macrolactones: clarithromycin (Biaxin) and azithromycin (Zithromax).
Topics: Azithromycin; Clarithromycin; Drug Interactions; Erythromycin; Humans; Respiratory Tract Infections | 1992 |
Azithromycin in lower respiratory tract infections.
Topics: Animals; Azithromycin; Erythromycin; Humans; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1992 |
Clinical use of the new macrolides, azalides, and streptogramins in pediatrics.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clinical Trials as Topic; Erythromycin; Humans; Infant; Virginiamycin | 1992 |
Clinical microbiology of azithromycin.
Topics: Animals; Azithromycin; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Serum Bactericidal Test | 1991 |
Azithromycin in the treatment of uncomplicated genital chlamydial infections.
Topics: Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Drug Administration Schedule; Erythromycin; Female; Half-Life; Humans; Male; Urethritis; Uterine Cervicitis | 1991 |
Tissue-directed pharmacokinetics.
Topics: Animals; Azithromycin; Biotransformation; Erythromycin; Extracellular Space; Half-Life; Humans | 1991 |
The pharmacokinetics of azithromycin and their clinical significance.
Topics: Administration, Oral; Azithromycin; Biological Availability; Drug Interactions; Drug Stability; Erythromycin; Half-Life; Humans; Time Factors; Tissue Distribution | 1991 |
Spectrum of activity of azithromycin.
Topics: Animals; Azithromycin; Bacteria; Drug Resistance, Microbial; Enterobacteriaceae; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Penicillin G; Toxoplasma | 1991 |
The activity of azithromycin in animal models of infection.
Topics: Animals; Azithromycin; Bacterial Infections; Disease Models, Animal; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Phagocytes; Tissue Distribution | 1991 |
Phagocyte uptake and transport of azithromycin.
Topics: Azithromycin; Erythromycin; Fibroblasts; Humans; Hydrogen-Ion Concentration; Legionella; Lysosomes; Phagocytes; Phagocytosis; Staphylococcus aureus; Temperature; Tissue Distribution | 1991 |
Clarithro- and azithromycin--better erythromycins?
Topics: Adult; Azithromycin; Clarithromycin; Erythromycin; Humans | 1991 |
New macrolides: expanded horizons for an old class of antibiotics.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Erythromycin; Escherichia coli; Haemophilus influenzae; Immune System | 1991 |
New macrolide antibiotics: usefulness in infections caused by mycobacteria other than Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteremia; Clarithromycin; Drug Synergism; Erythromycin; Humans; Microbial Sensitivity Tests; Multicenter Studies as Topic; Mycobacterium Infections, Nontuberculous; Randomized Controlled Trials as Topic | 1994 |
Azithromycin and clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests | 1993 |
Clinical safety and tolerance of azithromycin in children.
Topics: Adolescent; Azithromycin; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Erythromycin; Female; Humans; Incidence; Male; Randomized Controlled Trials as Topic | 1993 |
[Effect of the molecular structure of azithromycin on pharmacokinetics and the antimicrobial activity].
Topics: Anti-Bacterial Agents; Azithromycin; Erythromycin; Female; Gram-Negative Bacterial Infections; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Palatine Tonsil; Phagocytosis; Prostate; Uterus | 1995 |
[Azithromycin: critical points].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrogen-Ion Concentration; In Vitro Techniques; Macrolides | 1995 |
[Azithromycin, pharmacodynamic evaluation in animal models].
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cefaclor; Disease Models, Animal; Erythromycin; Legionnaires' Disease; Listeriosis; Lung Diseases; Mice; Mycobacterium avium; Parasitemia; Salmonella Infections, Animal; Tuberculosis | 1995 |
Chancroid.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Cephalosporins; Chancroid; Ciprofloxacin; Erythromycin; HIV Infections; Humans | 1996 |
Dirithromycin: a new macrolide.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Clarithromycin; Drug Interactions; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Macrolides; Respiratory Tract Infections | 1996 |
[Azithromycin (sumamed)--in the treatment of respiratory tract infections].
Topics: Anti-Bacterial Agents; Azithromycin; Child; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 1996 |
History of macrolide use in pediatrics.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Interactions; Erythromycin; Haemophilus Infections; Haemophilus influenzae; History, 20th Century; Humans; Infant; Infant, Newborn; Microscopy, Electron; Phagocytes; Phagocytosis | 1997 |
Microbiologic activity of the newer macrolide antibiotics.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Clarithromycin; Ear, Middle; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Penicillin Resistance; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pneumoniae | 1997 |
Macrolides in the management of streptococcal pharyngitis/tonsillitis.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Clarithromycin; Erythromycin; Humans; Penicillins; Pharyngitis; Streptococcal Infections; Tonsillitis | 1997 |
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Child; Clarithromycin; Drug Hypersensitivity; Drug Interactions; Erythromycin; Humans; Liver Function Tests | 1999 |
The macrolides: erythromycin, clarithromycin, and azithromycin.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Microbial Sensitivity Tests | 1999 |
Dental therapeutic indications for the newer long-acting macrolide antibiotics.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Clarithromycin; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Dental Care for Chronically Ill; Drug Costs; Endocarditis, Bacterial; Erythromycin; Focal Infection, Dental; Humans; Liver; Macrolides; Prodrugs; Tissue Distribution | 1999 |
[Antibiotic resistance: an always present problem].
Topics: Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Microbial; Erythromycin; Haemophilus; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; Tetracycline; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Treatment of sexually transmitted bacterial diseases in pregnant women.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Erythromycin; Female; Humans; Metronidazole; Penicillin G Benzathine; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Sexually Transmitted Diseases, Bacterial; Vaginosis, Bacterial | 2000 |
Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Erythromycin; Humans; Macrolides; Mixed Function Oxygenases; Substrate Specificity | 2000 |
Comparative safety of the different macrolides.
Topics: Anti-Bacterial Agents; Azithromycin; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Interactions; Erythromycin; Humans; Time Factors | 2001 |
[Objectives for antibiotic therapy in acute exacerbations of chronic bronchitis].
Topics: Acute Disease; Adrenal Cortex Hormones; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchitis, Chronic; Ciprofloxacin; Clavulanic Acid; Clinical Trials as Topic; Cost-Benefit Analysis; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Humans; Maximal Expiratory Flow-Volume Curves; Multicenter Studies as Topic; Penicillins; Placebos; Practice Guidelines as Topic; Prognosis; Recurrence; Respiratory Function Tests; Tetracycline; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
Therapy with macrolides in patients with cystic fibrosis.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Cystic Fibrosis; Erythromycin; Humans; Inflammation; Molecular Structure; Pseudomonas aeruginosa | 2002 |
The evolution and role of macrolides in infectious diseases.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Biological Availability; Child; Clarithromycin; Communicable Diseases; Drug Resistance, Bacterial; Erythromycin; Half-Life; Humans; Metabolic Clearance Rate | 2002 |
[Contribution of Japanese researchers to progress in the field of pulmonary medicine in the last 100 years: New pharmacological action of macrolides].
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; History, 20th Century; Humans; Japan; Lung Neoplasms; Respiratory Tract Infections | 2002 |
The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental?
Topics: Adverse Drug Reaction Reporting Systems; Anti-Bacterial Agents; Azithromycin; Case-Control Studies; Cohort Studies; Databases, Factual; Digestive System; Erythromycin; Female; Gastrointestinal Motility; Humans; Hypertrophy; Infant; Infant, Newborn; Male; Pyloric Stenosis; Retrospective Studies | 2002 |
Macrolide antibiotic therapy in patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Trials as Topic; Cystic Fibrosis; Erythromycin; Humans; Randomized Controlled Trials as Topic | 2003 |
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Chronic Disease; Clarithromycin; Community-Acquired Infections; Erythromycin; Humans; Inflammation; Macrolides; Respiratory Tract Infections | 2005 |
Antibiotics for whooping cough (pertussis).
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Clarithromycin; Contact Tracing; Erythromycin; Erythromycin Estolate; Erythromycin Ethylsuccinate; Humans; Infant; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough | 2005 |
[Therapeutic efficacy of macrolide anti-infective agents and other pharmacological actions].
Topics: Anti-Infective Agents; Asthma; Azithromycin; Bronchiolitis; Chronic Disease; Clinical Trials as Topic; Cystic Fibrosis; Erythromycin; Gene Expression Regulation, Bacterial; Humans; Macrolides; Mucins; Neutrophils; Pancreatic Elastase; Pseudomonas aeruginosa; Pulmonary Disease, Chronic Obstructive; Respiratory Mucosa; Sinusitis; Structure-Activity Relationship | 2005 |
Meta-analysis of bacterial resistance to macrolides.
Topics: Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2005 |
Approaches to the synthesis of immunolides: selective immunomodulatory macrolides for cystic fibrosis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Combinatorial Chemistry Techniques; Cystic Fibrosis; Drug Design; Erythromycin; Humans; Immunologic Factors; Inflammation; Macrolides | 2005 |
[Pertussis chemoprophylaxis: a sterile effort?].
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Clarithromycin; Drug Administration Schedule; Erythromycin; Humans; Risk Factors; Severity of Illness Index; Whooping Cough | 2006 |
[Optimising antibiotic policies in the Netherlands. IX. SWAB guidelines for antimicrobial therapy in adults with acute infectious diarrhoea].
Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Diarrhea; Dysentery; Erythromycin; Evidence-Based Medicine; Humans; Netherlands; Practice Guidelines as Topic; Treatment Outcome | 2006 |
[Antibiotics treatment of whooping cough].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Humans; Infant; Meta-Analysis as Topic; Patient Compliance; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough | 2006 |
[Diagnosis and therapy of Rhodococcus equi infection in the horse].
Topics: Actinomycetales Infections; Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Erythromycin; Horse Diseases; Horses; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Treatment Outcome | 2006 |
Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta-analysis of randomised controlled trials.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Costs and Cost Analysis; Databases, Factual; Erythromycin; Female; Gastrointestinal Diseases; Humans; Male; Patient Compliance; Pregnancy; Randomized Controlled Trials as Topic | 2007 |
Antibiotics for whooping cough (pertussis).
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Clarithromycin; Contact Tracing; Erythromycin; Erythromycin Estolate; Erythromycin Ethylsuccinate; Humans; Infant; Randomized Controlled Trials as Topic; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough | 2007 |
Chlamydia (uncomplicated, genital).
Topics: Amoxicillin; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Erythromycin; Humans | 2008 |
Long-acting erythromycins: assessing their role in treating outpatient odontogenic infections.
Topics: Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Delayed-Action Preparations; Erythromycin; Humans; Tooth Diseases | 2009 |
Recent advances in the medicinal chemistry of novel erythromycin-derivatized antibiotics.
Topics: Anti-Bacterial Agents; Azithromycin; Chemistry, Pharmaceutical; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Ketolides; Macrolides | 2010 |
Clinical inquiries. Which oral antibiotics are best for acne?
Topics: Acne Vulgaris; Administration, Oral; Anti-Bacterial Agents; Azithromycin; Drug Costs; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Evidence-Based Medicine; Humans; Minocycline | 2011 |
Chlamydia (uncomplicated, genital).
Topics: Amoxicillin; Azithromycin; Chlamydia; Chlamydia Infections; Chlamydia trachomatis; Erythromycin; Humans | 2010 |
Susceptibility of bacterial isolates from community-acquired infections in sub-Saharan Africa and Asia to macrolide antibiotics.
Topics: Adult; Africa South of the Sahara; Anti-Bacterial Agents; Asia; Azithromycin; Child; Clarithromycin; Community-Acquired Infections; Confounding Factors, Epidemiologic; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Humans; Klebsiella; Macrolides; Microbial Sensitivity Tests; Neisseria meningitidis; Salmonella enterica; Streptococcus agalactiae; Streptococcus pyogenes | 2011 |
Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bronchitis; Child; Community-Acquired Infections; Erythromycin; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Randomized Controlled Trials as Topic | 2012 |
Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Belgium; Clarithromycin; Drug Costs; Erythromycin; Health Care Costs; Humans; Macrolides; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2013 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Disease Progression; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic | 2013 |
Use of long-term macrolide therapy in chronic obstructive pulmonary disease.
Topics: Anti-Bacterial Agents; Azithromycin; Cost-Benefit Analysis; Disease Progression; Drug Administration Schedule; Drug Resistance, Bacterial; Erythromycin; Humans; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Sputum; Time Factors; Treatment Outcome | 2014 |
Inhalation of macrolides: a novel approach to treatment of pulmonary infections.
Topics: Administration, Inhalation; Aerosols; Animals; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Ketolides; Lung; Macrolides; Pulmonary Disease, Chronic Obstructive; Rats | 2015 |
Antibiotics for bronchiolitis in children under two years of age.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Clarithromycin; Erythromycin; Humans; Infant; Length of Stay; Randomized Controlled Trials as Topic | 2014 |
Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Erythromycin; Evidence-Based Medicine; Female; Forced Expiratory Volume; Humans; Macrolides; Male; Middle Aged; Randomized Controlled Trials as Topic; Respiration; Treatment Outcome | 2014 |
Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bronchitis; Child; Community-Acquired Infections; Erythromycin; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Randomized Controlled Trials as Topic | 2015 |
Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; Haemophilus Infections; History, 20th Century; History, 21st Century; Humans; Japan; Macrolides; Nasal Polyps; Rhinitis; Sinusitis | 2016 |
[A systematic review of the therapy for Mycoplasma pneumoniae infections in children].
Topics: Anti-Bacterial Agents; Azithromycin; Child; Cough; Erythromycin; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Macrolides; Mycoplasma Infections; Mycoplasma pneumoniae; Randomized Controlled Trials as Topic | 2016 |
Treatment of Infections Caused by Rhodococcus equi.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Horse Diseases; Horses; Pneumonia, Bacterial; Rhodococcus equi; Rifampin | 2017 |
[LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Erythromycin; Humans; Lung Diseases; Macrolides | 2016 |
Antimicrobial Resistance in
Topics: Animal Diseases; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Combinations; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Horses; Lincosamides; Macrolides; Microbial Sensitivity Tests; Rhodococcus equi; Rifampin; Streptogramin B | 2017 |
Macrolides for treatment of Haemophilus ducreyi infection in sexually active adults.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Chancroid; Erythromycin; Haemophilus ducreyi; Humans; Leucomycins; Macrolides; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2017 |
Macrolide antibiotics for bronchiectasis.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bronchiectasis; Child, Preschool; Clarithromycin; Erythromycin; Humans; Macrolides; Randomized Controlled Trials as Topic; Roxithromycin | 2018 |
Guidelines for the management of paediatric cholera infection: a systematic review of the evidence.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Cholera; Drug Resistance, Bacterial; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Guidelines as Topic; Humans; Infant; Infant, Newborn; Treatment Outcome; Vibrio cholerae; World Health Organization | 2018 |
Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Bias; Chlamydia Infections; Chlamydia trachomatis; Conjunctivitis, Bacterial; Drug Administration Schedule; Erythromycin; Female; Gastrointestinal Diseases; Humans; Infant, Newborn; Male; Pyloric Stenosis; Risk Factors; Trimethoprim | 2018 |
Effects of prophylactic antibiotics on patients with stable COPD: a systematic review and meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Bacterial Infections; Disease Progression; Erythromycin; Hospitalization; Humans; Outcome Assessment, Health Care; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic | 2018 |
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Disease Progression; Drug Administration Schedule; Erythromycin; Fluoroquinolones; Humans; Moxifloxacin; Pulmonary Disease, Chronic Obstructive; Quality of Life; Quinolines; Randomized Controlled Trials as Topic; Roxithromycin; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Antistreptococcal interventions for guttate and chronic plaque psoriasis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ascorbic Acid; Azithromycin; Child; Erythromycin; Humans; Middle Aged; Penicillin V; Psoriasis; Randomized Controlled Trials as Topic; Rifampin; Streptococcal Infections; Tonsillectomy; Vitamins | 2019 |
Fact versus Fiction: a Review of the Evidence behind Alcohol and Antibiotic Interactions.
Topics: Alcohols; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cephalosporins; Doxycycline; Drug Interactions; Erythromycin; Fluoroquinolones; Metronidazole; Penicillins; Tetracycline | 2020 |
Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Humans; Ketolides; Macrolides; Roxithromycin; Stevens-Johnson Syndrome | 2021 |
Delirium associated with the use of macrolide antibiotics: a review.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Delirium; Erythromycin; Humans | 2022 |
Antibiotics for Prophylaxis in the Setting of Preterm Prelabor Rupture of Membranes.
Topics: Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Drug Administration Routes; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious | 2020 |
Erythromycin vs azithromycin for treatment of preterm prelabor rupture of membranes: a systematic review and meta-analysis.
Topics: Azithromycin; Chorioamnionitis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Pregnancy | 2022 |
Legionella micdadei Aquaticum Infection: a Case Report and Literature Review.
Topics: Adult; Azithromycin; Erythromycin; Female; Humans; Legionella; Legionellaceae; Legionellosis; Levofloxacin; Male; Middle Aged; Pneumonia | 2022 |
Efficacy of erythromycin compared to clarithromycin and azithromycin in adults or adolescents with community-acquired pneumonia: A Systematic Review and meta-analysis of randomized controlled trials.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Erythromycin; Humans; Pneumonia; Randomized Controlled Trials as Topic | 2022 |
Pregnancy outcomes following maternal macrolide use: A systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Erythromycin; Female; Humans; Macrolides; Pregnancy; Pregnancy Outcome | 2023 |
Global status of Azithromycin and Erythromycin Resistance Rates in
Topics: Anti-Bacterial Agents; Azithromycin; Drug Resistance, Bacterial; Erythromycin; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2022 |
A review of antibiotic resistance among Campylobacter species in human, animal, and water sources in South Africa: a One Health Approach.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; One Health; South Africa; Water | 2023 |
91 trial(s) available for erythromycin and zithromax
| Article | Year |
|---|---|
Pharmacokinetics of EDP-420 after ascending single oral doses in healthy adult volunteers.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Bridged-Ring Compounds; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Macrolides; Male; Middle Aged; Treatment Outcome; Young Adult | 2009 |
New antibiotics look good against M. avium.
Topics: Acquired Immunodeficiency Syndrome; Azithromycin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Erythromycin; Humans; Mycobacterium avium-intracellulare Infection | 1992 |
Treatment of early Lyme disease.
Topics: Adult; Amoxicillin; Antibodies, Bacterial; Azithromycin; Borrelia burgdorferi Group; Doxycycline; Erythema Chronicum Migrans; Erythromycin; Female; Follow-Up Studies; Humans; Immunoglobulin G; Immunoglobulin M; Lyme Disease; Male; Middle Aged; Nervous System Diseases; Pilot Projects; Probenecid; Sensation; Treatment Outcome | 1992 |
In vitro activity of azithromycin and tetracycline against 358 clinical isolates of Brucella melitensis.
Topics: Azithromycin; Brucella; Erythromycin; Humans; Microbial Sensitivity Tests; Species Specificity; Tetracycline | 1992 |
Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis.
Topics: Aged; Amoxicillin; Azithromycin; Bronchitis; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 1992 |
A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group.
Topics: Adolescent; Adult; Azithromycin; Chlamydia trachomatis; Doxycycline; Erythromycin; Female; Humans; Lymphogranuloma Venereum; Male; Middle Aged; Urethritis; Uterine Cervicitis | 1992 |
Efficacy of single-dose azithromycin versus doxycycline in the treatment of cervical infections caused by Chlamydia trachomatis.
Topics: Azithromycin; Base Sequence; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Drug Administration Schedule; Erythromycin; Female; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Uterine Cervical Diseases | 1992 |
A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males.
Topics: Adolescent; Adult; Azithromycin; Chlamydia Infections; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Humans; Male; Treatment Outcome; Urethritis | 1992 |
Azithromycin in upper respiratory tract infections: a clinical trial in children with otitis media.
Topics: Administration, Oral; Amoxicillin; Azithromycin; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media; Otitis Media with Effusion | 1992 |
Erythema migrans: comparison of treatment with azithromycin, doxycycline and phenoxymethylpenicillin.
Topics: Adolescent; Adult; Aged; Azithromycin; Doxycycline; Erythema Chronicum Migrans; Erythromycin; Humans; Male; Middle Aged; Penicillin V; Prospective Studies; Random Allocation | 1992 |
Clinical comparative study of azithromycin versus erythromycin in the treatment of acute respiratory tract infections in children.
Topics: Acute Disease; Azithromycin; Bacterial Infections; Child; Child, Preschool; Drug Administration Schedule; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections; Treatment Outcome | 1992 |
The role of azalide antibiotics in the treatment of Chlamydia.
Topics: Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Drug Administration Schedule; Erythromycin; Female; Follow-Up Studies; Humans | 1991 |
Comparative study of azithromycin and amoxicillin/clavulanic acid in the treatment of lower respiratory tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Bronchitis; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Streptococcus pneumoniae | 1991 |
A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis.
Topics: Abdominal Pain; Adult; Azithromycin; Erythromycin; Female; Humans; Male; Penicillin V; Pharyngitis; Streptococcal Infections | 1991 |
Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Azithromycin; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Maxillary Sinusitis; Middle Aged; Staphylococcal Infections; Streptococcal Infections | 1991 |
Multicenter evaluation of azithromycin and cefaclor in acute lower respiratory tract infections.
Topics: Azithromycin; Bronchitis; Cefaclor; Erythromycin; Haemophilus Infections; Humans; Klebsiella Infections; Moraxella catarrhalis; Neisseriaceae Infections; Pneumonia; Prospective Studies; Sputum; Staphylococcal Infections; Streptococcal Infections | 1991 |
Azithromycin compared with cephalexin in the treatment of skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Cephalexin; Drug Administration Schedule; Erythromycin; Humans; Middle Aged; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections | 1991 |
Clinical toleration and safety of azithromycin.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Carbamazepine; Child; Child, Preschool; Cimetidine; Contraindications; Drug Evaluation; Drug Interactions; Eating; Erythromycin; Female; Humans; Male; Methylprednisolone; Middle Aged; Respiratory Tract Infections; Skin Diseases, Infectious; Theophylline; Urethritis; Uterine Cervicitis | 1991 |
An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Azithromycin; Drug Administration Schedule; Drug Tolerance; Erythromycin; Female; Humans; Male; Middle Aged | 1991 |
High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose.
Topics: Administration, Oral; Adult; Aged; Azithromycin; Biological Assay; Carcinoma, Bronchogenic; Chromatography, High Pressure Liquid; Drug Administration Schedule; Erythromycin; Humans; Lung; Lung Neoplasms; Middle Aged | 1991 |
Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Cefaclor; Double-Blind Method; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia | 1991 |
Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia.
Topics: Adult; Azithromycin; Chlamydia Infections; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Phagocytes; Pneumonia; Pneumonia, Mycoplasma; Q Fever | 1991 |
Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections.
Topics: Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Cellulitis; Cephalexin; Double-Blind Method; Drug Administration Schedule; Erythromycin; Female; Humans; Impetigo; Male; Middle Aged; Skin Diseases, Infectious; Wound Infection | 1991 |
Azithromycin for treatment of Mycobacterium avium-intracellulare complex infection in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Azithromycin; Bacteremia; Drug Administration Schedule; Drug Evaluation; Erythromycin; Follow-Up Studies; Homosexuality; Humans; Male; Mycobacterium avium-intracellulare Infection; Opportunistic Infections | 1991 |
The effects of an antacid or cimetidine on the serum concentrations of azithromycin.
Topics: Administration, Oral; Adult; Aluminum Hydroxide; Azithromycin; Cimetidine; Drug Combinations; Erythromycin; Humans; Magnesium Hydroxide; Male; Time Factors | 1991 |
Azithromycin in the treatment of sexually transmitted disease.
Topics: Adolescent; Adult; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gonorrhea; Humans; Male; Middle Aged; Mycoplasmatales Infections; Neisseria gonorrhoeae; Randomized Controlled Trials as Topic; Sexually Transmitted Diseases; Ureaplasma | 1990 |
Comparative studies of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species.
Topics: Adolescent; Adult; Aged; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Erythromycin; Female; Gonorrhea; Humans; Male; Middle Aged; Neisseria gonorrhoeae; Skin Diseases, Infectious; Staphylococcus; Streptococcus; Urethritis; Uterine Cervicitis | 1990 |
Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias.
Topics: Adolescent; Adult; Aged; Azithromycin; Child; Chlamydophila psittaci; Erythromycin; Female; Humans; Male; Middle Aged; Mycoplasma pneumoniae; Pneumonia; Pneumonia, Mycoplasma | 1990 |
[Azithromycin versus josamycin: treatment of 89 cases of acute pneumonia].
Topics: Adult; Aged; Aged, 80 and over; Azithromycin; Drug Administration Schedule; Drug Tolerance; Erythromycin; Female; Humans; Josamycin; Male; Middle Aged; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic | 1990 |
Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Asthma; Azithromycin; Child; Chlamydia Infections; Chlamydophila pneumoniae; Chronic Disease; Doxycycline; Erythromycin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Respiratory Function Tests; Time Factors; Treatment Outcome | 1995 |
Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Azithromycin; Community-Acquired Infections; Erythromycin; Female; Humans; Injections, Intravenous; Male; Middle Aged; Multivariate Analysis; Penicillin G; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Radiography; Treatment Outcome | 1995 |
[Use of oral macrolide and azalide antibiotics in children with bronchopulmonary diseases].
Topics: Administration, Oral; Azithromycin; Bronchial Diseases; Erythromycin; Humans; Infant; Infant, Newborn; Leucomycins; Lung Diseases | 1994 |
[Azithromycin in the treatment of syphilis].
Topics: Adolescent; Adult; Azithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Penicillins; Syphilis; Time Factors | 1994 |
Azithromycin does not alter the effects of oral midazolam on human performance.
Topics: Adult; Arousal; Azithromycin; Cross-Over Studies; Double-Blind Method; Drug Synergism; Erythromycin; Female; Humans; Male; Midazolam; Psychomotor Performance | 1994 |
Azithromycin and erythromycin in the treatment of cervical chlamydial infection during pregnancy.
Topics: Administration, Oral; Azithromycin; Chlamydia Infections; Erythromycin; Female; Gastrointestinal Diseases; Humans; Incidence; Pregnancy; Pregnancy Complications, Infectious; Surveys and Questionnaires; Treatment Outcome; Treatment Refusal; Uterine Cervical Diseases | 1994 |
[Comparative clinical effectiveness and tolerance of azithromycin (sumamed) and erythromycin in patients with sinusitis].
Topics: Acute Disease; Adult; Azithromycin; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Sinusitis | 1993 |
Randomised controlled trial of single-dose azithromycin in treatment of trachoma.
Topics: Administration, Oral; Adolescent; Adult; Antigens, Bacterial; Azithromycin; Child; Child, Preschool; Chlamydia trachomatis; Erythromycin; Female; Follow-Up Studies; Humans; Infant; Male; Middle Aged; Ointments; Patient Compliance; Recurrence; Single-Blind Method; Tetracycline; Trachoma | 1993 |
Clinical efficacy of azithromycin in lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Bronchitis; Chronic Disease; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Prospective Studies; Roxithromycin; Treatment Outcome | 1993 |
Single dose of azithromycin for the treatment of genital chlamydial infections in adolescents.
Topics: Administration, Oral; Adolescent; Adult; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Sexually Transmitted Diseases, Bacterial | 1993 |
Primary and secondary erythema migrans in central Wisconsin.
Topics: Administration, Oral; Adult; Amoxicillin; Antibodies, Bacterial; Azithromycin; Borrelia burgdorferi Group; Erythema Chronicum Migrans; Erythromycin; Female; Heart Diseases; Humans; Male; Middle Aged; Recurrence; Skin; Wisconsin | 1993 |
Compliance with antibiotic therapy: a comparison of deuterium oxide tracer, urine bioassay, bottle weights, and parental reports.
Topics: Adolescent; Azithromycin; Child; Child, Preschool; Deuterium; Deuterium Oxide; Drug Packaging; Erythromycin; Female; Humans; Male; Parents; Patient Compliance; Penicillin V; Pharyngitis; Regression Analysis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis; Water | 1993 |
A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.
Topics: Azithromycin; Child; Child, Preschool; Dicloxacillin; Drug Administration Schedule; Erythromycin; Floxacillin; Humans; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 1993 |
Clinical safety and tolerance of azithromycin in children.
Topics: Adolescent; Azithromycin; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Erythromycin; Female; Humans; Incidence; Male; Randomized Controlled Trials as Topic | 1993 |
Efficacy of azithromycin compared with spiramycin in the treatment of odontogenic infections.
Topics: Azithromycin; Bacterial Infections; Erythromycin; Female; Humans; Male; Mouth Diseases; Spiramycin; Tooth Diseases | 1993 |
Once-daily azithromycin in the treatment of adult skin and skin-structure infections.
Topics: Abscess; Acute Disease; Adolescent; Adult; Azithromycin; Dicloxacillin; Double-Blind Method; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Prospective Studies; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcus | 1993 |
Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Child; Clarithromycin; Drug Administration Schedule; Erythromycin; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Otitis Media; Pharyngitis; Respiratory Tract Infections; Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1993 |
A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Bronchitis; Clavulanic Acids; Drug Administration Schedule; Drug Combinations; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Male; Middle Aged; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Respiratory Tract Infections; Single-Blind Method; Streptococcus pneumoniae | 1993 |
Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Bronchitis; Clarithromycin; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections | 1993 |
The efficacy and tolerance of a three-day course of azithromycin in the treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Azithromycin; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pilot Projects; Pneumonia | 1993 |
Single-dose oral azithromycin versus seven-day doxycycline in the treatment of non-gonococcal urethritis in males.
Topics: Administration, Oral; Adolescent; Adult; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Drug Administration Schedule; Erythromycin; Follow-Up Studies; Humans; Male; Middle Aged; Neisseria gonorrhoeae; Neisseriaceae Infections; Prospective Studies; Ureaplasma Infections; Ureaplasma urealyticum; Urethritis | 1993 |
Comparison of azithromycin and doxycycline in the treatment of non-gonococcal urethritis in men.
Topics: Administration, Oral; Adult; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Drug Administration Schedule; Erythromycin; Humans; Male; Middle Aged; Neisseria gonorrhoeae; Neisseriaceae Infections; Urethritis | 1993 |
Comparison of azithromycin and co-amoxiclav in the treatment of otitis media in children.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Child; Child, Preschool; Clavulanic Acids; Drug Combinations; Erythromycin; Female; Humans; Infant; Male; Otitis Media | 1993 |
A comparative study of azithromycin and amoxycillin in paediatric patients with acute otitis media.
Topics: Acute Disease; Amoxicillin; Azithromycin; Bacterial Infections; Child; Child, Preschool; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Otitis Media; Respiratory Tract Infections | 1993 |
Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Child; Child, Preschool; Clavulanic Acids; Drug Administration Schedule; Drug Combinations; Erythromycin; Female; Humans; Infant; Male; Otitis Media | 1993 |
Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children.
Topics: Acute Disease; Azithromycin; Child; Child, Preschool; Erythromycin; Female; Humans; Male; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1993 |
Multicentre comparison of azithromycin versus erythromycin in the treatment of paediatric pharyngitis or tonsillitis caused by group A streptococci.
Topics: Acute Disease; Azithromycin; Child; Child, Preschool; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1993 |
Influence of the antibiotics erythromycin and azithromycin on the pharmacokinetics and pharmacodynamics of midazolam.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cross-Over Studies; Drug Interactions; Erythromycin; Female; Half-Life; Humans; Hypnotics and Sedatives; Male; Midazolam; Middle Aged; Psychomotor Performance; Sleep | 1996 |
A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Carrier State; Child; Child, Preschool; Drug Resistance, Microbial; Erythromycin; Humans; Longitudinal Studies; Nasopharynx; Native Hawaiian or Other Pacific Islander; Northern Territory; Pneumococcal Infections; Prospective Studies; Streptococcus pneumoniae; Trachoma | 1997 |
Prospective open randomized study comparing efficacies and safeties of a 3-day course of azithromycin and a 10-day course of erythromycin in children with community-acquired acute lower respiratory tract infections.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bronchitis; Child; Child, Preschool; Community-Acquired Infections; Erythromycin; Follow-Up Studies; Humans; Pneumonia; Prospective Studies; Respiratory Tract Infections | 1996 |
[A trial of the use of rulid, sumamed and makropen in the combined treatment of generalized periodontitis at a stage of exacerbation].
Topics: Acute Disease; Adolescent; Adult; Anti-Bacterial Agents; Antifungal Agents; Azithromycin; Chronic Disease; Drug Therapy, Combination; Erythromycin; Humans; Leucomycins; Middle Aged; Nystatin; Periodontitis; Roxithromycin | 1997 |
Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin.
Topics: Anti-Anxiety Agents; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clarithromycin; Cross-Over Studies; Drug Interactions; Erythromycin; Female; Humans; Male; Midazolam | 1997 |
Chlamydia in pregnancy: a randomized trial of azithromycin and erythromycin.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Erythromycin; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Uterine Cervicitis | 1998 |
Single-dose azithromycin for Chlamydia in pregnant women.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Erythromycin; Female; Gestational Age; Humans; Logistic Models; Pregnancy; Pregnancy Complications, Infectious; Sexual Partners; Tetracycline | 1998 |
Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
Topics: Administration, Oral; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Azithromycin; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Double-Blind Method; Erythromycin; Humans; Hypnotics and Sedatives; In Vitro Techniques; Microsomes, Liver; Oxidoreductases, N-Demethylating; Time Factors; Triazolam; Troleandomycin | 1998 |
[Clinical significance of fungal and microbial associations and antibacterial therapy for treatment of chronic inflammatory respiratory tract diseases in children].
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Candida albicans; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Humans; Moraxella catarrhalis; Respiratory Tract Diseases; Streptococcus pneumoniae | 1998 |
Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia in children.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Chlamydia Infections; Chlamydophila pneumoniae; Communicable Diseases; Double-Blind Method; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Male; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma | 1998 |
Etiology and treatment of community-acquired pneumonia in ambulatory children.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Viral; Azithromycin; Child; Child, Preschool; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Infant; Nasopharynx; Outpatient Clinics, Hospital; Pneumonia, Bacterial; Pneumonia, Viral; Prospective Studies | 1999 |
Macrolides and changes in the oral flora.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Double-Blind Method; Drug Resistance, Microbial; Erythromycin; Humans; Josamycin; Middle Aged; Mouth; Periodontitis; Streptococcus | 1999 |
Comparative study of dirithromycin and azithromycin in the treatment of acute bacterial exacerbations of chronic bronchitis.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis; Drug Costs; Erythromycin; Female; Haemophilus influenzae; Humans; Macrolides; Male; Middle Aged; Moraxella catarrhalis; Streptococcus pneumoniae; Treatment Outcome | 1999 |
Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.
Topics: Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Pneumonia; Prospective Studies | 2000 |
[Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia].
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Chlamydophila pneumoniae; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Male; Mycoplasma pneumoniae; Pneumonia, Bacterial; Pneumonia, Mycoplasma | 1998 |
The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers.
Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Biological Availability; Drug Combinations; Erythromycin; Half-Life; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Piperazines; Purines; Pyrimidinones; Sildenafil Citrate; Sulfones | 2002 |
Cost-effectiveness of IV-to-oral switch therapy: azithromycin vs cefuroxime with or without erythromycin for the treatment of community-acquired pneumonia.
Topics: Administration, Oral; Adult; Aged; Azithromycin; Cefuroxime; Community-Acquired Infections; Confidence Intervals; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Erythromycin; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia; Probability; Sensitivity and Specificity | 2002 |
Comparison of single-dose azithromycin and 12-dose, 3-day erythromycin for childhood cholera: a randomised, double-blind trial.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bangladesh; Child; Child, Preschool; Cholera; Double-Blind Method; Drug Administration Schedule; Erythromycin; Feces; Humans; Infant; Male; Treatment Outcome; Vibrio cholerae O1; Vibrio cholerae O139 | 2002 |
Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Topics: Adolescent; Age Factors; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Community-Acquired Infections; Drug Administration Schedule; Erythromycin; Female; Follow-Up Studies; Humans; Infant; Male; Penicillins; Pneumonia, Bacterial; Time Factors; Treatment Outcome | 2003 |
The efficacy of azithromycin in the treatment of acute infraorbital space infection.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Chi-Square Distribution; Drainage; Erythromycin; Eye Infections, Bacterial; Female; Focal Infection, Dental; Humans; Male; Middle Aged; Orbital Diseases; Statistics, Nonparametric; Tooth Extraction; Treatment Outcome | 2003 |
A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Azithromycin; Drug Administration Schedule; Erythromycin; Female; Humans; Macrolides; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Single-Blind Method; Time Factors; Treatment Outcome | 2003 |
Azithromycin in the treatment of cholera in children.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Cholera; Double-Blind Method; Erythromycin; Feces; Humans; India; Male; Severity of Illness Index; Treatment Outcome; Vibrio cholerae | 2003 |
No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; Azithromycin; Drug Combinations; Drug Interactions; Erythromycin; Humans; Male; Pyrimidines; Triazoles; Voriconazole | 2003 |
A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Chemistry, Pharmaceutical; Child; Double-Blind Method; Drug Stability; Erythromycin; Female; Humans; Male; Rosacea; Solutions | 2004 |
Which treatment for genital tract Chlamydia trachomatis infection?
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Doxycycline; Erythromycin; Female; Humans; Pilot Projects; Sexually Transmitted Diseases; Treatment Outcome | 2004 |
[Efficacy and safety of azithromycin prophylaxis of respiratory tract infections in military community].
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Carrier State; Clindamycin; Community-Acquired Infections; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Military Personnel; Nasopharyngeal Diseases; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Russia; Streptococcus pneumoniae | 2004 |
Azithromycin does not cure pityriasis rosea.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Double-Blind Method; Erythromycin; Female; Humans; Male; Pityriasis Rosea | 2006 |
Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Female; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia; Prospective Studies; Random Allocation; Treatment Outcome | 2007 |
Single oral dose of azithromycin versus 5 days of oral erythromycin or no antibiotic in treatment of campylobacter enterocolitis in children: a prospective randomized assessor-blind study.
Topics: Administration, Oral; Azithromycin; Campylobacter; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Enterocolitis; Erythromycin; Female; Humans; Infant; Intention to Treat Analysis; Male; Prospective Studies; Single-Blind Method | 2010 |
Macrolide antibiotics and survival in patients with acute lung injury.
Topics: Acute Lung Injury; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; APACHE; Azithromycin; Clarithromycin; Combined Modality Therapy; Drug Administration Schedule; Erythromycin; Female; Hospital Mortality; Humans; Length of Stay; Macrolides; Male; Middle Aged; Pentoxifylline; Respiration, Artificial; Survival Rate; Tidal Volume | 2012 |
Correlation study of cough variant asthma and mycoplasma pneumonia infection in children.
Topics: Adolescent; Asthma; Azithromycin; Child; Child, Preschool; China; Comorbidity; Cough; Erythromycin; Female; Humans; Immunoglobulin M; Incidence; Infant; Male; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Treatment Outcome | 2017 |
Cost Analysis of Azithromycin versus Erythromycin in Pregnancies Complicated by Preterm Premature Rupture of Membranes.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cost-Benefit Analysis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Outcome | 2019 |
Clinical effect of sequential therapy with azithromycin in children mycoplasma pneumoniae pneumonia.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Drug Administration Schedule; Erythromycin; Female; Hospitalization; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Pneumonia, Mycoplasma; Time Factors | 2018 |
Assessment of Long-Term Macrolide Exposure on the Oropharyngeal Microbiome and Macrolide Resistance in Healthy Adults and Consequences for Onward Transmission of Resistance.
Topics: Adult; Anti-Bacterial Agents; Australia; Azithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Microbiota; RNA, Ribosomal, 16S; Streptococcus | 2022 |
Different azithromycin protocols for management of preterm prelabour rupture of membranes: a randomized clinical trial.
Topics: Anti-Bacterial Agents; Azithromycin; Coinfection; Erythromycin; Female; Humans; Infant, Newborn; Pregnancy; Puerperal Infection | 2022 |
526 other study(ies) available for erythromycin and zithromax
| Article | Year |
|---|---|
Quantitative structure-activity relationships among macrolide antibacterial agents: in vitro and in vivo potency against Pasteurella multocida.
Topics: Animals; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Macrolides; Mice; Microbial Sensitivity Tests; Molecular Structure; Pasteurella Infections; Pasteurella multocida; Structure-Activity Relationship | 1997 |
Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Crystallography, X-Ray; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Ketolides; Macrolides; Male; Mice; Models, Molecular; Molecular Conformation; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Streptococcus; Streptococcus pneumoniae | 1998 |
Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens.
Topics: Animals; Anti-Bacterial Agents; Drug Design; Drug Resistance, Microbial; Haemophilus influenzae; Lung; Lung Diseases; Macrolides; Mice; Models, Molecular; Rats; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Structure-Activity Relationship | 2000 |
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Cell-Free System; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Ketolides; Lung; Mice; Models, Molecular; Protein Biosynthesis; Protein Synthesis Inhibitors; Rats; Respiratory Tract Infections; Ribosomes; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Transcription, Genetic | 2001 |
Synthesis and antibacterial activity of a novel series of acylides: 3-O-(3-pyridyl)acetylerythromycin A derivatives.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Area Under Curve; Drug Resistance, Multiple, Bacterial; Erythromycin; Haemophilus influenzae; Macrolides; Mice; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Streptococcal Infections; Streptococcus pneumoniae; Structure-Activity Relationship | 2003 |
Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats.
Topics: Animals; Antibiotics, Antineoplastic; Azithromycin; Bile; Bile Ducts; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Humans; Intracellular Fluid; K562 Cells; Liver; Male; Rats; Rats, Sprague-Dawley | 2004 |
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin.
Topics: Amodiaquine; Animals; Antimalarials; Azithromycin; DNA, Protozoan; Drug Resistance; Erythrocytes; Humans; Malaria, Falciparum; Models, Structural; Parasitic Sensitivity Tests; Plasmodium falciparum; Protozoan Proteins | 2007 |
Acetylated flavanone glycosides from the rhizomes of Cyclosorus acuminatus.
Topics: Anti-Infective Agents; Drugs, Chinese Herbal; Escherichia coli; Ferns; Flavanones; Glycosides; Haemophilus influenzae; Molecular Structure; Plants, Medicinal; Rhizome; Staphylococcus aureus; Streptococcus pneumoniae | 2006 |
Synergistic interaction between phenothiazines and antimicrobial agents against Burkholderia pseudomallei.
Topics: Anti-Infective Agents; Burkholderia pseudomallei; Cells, Cultured; Drug Synergism; Humans; Lung; Macrophages; Melioidosis; Microbial Sensitivity Tests; Phenothiazines; Proton Pump Inhibitors | 2007 |
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Culture Media; Drug Resistance, Bacterial; Genotype; Humans; Ketolides; Methyltransferases; Microbial Sensitivity Tests; Mutation; Phenotype; Pneumococcal Infections; Ribosomal Proteins; Streptococcus pneumoniae | 2007 |
Roxithromycin favorably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Disease Models, Animal; Drug Resistance, Bacterial; Lung; Macrolides; Male; Matrix Metalloproteinase 7; Mice; Mice, Inbred CBA; Pneumonia, Pneumococcal; Roxithromycin; Streptolysins | 2007 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
Topics: Anti-Bacterial Agents; Clone Cells; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Erythromycin; Genes, Bacterial; Microbial Sensitivity Tests; Phenotype; Pneumococcal Infections; Serotyping; Spain; Streptococcus pneumoniae; Tetracycline Resistance | 2007 |
Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Chlamydophila psittaci; DNA Mutational Analysis; Drug Resistance, Bacterial; Erythromycin; Gene Frequency; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Ribosomal Proteins; RNA, Ribosomal, 23S | 2007 |
Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Biofilms; Culture Media; Drug Resistance, Bacterial; Gentamicins; Green Fluorescent Proteins; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 2008 |
Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Infant; Infant, Newborn; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; RNA, Ribosomal, 23S | 2008 |
Induction of erm(C) expression by noninducing antibiotics.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enzyme Induction; Escherichia coli; Gene Expression Regulation, Bacterial; Ketolides; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Protein Conformation; Protein Sorting Signals; Ribosomes; RNA, Messenger | 2008 |
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Multigene Family; Sequence Analysis, DNA; Substrate Specificity | 2008 |
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
Topics: Anti-Infective Agents; Bacteria; Community-Acquired Infections; Cross Infection; Enterococcus; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Respiratory System; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Emergence of macrolide resistance gene mph(B) in Streptococcus uberis and cooperative effects with rdmC-like gene.
Topics: Azithromycin; Drug Resistance, Bacterial; Enterococcus faecalis; Erythromycin; Escherichia coli; Genes, Bacterial; Josamycin; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Staphylococcus aureus; Streptococcus; Tylosin | 2008 |
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Cricetinae; Fibroblasts; Gram-Negative Bacteria; Kidney Cortex; Lung; Microbial Sensitivity Tests; Microvilli; Polymyxin B; Rats; Structure-Activity Relationship | 2008 |
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
Topics: Aminopyridines; Anti-Bacterial Agents; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma fermentans; Mycoplasma genitalium; Mycoplasma hominis; Mycoplasma Infections; Mycoplasma pneumoniae; Ureaplasma; Ureaplasma Infections | 2008 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Site-directed mutagenesis reveals amino acid residues in the Escherichia coli RND efflux pump AcrB that confer macrolide resistance.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Macrolides; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Mutagenesis, Site-Directed; Sequence Homology, Amino Acid | 2009 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Community-Acquired Infections; Drug Resistance, Bacterial; Global Health; Humans; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Population Surveillance; Respiratory Tract Infections; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus pyogenes | 2009 |
Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Clarithromycin; Culture Media; Drug Resistance, Bacterial; Erythromycin; Humans; Infant, Newborn; Infant, Premature, Diseases; Microbial Sensitivity Tests; Point Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Species Specificity; Tetracycline; Ureaplasma; Ureaplasma Infections | 2009 |
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Child; China; Drug Resistance, Bacterial; Genes, rRNA; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Respiratory Tract Infections; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2009 |
Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.
Topics: Anti-Bacterial Agents; Child; China; Drug Resistance, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Point Mutation; Respiratory Tract Infections; RNA, Ribosomal, 23S | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Escherichia coli; Escherichia coli Proteins; Genetic Complementation Test; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Neisseria meningitidis | 2010 |
In vitro activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with defined macrolide resistance mechanisms.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Macrolides; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; New South Wales; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Nucleotide selectivity of antibiotic kinases.
Topics: Anti-Bacterial Agents; Bacteria; Binding, Competitive; Drug Resistance, Bacterial; Guanosine Triphosphate; Kanamycin Kinase; Models, Chemical; Nucleotides; Phosphotransferases (Alcohol Group Acceptor); Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Substrate Specificity | 2010 |
Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Base Sequence; Biofilms; DNA Primers; Dose-Response Relationship, Drug; Erythromycin; Gene Expression; Genes, Bacterial; Humans; In Vitro Techniques; Macrolides; Microscopy, Electron, Scanning; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcal Infections; Staphylococcus epidermidis | 2010 |
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
Topics: Anti-Bacterial Agents; Azithromycin; Clindamycin; Cystic Fibrosis; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Macrolides; Streptococcus milleri Group; Tetracycline | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
Synthesis and antibacterial activity of novel 4''-O-arylalkylcarbamoyl and 4''-O-((arylalkylamino)-4-oxo-butyl)carbamoyl clarithromycin derivatives.
Topics: Anti-Bacterial Agents; Clarithromycin; Genes, Bacterial; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2010 |
In vitro activity of azithromycin against nontyphoidal Salmonella enterica.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Drug Resistance, Bacterial; Finland; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Salmonella enterica; Salmonella Infections | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Synthesis and antibacterial activity of 3-O-carbamoyl derivatives of 6,11-di-O-methylerythromycin A: a novel class of acylides.
Topics: Anti-Bacterial Agents; Bacteria; Clarithromycin; Drug Discovery; Microbial Sensitivity Tests | 2010 |
High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Drug Resistance, Bacterial; Neisseria gonorrhoeae; Point Mutation; Polymerase Chain Reaction; Promoter Regions, Genetic; Repressor Proteins; RNA, Ribosomal, 23S | 2010 |
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
Topics: Anti-Infective Agents; Azithromycin; Chlamydia trachomatis; Clarithromycin; Doxycycline; Erythromycin; Genotype; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2010 |
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Neisseria gonorrhoeae; Ontario; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sequence Analysis, DNA | 2011 |
Synthesis and antibacterial evaluation of novel clarithromycin derivatives with C-4″ elongated arylalkyl groups against macrolide-resistant strains.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Design; Drug Resistance, Bacterial; Macrolides; Microbial Sensitivity Tests; Molecular Conformation; Staphylococcus aureus; Stereoisomerism; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 2011 |
Chemistry and biology of macrolide antiparasitic agents.
Topics: Anti-Bacterial Agents; Antiparasitic Agents; Cells, Cultured; Humans; Macrolides; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Toxoplasma | 2011 |
Synthesis and antibacterial activity of novel 4″-O-benzimidazolyl clarithromycin derivatives.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzimidazoles; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Gene Expression; Hydrazines; Membrane Proteins; Methyltransferases; Staphylococcus aureus; Streptococcus pneumoniae; Structure-Activity Relationship | 2011 |
Novel C-4'' modified azithromycin analogs with remarkably enhanced activity against erythromycin-resistant Streptococcus pneumoniae: the synthesis and antimicrobial evaluation.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Drug Resistance, Bacterial; Erythromycin; Gene Expression; Humans; Membrane Proteins; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae | 2011 |
Synthesis and antibacterial activity of a novel series of acylides active against community acquired respiratory pathogens.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Drug Design; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Models, Chemical; Nitrogen; Respiratory Tract Infections; Streptococcus pneumoniae | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis and antibacterial evaluation of novel 11,4″-disubstituted azithromycin analogs with greatly improved activity against erythromycin-resistant bacteria.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Resistance, Bacterial; Erythromycin; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Streptococcus pneumoniae | 2013 |
Design, synthesis and biological evaluation of azithromycin glycosyl derivatives as potential antibacterial agents.
Topics: Anti-Bacterial Agents; Azithromycin; Dose-Response Relationship, Drug; Drug Design; Escherichia coli; Glycosylation; Microbial Sensitivity Tests; Molecular Conformation; Staphylococcus; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Identification of elaiophylin derivatives from the marine-derived actinomycete Streptomyces sp. 7-145 using PCR-based screening.
Topics: Anti-Bacterial Agents; Macrolides; Marine Biology; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Polymerase Chain Reaction; Streptomyces; Vancomycin | 2013 |
Volume of Distribution in Drug Design.
Topics: Drug Design; Half-Life; Pharmacokinetics | 2015 |
Ribosome-targeting antibiotics as inhibitors of oncogenic microRNAs biogenesis: Old scaffolds for new perspectives in RNA targeting.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; DEAD-box RNA Helicases; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Models, Molecular; Molecular Sequence Data; Neoplasms; Ribonuclease III; Ribosomes; Tetracyclines | 2015 |
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium.
Topics: Anti-Bacterial Agents; Drug Design; Genistein; Mycobacterium avium; Quinolones | 2017 |
Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility.
Topics: 1-Octanol; Cell Membrane Permeability; Cyclosporins; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Peptides; Peptides, Cyclic; Pharmaceutical Preparations; Small Molecule Libraries; Solubility; Structure-Activity Relationship; Water | 2018 |
Synthesis and evaluation of biological activity for dual-acting antibiotics on the basis of azithromycin and glycopeptides.
Topics: Anti-Bacterial Agents; Azithromycin; Dose-Response Relationship, Drug; Enterococcus faecalis; Enterococcus faecium; Glycopeptides; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship | 2019 |
Synthesis and biological evaluation of solithromycin analogs against multidrug resistant pathogens.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Escherichia coli; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship; Triazoles | 2019 |
Differentiating the Pharmacodynamics and Toxicology of Macrolide and Ketolide Antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Drug-Related Side Effects and Adverse Reactions; Humans; Ketolides; Macrolides | 2020 |
Azithromycin-induced block of elementary body formation in Chlamydia trachomatis.
Topics: Animals; Azithromycin; Bacterial Proteins; Chlamydia trachomatis; Culture Techniques; Erythromycin; Mice; RNA, Bacterial | 1992 |
Influence of outer membrane mutations on susceptibility of Escherichia coli to the dibasic macrolide azithromycin.
Topics: Azithromycin; Bacterial Outer Membrane Proteins; Erythromycin; Escherichia coli; Membranes; Microbial Sensitivity Tests; Mutation | 1992 |
New macrolide antibiotics: azithromycin and clarithromycin.
Topics: Animals; Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans | 1992 |
Two macrolide antimicrobials approved for marketing.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Humans; United States; United States Food and Drug Administration | 1992 |
Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice.
Topics: Animals; Azithromycin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Mice; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal | 1992 |
Clarithromycin and azithromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Clinical Trials as Topic; Erythromycin; Humans; Microbial Sensitivity Tests | 1992 |
Updates on Chlamydia.
Topics: Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Erythromycin; Humans; Ofloxacin | 1992 |
Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum.
Topics: Anti-Bacterial Agents; Azithromycin; Blood Proteins; Erythromycin; Escherichia coli; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Protein Binding; Roxithromycin; Staphylococcus aureus; Thymidine | 1992 |
Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms.
Topics: Azithromycin; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Mycobacterium; Roxithromycin | 1992 |
Synthesis and antibacterial activity of O-methylazithromycin derivatives.
Topics: Anti-Bacterial Agents; Azithromycin; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Methylation; Microbial Sensitivity Tests; Structure-Activity Relationship | 1992 |
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.
Topics: Azithromycin; Cells, Cultured; Chlamydia; Chlamydia trachomatis; Drug Resistance, Microbial; Erythromycin; HeLa Cells; Humans; Microbial Sensitivity Tests; Tetracycline; Tetracycline Resistance | 1992 |
Disk diffusion sensitivity testing and antibacterial activity of azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Bacteria, Anaerobic; Bacterial Infections; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests | 1992 |
Once-a-week azithromycin in AIDS patients: tolerability, kinetics, and effects on zidovudine disposition.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Azithromycin; Biotransformation; Drug Administration Schedule; Drug Tolerance; Erythromycin; Female; Humans; Male; Zidovudine | 1992 |
Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.
Topics: Animals; Azithromycin; Brain; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Lung; Mice; Pyrimethamine; Sulfadiazine; Survival Rate; Toxoplasmosis, Animal | 1992 |
Activity and local delivery of azithromycin in a mouse model of Haemophilus influenzae lung infection.
Topics: Administration, Oral; Animals; Azithromycin; Bronchoalveolar Lavage Fluid; Drug Evaluation, Preclinical; Erythromycin; Female; Haemophilus Infections; Haemophilus influenzae; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Models, Biological; Phagocytes; Respiratory Tract Infections | 1992 |
In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Cells, Cultured; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Ofloxacin | 1992 |
Influence of azithromycin and other macrolides on the intracellular killing of Staphylococcus aureus by human polymorphonuclear leucocytes of healthy donors and a patient with Chédiak-Higashi syndrome.
Topics: Anti-Bacterial Agents; Azithromycin; Chediak-Higashi Syndrome; Child; Clarithromycin; Colony Count, Microbial; Erythromycin; Female; Humans; Neutrophils; Phagocytosis; Roxithromycin; Staphylococcus aureus | 1992 |
[Pneumopathies caused by Chlamydia pneumoniae].
Topics: Aged; Azithromycin; Chlamydia Infections; Chlamydophila pneumoniae; Erythromycin; Female; Fluorescent Antibody Technique; Humans; Male; Middle Aged; Pneumonia; Prospective Studies; Roxithromycin; Serologic Tests | 1992 |
Activity of azithromycin (CP-62,993) and erythromycin against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.
Topics: Animals; Antiprotozoal Agents; Azithromycin; Chloroquine; Drug Interactions; Drug Resistance; Erythromycin; Plasmodium falciparum | 1992 |
The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Topics: Azithromycin; Bacteria; Cefotaxime; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Gentamicins; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Miocamycin; Roxithromycin; Virginiamycin | 1992 |
Equivalence of a high-performance liquid chromatographic assay and a bioassay of azithromycin in human serum samples.
Topics: Azithromycin; Biological Assay; Chromatography, High Pressure Liquid; Erythromycin; Humans | 1992 |
In vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans.
Topics: Actinobacillus; Actinobacillus Infections; Azithromycin; Colony Count, Microbial; Erythromycin | 1992 |
In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence.
Topics: Adult; Azithromycin; Erythromycin; Female; Haemophilus influenzae; Humans; In Vitro Techniques; Leukocytes; Luminescent Measurements; Luminol; Male; Oxidation-Reduction; Phagocytosis; Tetradecanoylphorbol Acetate | 1992 |
Activity of azithromycin against Mycobacterium avium infection in beige mice.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Culture Media; Drug Therapy, Combination; Erythromycin; Female; Male; Mice; Mice, Inbred C57BL; Mycobacterium avium; Tuberculosis | 1992 |
Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin.
Topics: Azithromycin; Cell Movement; Erythromycin; Flagella; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa | 1992 |
Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Bacteria, Anaerobic; Erythromycin; Microbial Sensitivity Tests; Mouth; Streptococcus; Virginiamycin | 1992 |
[Effect of azithromycin on human serum sensitivity of Pseudomonas aeruginosa].
Topics: Azithromycin; Blood Bactericidal Activity; Erythromycin; Humans; In Vitro Techniques; Pseudomonas aeruginosa | 1992 |
The in vitro profile of selected 14-membered azalides.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 1992 |
In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes.
Topics: Anti-Bacterial Agents; Azithromycin; Chemotaxis, Leukocyte; Ciprofloxacin; Drug Delivery Systems; Erythromycin; Growth Inhibitors; Humans; Microbial Sensitivity Tests; Neutrophils; Rifampin; Streptococcus pyogenes | 1992 |
Relationship between antibiotic concentration in bone and efficacy of treatment of staphylococcal osteomyelitis in rats: azithromycin compared with clindamycin and rifampin.
Topics: Animals; Azithromycin; Bone and Bones; Clindamycin; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Male; Osteomyelitis; Rats; Rifampin; Staphylococcal Infections | 1992 |
Azithromycin pharmacokinetics and penetration to lymph.
Topics: Adult; Azithromycin; Erythromycin; Humans; Lymph; Male; Reference Values; Tissue Distribution | 1992 |
Potentiation of azithromycin activity against Escherichia coli by human serum ultrafiltrate.
Topics: Azithromycin; Blood Bactericidal Activity; Blood Physiological Phenomena; Blood Proteins; Carbon Radioisotopes; Erythromycin; Escherichia coli; Humans; Microbial Sensitivity Tests; Thymidine | 1992 |
Azithromycin for cerebral toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Azithromycin; Erythromycin; Humans; Male; Toxoplasmosis, Cerebral | 1992 |
Short-Course Therapy: Improved Patient Compliance and Therapeutic Benefit. Proceedings of a symposium at the 5th European Congress of Clinical Microbiology and Infectious Diseases. Oslo, Norway, 9-11 September 1991.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Administration Schedule; Erythromycin; Humans; Patient Compliance | 1992 |
Activity of azithromycin against cryptosporidia in immunosuppressed rats.
Topics: Animals; Azithromycin; Cryptosporidiosis; Disease Models, Animal; Erythromycin; Female; Ileum; Immune Tolerance; Random Allocation; Rats; Rats, Inbred Strains; Spiramycin | 1991 |
Evaluation of the effect of drugs on the cyst form of Toxoplasma gondii.
Topics: Adenine; Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Brain; Clindamycin; Coccidiostats; Erythromycin; Fluorouracil; Mice; Mice, Inbred CBA; Naphthoquinones; Pyrimethamine; Sulfadiazine; Toxoplasma | 1991 |
Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Leprosy; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Roxithromycin | 1991 |
The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Legionella; Leucomycins; Microbial Sensitivity Tests; Mycoplasma; Roxithromycin; Staphylococcus; Ureaplasma | 1991 |
High-performance liquid chromatographic assay with electrochemical detection for azithromycin in serum and tissues.
Topics: Azithromycin; Brain Chemistry; Chromatography, High Pressure Liquid; Electrochemistry; Erythromycin; Humans; Kidney; Liver; Muscles | 1991 |
In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
Topics: Animals; Azithromycin; Disease Models, Animal; Drug Evaluation, Preclinical; Erythromycin; Female; Mice; Roxithromycin; Spiramycin; Tissue Distribution; Toxoplasma; Toxoplasmosis, Animal | 1991 |
Introduction: revolutionary changes in the macrolide and azalide antibiotics.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Drug Resistance, Microbial; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans | 1991 |
Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia.
Topics: Animals; Azithromycin; Blood; Drug Evaluation, Preclinical; Erythromycin; Female; Lung; Mice; Mice, Inbred C57BL; Pneumonia, Pneumococcal | 1991 |
Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450.
Topics: Animals; Azithromycin; Body Weight; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Erythromycin; Erythromycin Estolate; Liver; Male; Micrococcus; Microsomes; Microsomes, Liver; Mixed Function Oxygenases; NADPH-Ferrihemoprotein Reductase; Pregnenolone Carbonitrile; Rats; Rats, Inbred Strains | 1991 |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages.
Topics: 4-Quinolones; Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Azithromycin; Cell Division; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; In Vitro Techniques; Leprostatic Agents; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium Complex; Quinolones; Rifampin | 1991 |
Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis.
Topics: Animals; Azithromycin; Dose-Response Relationship, Drug; Drug Synergism; Erythromycin; Female; Interferon-gamma; Mice; Toxoplasmosis, Animal | 1991 |
Pharmacokinetics of azithromycin after single oral dosing of experimental animals.
Topics: Administration, Oral; Animals; Azithromycin; Erythromycin; Female; Male; Rabbits; Rats; Rats, Inbred F344; Tissue Distribution | 1991 |
In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin.
Topics: Azithromycin; Campylobacter coli; Campylobacter jejuni; Drug Resistance, Microbial; Erythromycin; Microbial Sensitivity Tests | 1991 |
In-vitro potency of azithromycin against gram-negative bacilli is method-dependent.
Topics: Azithromycin; Enterobacteriaceae; Erythromycin; Gram-Negative Bacteria; Microbial Sensitivity Tests | 1991 |
Azithromycin: an antibiotic with unusual properties.
Topics: Azithromycin; Bacterial Infections; Erythromycin; Humans | 1991 |
Effects of environmental factors on the in vitro potency of azithromycin.
Topics: Anaerobiosis; Azithromycin; Bacteria, Anaerobic; Carbon Dioxide; Culture Media; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Time Factors | 1991 |
Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic azithromycin.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Drug Resistance, Microbial; Enterobacteriaceae; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Suture Techniques | 1991 |
Influence of the test medium on azithromycin and erythromycin regression statistics.
Topics: Azithromycin; Culture Media; Erythromycin; Gram-Positive Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Regression Analysis | 1991 |
Concentrations of azithromycin in human tonsillar tissue.
Topics: Administration, Oral; Adult; Azithromycin; Capsules; Chronic Disease; Drug Administration Schedule; Erythromycin; Half-Life; Humans; Male; Palatine Tonsil; Time Factors; Tonsillitis | 1991 |
Azithromycin concentrations in sinus fluid and mucosa after oral administration.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Azithromycin; Body Fluids; Chronic Disease; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Maxillary Sinusitis; Middle Aged; Nasal Mucosa | 1991 |
Azithromycin levels in plasma and gastric tissue, juice and mucus.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Azithromycin; Chromatography, High Pressure Liquid; Erythromycin; Female; Gastric Juice; Gastric Mucosa; Humans; Male; Middle Aged; Mucus; Stomach; Stomach Neoplasms; Time Factors | 1991 |
Gynaecological tissue levels of azithromycin.
Topics: Adolescent; Adult; Aged; Ascitic Fluid; Azithromycin; Cervix Uteri; Drug Administration Schedule; Erythromycin; Fallopian Tubes; Female; Genitalia, Female; Humans; Middle Aged; Uterus | 1991 |
A modified broth dilution assay for antibiotic sensitivity testing of Mycobacterium avium-intracellulare using paraffin slide cultures.
Topics: Amikacin; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Erythromycin; Microbial Sensitivity Tests; Mycobacterium avium Complex | 1991 |
The effect of a single oral dose of azithromycin on chlamydial salpingitis in mice.
Topics: Animals; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Erythromycin; Female; Mice; Mice, Inbred C3H; Salpingitis | 1991 |
Stimulation with cytokines enhances penetration of azithromycin into human macrophages.
Topics: Azithromycin; Erythromycin; Humans; Interferon-gamma; Macrophages; Mycobacterium avium-intracellulare Infection; Recombinant Proteins; Tumor Necrosis Factor-alpha | 1991 |
Concentration of azithromycin in human prostatic tissue.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Azithromycin; Chromatography, High Pressure Liquid; Erythromycin; Half-Life; Humans; Male; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Time Factors | 1991 |
In vitro activity of azithromycin against clinical isolates of Legionella species.
Topics: Animals; Azithromycin; Erythromycin; Guinea Pigs; Humans; Legionella; Macrophages; Microbial Sensitivity Tests; Pulmonary Alveoli | 1991 |
[New macrolide antibiotics, rifamycins and peptide antibiotics discussed at the 27th International Conference on Antimicrobial Agents and Chemotherapy].
Topics: Acetylcysteine; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Congresses as Topic; Daptomycin; Disaccharides; Drug Evaluation; Erythromycin; Glycopeptides; Humans; New York City; Peptides; Rifamycins | 1991 |
Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cells, Cultured; Erythromycin; Macrolides; Microbial Sensitivity Tests; Plasmids; Ribosomes; Staphylococcus epidermidis; Structure-Activity Relationship | 1990 |
Chlamydia trachomatis: in vitro susceptibility of genital and ocular isolates to some quinolones, amoxicillin and azithromycin.
Topics: Amoxicillin; Anti-Infective Agents; Azithromycin; Cervix Uteri; Chlamydia trachomatis; Ciprofloxacin; Conjunctiva; Drug Evaluation, Preclinical; Erythromycin; Female; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Urethra | 1990 |
Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.
Topics: Azithromycin; Erythromycin; Humans; Neutrophils; Opsonin Proteins; Phagocytosis; Roxithromycin; Staphylococcus aureus | 1990 |
Azithromycin concentrations at the sites of pulmonary infection.
Topics: Azithromycin; Bacterial Infections; Bronchi; Bronchoalveolar Lavage Fluid; Cell Count; Epithelium; Erythromycin; Female; Humans; Lung Diseases; Macrophages; Male; Sputum | 1990 |
Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma pneumoniae; Quinolones; Reproducibility of Results; Ureaplasma | 1990 |
Post-antibiotic effect of azithromycin on respiratory tract pathogens.
Topics: Azithromycin; Erythromycin; Klebsiella; Microbial Sensitivity Tests; Respiratory System | 1990 |
Antimicrobial interference with bacterial mechanisms of pathogenicity: effect of sub-MIC azithromycin on gonococcal piliation and attachment to human epithelial cells.
Topics: Azithromycin; Blotting, Western; Cells, Cultured; Epithelial Cells; Erythromycin; Fimbriae, Bacterial; Humans; Microbial Sensitivity Tests; Mouth Mucosa; Neisseria gonorrhoeae | 1990 |
Failure of azythromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment.
Topics: Adult; Azithromycin; Campylobacter Infections; Drug Resistance, Microbial; Erythromycin; Gastritis; Humans | 1990 |
Intraphagocytic activity of erythromycin, roxithromycin and azithromycin.
Topics: Azithromycin; Erythromycin; Humans; Neutrophils; Roxithromycin; Staphylococcus aureus | 1990 |
Azithromycin (CP-62,993): the first azalide antimicrobial agent. The Fourth European Congress of Clinical Microbiology. Nice, France, 17-20 April 1989. Proceedings.
Topics: Animals; Azithromycin; Erythromycin; Humans | 1990 |
In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
Topics: Azithromycin; Chlamydia trachomatis; Ciprofloxacin; Erythromycin; Haemophilus ducreyi; Neisseria gonorrhoeae; Norfloxacin | 1990 |
Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol.
Topics: Administration, Oral; Animals; Azithromycin; Erythromycin; Female; Guinea Pigs; Infusions, Parenteral; Legionella; Legionnaires' Disease | 1990 |
In-vitro activity of azithromycin and CP-63,956 against Treponema pallidum.
Topics: Azithromycin; Erythromycin; Protein Biosynthesis; Treponema pallidum | 1990 |
In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria.
Topics: Azithromycin; Bacteria, Anaerobic; Erythromycin; Gram-Negative Bacteria; Roxithromycin | 1990 |
Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
Topics: Azithromycin; Bacteria, Anaerobic; Bacteroides fragilis; Clostridium; Erythromycin; Gram-Positive Bacteria; Haemophilus influenzae; Staphylococcus; Streptococcus | 1990 |
Bacteriostatic and bactericidal activity of azithromycin against Haemophilus influenzae.
Topics: Azithromycin; Erythromycin; Haemophilus influenzae; Roxithromycin | 1990 |
In-vitro activity of azithromycin compared with other macrolides and oral antibiotics against Salmonella typhi.
Topics: Anti-Bacterial Agents; Azithromycin; Erythromycin; Salmonella typhi | 1990 |
In-vitro and in-vivo susceptibility of Borrelia burgdorferi to azithromycin.
Topics: Animals; Azithromycin; Borrelia burgdorferi Group; Cricetinae; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Lyme Disease; Mesocricetus; Tetracycline; Tissue Distribution | 1990 |
Comparison of the acid stability of azithromycin and erythromycin A.
Topics: Acetonitriles; Azithromycin; Chromatography, High Pressure Liquid; Drug Stability; Erythromycin; Hydrogen-Ion Concentration; Hydrolysis | 1990 |
Pharmacokinetics of azithromycin in rats and dogs.
Topics: Administration, Oral; Animals; Azithromycin; Biological Availability; Dogs; Erythromycin; Half-Life; Infusions, Intravenous; Rats; Tissue Distribution | 1990 |
Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bacteroides fragilis; Ciprofloxacin; Disease Models, Animal; Erythromycin; Escherichia coli; Female; Liver; Male; Mice; Rats; Salmonella enteritidis; Staphylococcus aureus | 1990 |
In-vitro activity of azithromycin against Chlamydia trachomatis.
Topics: Azithromycin; Chlamydia trachomatis; Doxycycline; Erythromycin; HeLa Cells | 1990 |
The pharmacokinetics of azithromycin in human serum and tissues.
Topics: Adolescent; Adult; Azithromycin; Biological Availability; Erythromycin; Half-Life; Humans; Least-Squares Analysis; Male; Middle Aged; Tissue Distribution | 1990 |
Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo.
Topics: Animals; Azithromycin; Bacteria; Dose-Response Relationship, Drug; Erythromycin; Escherichia coli; Gerbillinae; Haemophilus influenzae; Klebsiella pneumoniae; Male; Mice; Rats; Roxithromycin; Streptococcus pneumoniae | 1990 |
Efficacy of azithromycin for therapy of active syphilis in the rabbit model.
Topics: Animals; Azithromycin; Erythromycin; Male; Penicillin G Benzathine; Rabbits; Syphilis; Treponema pallidum | 1990 |
Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria.
Topics: Azithromycin; Bacillus subtilis; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Hydrogen-Ion Concentration; Kinetics; Methods; Protons; Ribosomes; Staphylococcus aureus | 1990 |
Activity in vitro against Toxoplasma gondii of azithromycin and clarithromycin alone and with pyrimethamine.
Topics: Animals; Azithromycin; Clarithromycin; Drug Interactions; Erythromycin; Pyrimethamine; Regression Analysis; Toxoplasma | 1990 |
[Activity of azithromycin and roxithromycin alone or in combination against Mycobacterium avium and Mycobacterium xenopi].
Topics: Azithromycin; Cholecalciferol; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; In Vitro Techniques; Mycobacterium; Mycobacterium avium; Roxithromycin | 1990 |
Intracellular accumulation of azithromycin by cultured human fibroblasts.
Topics: 2-Chloroadenosine; 2,4-Dinitrophenol; Azithromycin; Carbon Radioisotopes; Cells, Cultured; Dinitrophenols; Erythromycin; Fibroblasts; Formaldehyde; Humans; Hydrogen-Ion Concentration; Sodium Fluoride; Temperature | 1990 |
Mechanism of azithromycin uptake in human polymorphonuclear leucocytes.
Topics: Adult; Azithromycin; Erythromycin; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Neutrophils; Temperature | 1990 |
The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.
Topics: Administration, Oral; Adult; Azithromycin; Blister; Erythromycin; Exudates and Transudates; Half-Life; Humans; Male | 1990 |
Erythromycin and azithromycin transport into Haemophilus influenzae ATCC 19418 under conditions of depressed proton motive force (delta mu H).
Topics: Azithromycin; Bacterial Proteins; Biological Transport; Cell Membrane; Edetic Acid; Erythromycin; Haemophilus influenzae; Membrane Potentials; Protons; Valinomycin | 1990 |
Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Enterobacteriaceae; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Microbial Sensitivity Tests; Ribosomes; RNA, Bacterial; RNA, Messenger; Staphylococcus aureus | 1987 |
In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex.
Topics: Animals; Azithromycin; Disease Models, Animal; Erythromycin; Female; Hepatomegaly; Mice; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Specific Pathogen-Free Organisms; Splenomegaly | 1989 |
In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Blood Bactericidal Activity; Erythromycin; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C3H; Oxidation-Reduction; Phagocytes; Rats; Rats, Inbred F344; Time Factors | 1989 |
The development of macrolides and related compounds.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Design; Erythromycin | 1989 |
Azithromycin (CP-62,993) in acute exacerbations of chronic bronchitis: an open clinical, microbiological and pharmacokinetic study.
Topics: Acute Disease; Aged; Aged, 80 and over; Azithromycin; Bronchitis; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sputum; Time Factors | 1989 |
In vitro susceptibilities of Entamoeba histolytica to azithromycin, CP-63,956, erythromycin, and metronidazole.
Topics: Animals; Antiprotozoal Agents; Azithromycin; Entamoeba histolytica; Erythromycin; Metronidazole; Time Factors | 1989 |
Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
Topics: Azithromycin; Bacteria; Drug Resistance, Microbial; Enterococcus faecalis; Erythromycin; Escherichia coli; Haemophilus influenzae; Microbial Sensitivity Tests; Quality Control; Staphylococcus aureus; Statistics as Topic | 1989 |
Comparative antimicrobial activity of the new macrolides against Borrelia burgdorferi.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Azithromycin; Borrelia; Clarithromycin; Erythromycin; Fluoroquinolones; Gerbillinae; Leucomycins; Lyme Disease; Microbial Sensitivity Tests; Quinolones; Species Specificity | 1989 |
Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis.
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella; Bordetella pertussis; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Leucomycins; Macrolides; Microbial Sensitivity Tests | 1989 |
Interaction of azithromycin and human phagocytic cells. Uptake of the antibiotic and the effect on the survival of ingested bacteria in phagocytes.
Topics: Azithromycin; Bacteria; Erythrocytes; Erythromycin; Haemophilus influenzae; Humans; In Vitro Techniques; Legionella; Microbial Sensitivity Tests; Monocytes; Neutrophils; Phagocytes; Pulmonary Alveoli; Staphylococcus aureus | 1989 |
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Disease Models, Animal; Erythromycin; Female; Gerbillinae; Half-Life; Haplorhini; Male; Rats; Species Specificity; Tissue Distribution | 1987 |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii.
Topics: Animals; Azithromycin; Clarithromycin; Erythromycin; Female; Leucomycins; Macrophages; Mice; Toxoplasma; Tritium; Uracil | 1988 |
The in-vitro activity of CP-62,993 against Haemophilus influenzae, Branhamella catarrhalis, staphylococci and streptococci.
Topics: Azithromycin; Dose-Response Relationship, Drug; Erythromycin; Haemophilus influenzae; Moraxella catarrhalis; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 1988 |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin.
Topics: Azithromycin; Bacteria; Clarithromycin; Clindamycin; Culture Media; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Hydrogen-Ion Concentration; Leucomycins | 1988 |
Azithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondii.
Topics: Animals; Azithromycin; Brain Diseases; Erythromycin; Mice; Peritonitis; Toxoplasmosis, Animal | 1988 |
Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Azithromycin; Clavulanic Acids; Drug Combinations; Erythromycin; Humans; Moraxella catarrhalis; Time Factors | 1988 |
In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Topics: Azithromycin; Doxycycline; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma pneumoniae; Tetracycline; Ureaplasma | 1988 |
Efficacy of a new macrolide (azithromycin). For acute otitis media in the chinchilla model.
Topics: Acute Disease; Ampicillin; Animals; Azithromycin; Chinchilla; Disease Models, Animal; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Otitis Media | 1988 |
Comparative in vitro activity of the new oral macrolide azithromycin.
Topics: Azithromycin; Bacteria; Erythromycin; Haemophilus; Staphylococcus; Streptococcus | 1988 |
Comparative studies on the effects of erythromycin A and azithromycin upon extracellular release of lysosomal enzymes in inflammatory processes.
Topics: Acetylglucosaminidase; Animals; Arthritis, Experimental; Azithromycin; Erythromycin; Female; Glucuronidase; Humans; In Vitro Techniques; Inflammation; L-Lactate Dehydrogenase; Lysosomes; Male; Neutrophils; Rats; Rats, Inbred Strains | 1988 |
Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex.
Topics: Amikacin; Azithromycin; Cells, Cultured; Drug Interactions; Erythromycin; Humans; Leucomycins; Macrophage Activation; Macrophages; Mycobacterium avium Complex; Tumor Necrosis Factor-alpha | 1988 |
Interpretative criteria for the agar diffusion susceptibility test with azithromycin.
Topics: Agar; Azithromycin; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1988 |
In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens.
Topics: Azithromycin; Bacteria; Clostridium; Enterobacteriaceae; Erythromycin; Salmonella typhi | 1988 |
In-vitro activity of erythromycin, roxithromycin and CP 62993 against common paediatric pathogens.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Child; Erythromycin; Humans; Leucomycins | 1987 |
In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Clindamycin; Erythromycin; Female; Humans; Microbial Sensitivity Tests; Tetracycline | 1987 |
In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Drug Evaluation, Preclinical; Drug Stability; Erythromycin; Female; Half-Life; Klebsiella Infections; Macrolides; Mice; Mice, Inbred DBA; Molecular Structure; Staphylococcal Infections; Streptococcal Infections | 1995 |
Susceptibility of Streptococcus pyogenes to azithromycin, clarithromycin, erythromycin and roxithromycin in vitro.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests; Netherlands; Roxithromycin; Streptococcus pyogenes | 1995 |
[Comparative activity of azithromycin against 100 strains of Neisseria gonorrhoeae].
Topics: Anti-Bacterial Agents; Azithromycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Erythromycin; Humans; In Vitro Techniques; Lactams; Male; Neisseria gonorrhoeae | 1995 |
Susceptibilities of 201 anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin by oxyrase agar dilution and E test methodologies.
Topics: Agar; Azithromycin; Bacteria, Anaerobic; Bacterial Infections; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests; Oxygenases; Roxithromycin | 1995 |
Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Azithromycin; Bacteremia; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; HIV Infections; Humans; Imipenem; Male; Pleurisy; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Sputum; Teicoplanin; Vancomycin | 1994 |
Preclinical toxicology studies with azithromycin: genetic toxicology evaluation.
Topics: Animals; Azithromycin; Biotransformation; Bone Marrow Cells; Cells, Cultured; Chromosome Aberrations; Erythromycin; Female; Humans; Lymphocytes; Male; Mice; Mutagenicity Tests; Mutagens; Salmonella typhimurium | 1993 |
Pharmacokinetics of azithromycin and erythromycin in human endometrial epithelial cells and in cells infected with Chlamydia trachomatis.
Topics: Azithromycin; Cells, Cultured; Chlamydia trachomatis; Endometrium; Epithelium; Erythromycin; Female; Humans | 1994 |
Profiles of outer membrane proteins and lipopolysaccharide of Pseudomonas aeruginosa grown in the presence of sub-MICs of macrolide antibiotics and their relation to enhanced serum sensitivity.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Outer Membrane Proteins; Blood; Erythromycin; Humans; Immunoblotting; Josamycin; Lipopolysaccharides; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sugar Acids | 1994 |
Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis.
Topics: Azithromycin; Erythromycin; Humans; Neutrophils; Phagocytosis; Streptococcus; Streptococcus mutans; Streptococcus pyogenes; Streptococcus sanguis; Surface Properties | 1995 |
Erythromycin inhibits the assembly of the large ribosomal subunit in growing Escherichia coli cells.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Escherichia coli Proteins; Mutation; Peptide Chain Elongation, Translational; Protein Biosynthesis; Ribosomal Proteins; Ribosomes; RNA-Binding Proteins; Structure-Activity Relationship | 1995 |
[The prospects for using the new macrolide antibiotic azithromycin (Sumamed) in the combined treatment of periodontitis].
Topics: Adolescent; Adult; Azithromycin; Bacteria; Drug Evaluation; Erythromycin; Humans; Microbial Sensitivity Tests; Middle Aged; Periodontitis | 1995 |
Intracellular activity of azithromycin against bacterial enteric pathogens.
Topics: Azithromycin; Cefotaxime; Diarrhea; Enterobacteriaceae; Erythromycin; Escherichia coli; Humans; Intestines; Intracellular Fluid; Microbial Sensitivity Tests; Neutrophils; Phagocytosis | 1994 |
Azithromycin uptake and intracellular accumulation by Toxoplasma gondii-infected macrophages.
Topics: Animals; Azithromycin; Erythromycin; Macrophages; Mice; Micrococcus luteus; Microscopy, Electron; Toxoplasma | 1994 |
Validation of NCCLS macrolide (azithromycin, clarithromycin, and erythromycin) interpretive criteria for Haemophilus influenzae tested with the Haemophilus test medium. National Committee for Clinical Laboratory Standards.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Culture Media; Erythromycin; Guidelines as Topic; Haemophilus influenzae; Humans; Microbial Sensitivity Tests | 1994 |
Intravenous azithromycin as salvage therapy in a patient with Legionnaire's disease.
Topics: Adult; Azithromycin; Erythromycin; Humans; Injections, Intravenous; Legionnaires' Disease; Lung; Male; Radiography; Rifampin; Salvage Therapy; Treatment Failure | 1994 |
In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cricetinae; Erythromycin; Lung; Male; Mesocricetus; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Roxithromycin | 1994 |
[Effectiveness of azithromycin relative to chlamydia infection in reactive arthritis].
Topics: Arthritis, Reactive; Azithromycin; Chlamydia Infections; Erythromycin; Female; Humans; Male | 1993 |
Azithromycin for cerebral toxoplasmosis in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Azithromycin; Erythromycin; Humans; Male; Toxoplasmosis, Cerebral | 1993 |
Azithromycin resistance in Campylobacter jejuni and Campylobacter coli.
Topics: Azithromycin; Campylobacter coli; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Humans; Microbial Sensitivity Tests | 1993 |
[Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Roxithromycin; Streptococcal Infections; Streptococcus pyogenes; Time Factors | 1993 |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.
Topics: Azithromycin; Bacteria, Anaerobic; Carbon Dioxide; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Oxygenases; Roxithromycin | 1994 |
Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages.
Topics: Animals; Azithromycin; Bronchoalveolar Lavage Fluid; Erythromycin; Guinea Pigs; Intracellular Fluid; Legionella pneumophila; Legionnaires' Disease; Lung; Macrophages, Alveolar; Male | 1994 |
Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa.
Topics: ADP Ribose Transferases; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Bacterial Toxins; Endopeptidases; Erythromycin; Exotoxins; Microbial Sensitivity Tests; Miocamycin; Pancreatic Elastase; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas aeruginosa Exotoxin A; Roxithromycin; Type C Phospholipases; Virulence Factors | 1994 |
Inhibition of Toxoplasma gondii protein synthesis by azithromycin.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cells, Cultured; Erythromycin; Macrolides; Macrophages; Methionine; Mice; Protozoan Proteins; RNA, Protozoan; Sulfur Radioisotopes; Time Factors; Toxoplasma | 1993 |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi.
Topics: Animals; Azithromycin; Borrelia burgdorferi Group; Clarithromycin; Erythromycin; Humans; Kinetics; Mice; Microbial Sensitivity Tests; Ticks; Time Factors | 1993 |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance.
Topics: Azithromycin; Clarithromycin; Drug Resistance, Microbial; Enterococcus; Erythromycin; Fusobacterium; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Pasteurella multocida; Regression Analysis; Staphylococcus; Statistics as Topic; Streptococcus | 1993 |
Azithromycin inhibition of intracellular Legionella micdadei.
Topics: Azithromycin; Erythromycin; Humans; In Vitro Techniques; Legionella; Microbial Sensitivity Tests; Monocytes; Neutrophils; Phagocytosis | 1993 |
Two new macrolide antibiotics: clarithromycin and azithromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Drug Costs; Erythromycin; Humans | 1993 |
Oxyrase, a method which avoids CO2 in the incubation atmosphere for anaerobic susceptibility testing of antibiotics affected by CO2.
Topics: Anaerobiosis; Azithromycin; Bacteria, Anaerobic; Carbon Dioxide; Drug Resistance, Microbial; Erythromycin; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests; Oxygenases | 1993 |
In-vitro activity of azithromycin on Chlamydia trachomatis infected, polarized human endometrial epithelial cells.
Topics: Azithromycin; Cells, Cultured; Chlamydia Infections; Chlamydia trachomatis; Endometrium; Epithelium; Erythromycin; Female; Humans; Microbial Sensitivity Tests; Microscopy, Electron; Time Factors; Uterine Diseases | 1993 |
Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension.
Topics: Administration, Oral; Adolescent; Azithromycin; Child; Child, Preschool; Erythromycin; Female; Half-Life; Humans; Male; Pharyngitis; Streptococcal Infections; Suspensions | 1993 |
Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria.
Topics: Azithromycin; Cell Membrane; Clarithromycin; Erythromycin; Escherichia coli; Gram-Negative Bacteria; Lipopolysaccharides; Microbial Sensitivity Tests; Polymyxins; Roxithromycin; Salmonella typhimurium | 1993 |
Azithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporine.
Topics: Animals; Antitubercular Agents; Azithromycin; Cyclosporine; Erythromycin; Male; Mycobacterium avium-intracellulare Infection; Rats; Rats, Sprague-Dawley; Rifabutin; Rifampin; Rifamycins; Tissue Distribution | 1993 |
Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice.
Topics: Animals; Azithromycin; Ciprofloxacin; Colony Count, Microbial; Erythromycin; Female; Mice; Microbial Sensitivity Tests; Salmonella Infections, Animal; Salmonella typhimurium; Spleen | 1993 |
Uptake and subcellular distribution of azithromycin in human phagocytic cells. Demonstration of the antibiotic in neutrophil polymorphonuclear leucocytes and monocytes by autoradiography and electron microscopy.
Topics: Autoradiography; Azithromycin; Erythromycin; Humans; In Vitro Techniques; Macrophages, Alveolar; Microscopy, Electron; Monocytes; Neutrophils; Phagocytes | 1993 |
Effectiveness of early Lyme disease treatment.
Topics: Azithromycin; Drug Administration Schedule; Erythromycin; Humans; Lyme Disease | 1993 |
Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Fluoroquinolones; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Quinolones | 1993 |
In-vitro activity of ciprofloxacin, temafloxacin, azithromycin, clarithromycin and metronidazole against Giardia lamblia.
Topics: Animals; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Fluoroquinolones; Giardia lamblia; Metronidazole; Microbial Sensitivity Tests; Quinolones | 1993 |
Preincubation of Haemophilus influenzae with subinhibitory concentrations of macrolides: influence on human neutrophil chemiluminescence.
Topics: Anti-Bacterial Agents; Azithromycin; Erythromycin; Filtration; Haemophilus influenzae; Humans; Luminescent Measurements; Microbial Sensitivity Tests; Neutrophils; Opsonin Proteins; Suspensions; Tetradecanoylphorbol Acetate | 1993 |
In vitro activity of azithromycin against bacterial enteric pathogens.
Topics: Azithromycin; Enterobacteriaceae; Enterobacteriaceae Infections; Erythromycin; Humans; Microbial Sensitivity Tests | 1993 |
Azithromycin for treatment of severe Cryptosporidium diarrhea in two children with cancer.
Topics: Administration, Oral; Azithromycin; Child, Preschool; Combined Modality Therapy; Cryptosporidiosis; Diarrhea; Diarrhea, Infantile; Drug Evaluation; Erythromycin; Fluid Therapy; Humans; Infant; Male; Mediastinal Neoplasms; Neuroblastoma; Opportunistic Infections; Sarcoma | 1993 |
Glycoside antibiotics alone and combined with tetracyclines for prophylaxis of experimental cryptosporidiosis in neonatal BALB/c mice.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cryptosporidiosis; Cryptosporidium parvum; Disease Models, Animal; Doxycycline; Drug Synergism; Drug Therapy, Combination; Erythromycin; Mice; Mice, Inbred BALB C; Minocycline; Paromomycin; Tetracyclines | 1993 |
Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Movement; Clarithromycin; Erythromycin; Hemolysin Proteins; Humans; Lipase; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Pyocyanine; Virulence | 1993 |
Antimalarial activity of azithromycin and erythromycin against Plasmodium berghei.
Topics: Animals; Antiprotozoal Agents; Azithromycin; Chloroquine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Erythromycin; Malaria; Male; Mice; Plasmodium berghei; Specific Pathogen-Free Organisms | 1993 |
Azithromycin-induced acute interstitial nephritis.
Topics: Acute Disease; Adult; Azithromycin; Erythromycin; Humans; Male; Nephritis, Interstitial; Respiratory Tract Infections | 1993 |
In-vitro concentration of azithromycin in human phagocytic cells.
Topics: Azithromycin; Chromatography, High Pressure Liquid; Erythromycin; Humans; Intracellular Fluid; Macrophages, Alveolar; Neutrophils | 1993 |
Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses.
Topics: Abscess; Animals; Azithromycin; Cephalexin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Male; Mice; Mice, Inbred Strains; Rats; Roxithromycin; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1993 |
A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease.
Topics: Administration, Inhalation; Administration, Oral; Aerosols; Animals; Azithromycin; Clarithromycin; Disease Models, Animal; Erythromycin; Female; Guinea Pigs; Legionella pneumophila; Legionnaires' Disease; Lung | 1993 |
Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhoea in men and women.
Topics: Administration, Oral; Adolescent; Adult; Azithromycin; Chlamydia Infections; Drug Administration Schedule; Erythromycin; Female; Follow-Up Studies; Gonorrhea; Humans; Male; Middle Aged; Neisseria gonorrhoeae | 1993 |
The comparative activity of azithromycin, macrolides and amoxycillin against streptococci in experimental infections.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Endocarditis, Bacterial; Erythromycin; Female; Gerbillinae; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Otitis Media; Pneumococcal Infections; Pneumonia; Rats; Roxithromycin; Streptococcal Infections; Streptococcus pyogenes | 1993 |
Selection of dose regimens of azithromycin .
Topics: Administration, Oral; Azithromycin; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Models, Biological; Palatine Tonsil; Prostate; Uterus | 1993 |
Preferential concentration of azithromycin in an infected mouse thigh model.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Erythromycin; Histamine; Inflammation; Male; Mice; Mice, Inbred Strains; Staphylococcal Infections; Staphylococcus aureus; Thigh | 1993 |
Comparison of the pharmacokinetics of three-day and five-day regimens of azithromycin in plasma and urine.
Topics: Administration, Oral; Adult; Azithromycin; Drug Administration Schedule; Erythromycin; Female; Half-Life; Humans; Male; Middle Aged | 1993 |
Pharmacokinetics of azithromycin in patients with impaired hepatic function.
Topics: Adult; Aged; Azithromycin; Erythromycin; Female; Half-Life; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Tissue Distribution | 1993 |
In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline.
Topics: Azithromycin; Chlamydia trachomatis; Erythromycin; Microbial Sensitivity Tests; Minocycline; Mycoplasma; Roxithromycin; Ureaplasma urealyticum | 1993 |
9a,11-cyclic carbamates of 15-membered azalides.
Topics: Azithromycin; Bacteria; Erythromycin; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Structure-Activity Relationship | 1993 |
[The particular case of azalides: antibiotic diapedesis. Experimental data from a murine model of pneumococcal pneumonia].
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Erythromycin; Injections, Subcutaneous; Mice; Pneumonia, Pneumococcal; Roxithromycin; Spiramycin | 1995 |
In vivo efficacy of azithromycin in treatment of systemic infection and septic arthritis induced by type IV group B Streptococcus strains in mice: comparative study with erythromycin and penicillin G.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Infectious; Azithromycin; Chronic Disease; Erythromycin; Female; Joints; Kidney; Male; Mice; Microbial Sensitivity Tests; Penicillin G; Penicillins; Streptococcal Infections; Streptococcus agalactiae | 1995 |
Treatment of syphilis with azithromycin.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Drug Administration Schedule; Erythromycin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Penicillins; Remission Induction; Syphilis; Time Factors; Treatment Outcome | 1996 |
Interaction of macrolides with alpha dornase during DNA hydrolysis.
Topics: Azithromycin; Deoxyribonuclease I; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythromycin; Humans; Hydrolysis; Kinetics; Recombinant Proteins; Roxithromycin | 1996 |
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Tetracycline | 1996 |
Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods.
Topics: Agar; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Evaluation Studies as Topic; Gonorrhea; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1996 |
Susceptibility of macrolide and beta-lactam antibiotics of Streptococcus pyogenes strains isolated over a four-year period in central Italy.
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactam Resistance; Ceftibuten; Ceftriaxone; Cephalosporins; Chi-Square Distribution; Erythromycin; Humans; Italy; Microbial Sensitivity Tests; Penicillin G; Streptococcus pyogenes | 1996 |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; United States | 1996 |
Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides.
Topics: Anti-Bacterial Agents; Azithromycin; Base Sequence; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Molecular Sequence Data; Staphylococcus aureus | 1996 |
Effect of macrolide antibiotics on macrophage functions.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cell Line; Chemotaxis; Clarithromycin; Cytotoxicity, Immunologic; Dose-Response Relationship, Drug; Erythromycin; Macrophages; Mice; Phagocytosis; Roxithromycin | 1996 |
Cytotoxicity of macrolide antibiotics in a cultured human liver cell line.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Epithelial Cells; Epithelium; Erythromycin; Humans; Liver; Proteins; Roxithromycin; Tetrazolium Salts; Thiazoles | 1996 |
Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Clarithromycin; Erythromycin; Kinetics; Microbial Sensitivity Tests; Protein Synthesis Inhibitors; Pseudomonas aeruginosa | 1996 |
Comparison of Etest to broth microdilution method for testing Streptococcus pneumoniae susceptibility to levofloxacin and three macrolides.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae | 1996 |
In vitro activity of macrolides against intracellular Legionella pneumophila.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Clarithromycin; Erythromycin; Humans; Legionella pneumophila; Legionnaires' Disease; Microbial Sensitivity Tests | 1996 |
Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils.
Topics: Adult; Anti-Asthmatic Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Azithromycin; Calcimycin; Cell Membrane; Clarithromycin; Erythromycin; Humans; Ionophores; Luminescent Measurements; Lysophosphatidylcholines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Respiratory Burst; Roxithromycin; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1996 |
The Etest for antimicrobial susceptibility testing of Bartonella henselae.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bartonella henselae; Cats; Ciprofloxacin; Doxycycline; Erythromycin; Humans; Microbial Sensitivity Tests; Rifampin; Vancomycin | 1996 |
Depression of the N-demethylation of erythromycin, azithromycin, clarithromycin and clindamycin in murine Toxoplasma infection.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Azithromycin; Clarithromycin; Clindamycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Erythromycin; Intestinal Mucosa; Jejunum; Kinetics; Mice; Microsomes; Microsomes, Liver; Oxidoreductases, N-Demethylating; Reference Values; Time Factors; Toxoplasmosis, Animal | 1996 |
Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes.
Topics: Anti-Bacterial Agents; Azithromycin; Calcium; Clarithromycin; Drug Evaluation, Preclinical; Erythromycin; Humans; Hydrogen-Ion Concentration; Macrophages, Alveolar; Monocytes; Neutrophils; Phagocytes; Temperature | 1997 |
The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteroides fragilis; Chlamydia; Ciprofloxacin; Clarithromycin; Doxycycline; Enterobacter; Erythromycin; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Haemophilus influenzae; Microbial Sensitivity Tests; Naphthyridines; Piperazines; Pseudomonas aeruginosa; Quinolones; Streptococcus pneumoniae | 1997 |
Effect of macrolide antibiotics on neutrophil function in human peripheral blood.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chemotaxis, Leukocyte; Erythromycin; Humans; Miocamycin; Neutrophil Activation; Neutrophils | 1997 |
Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Drug Resistance, Microbial; Erythromycin; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1997 |
Comparison of Etest and agar dilution for testing the activity of three macrolides against Bordetella parapertussis.
Topics: Agar; Anti-Bacterial Agents; Azithromycin; Bordetella; Child; Clarithromycin; Erythromycin; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests | 1997 |
Azithromycin in gonorrhoea.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Resistance, Microbial; Erythromycin; Gonorrhea; Humans; Neisseria gonorrhoeae | 1997 |
Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; United States | 1997 |
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Clarithromycin; Clindamycin; Endocarditis, Bacterial; Erythromycin; Rabbits; Streptococcus | 1997 |
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteriological Techniques; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Sensitivity and Specificity; Species Specificity; Streptococcus pneumoniae | 1997 |
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Erythromycin; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Roxithromycin; Streptococcus pneumoniae | 1997 |
Comparative antianaerobic activities of the ketolides HMR 3647 (RU 66647) and HMR 3004 (RU 64004).
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Carbon Dioxide; Clarithromycin; Erythromycin; Hydrogen-Ion Concentration; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin | 1997 |
In vitro activity of trovafloxacin against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chlamydophila pneumoniae; Doxycycline; Erythromycin; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin | 1997 |
Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Charcoal; Ciprofloxacin; Clarithromycin; Culture Media; Erythromycin; Humans; Legionella; Legionella pneumophila; Legionellosis; Microbial Sensitivity Tests; Ofloxacin; Reproducibility of Results; Starch | 1997 |
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin; Streptococcus pneumoniae | 1997 |
[Comparative antimicrobial activity of RP 59,500 (quinupristin-dalfopristin), the first semisynthetic injectable streptgramin, against gram-positive cocci and other recent clinical pathogens].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Enterococcus; Erythromycin; Gram-Positive Cocci; Humans; Methicillin Resistance; Roxithromycin; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes; Virginiamycin | 1997 |
[Diagnosis and therapy of Chlamydia pneumoniae and trachomatis].
Topics: Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlamydophila pneumoniae; Dose-Response Relationship, Drug; Doxycycline; Drug Administration Schedule; Erythromycin; Humans; Immunoglobulin A; Immunoglobulin G; Microbial Sensitivity Tests | 1997 |
[Five years of sumamed on Russian market].
Topics: Anti-Bacterial Agents; Azithromycin; Clinical Trials as Topic; Erythromycin; Gram-Negative Bacteria; Humans; Product Surveillance, Postmarketing; Therapeutic Equivalency | 1997 |
Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Disease Models, Animal; Erythromycin; Female; Mice; Peritonitis; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1998 |
Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Erythromycin; HL-60 Cells; Humans; Legionella; Legionella pneumophila; Macrolides; Microbial Sensitivity Tests; Monocytes; Roxithromycin; Virginiamycin | 1998 |
In vitro activity of oral antimicrobial agents against clinical isolates of Pasteurella multocida.
Topics: Anti-Bacterial Agents; Antimalarials; Azithromycin; Erythromycin; Humans; Lactams; Microbial Sensitivity Tests; Pasteurella multocida; Tetracyclines; Trimethoprim | 1998 |
In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella; Bordetella pertussis; Clarithromycin; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Rifabutin; Rifampin; Roxithromycin | 1998 |
Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Bacterial Infections; Carbon Dioxide; Clarithromycin; Colony Count, Microbial; Culture Media; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Gram-Negative Bacteria; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Oxygenases | 1998 |
Synergic interactions of macrolides and proton-pump inhibitors against Helicobacter pylori: a comparative in-vitro study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Synergism; Erythromycin; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Roxithromycin | 1998 |
Computer-aided prediction of macrolide antibiotic concentrations in human circulating polymorphonuclear leucocytes.
Topics: Anti-Bacterial Agents; Azithromycin; Computer Simulation; Erythromycin; Humans; Models, Biological; Neutrophils; Predictive Value of Tests | 1998 |
Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated f
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacteria, Aerobic; Bacteria, Anaerobic; Bites, Human; Clarithromycin; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin; Skin Diseases, Bacterial; Soft Tissue Infections; Wounds and Injuries | 1998 |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae | 1998 |
[Effects of macrolide antibiotics to inhibit infiltration and proliferation of malignant tumor cells--in vitro evaluation].
Topics: Anti-Bacterial Agents; Azithromycin; Cell Division; Cell Line; Clarithromycin; Erythromycin; Fibrosarcoma; Humans; Immunologic Factors; Neoplasm Invasiveness; Roxithromycin; Teratocarcinoma; Tumor Cells, Cultured | 1997 |
[Actions of macrolide antibiotics on alginate production by Pseudomonas aeruginosa].
Topics: Alginates; Animals; Anti-Bacterial Agents; Antigen-Antibody Complex; Azithromycin; Clarithromycin; Erythromycin; Humans; Leucomycins; Macrolides; Mice; Pseudomonas aeruginosa; Roxithromycin | 1997 |
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Chlamydophila pneumoniae; Erythromycin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Roxithromycin | 1998 |
Comparison of four antibiotics in a murine model of necrotizing cutaneous infections caused by toxigenic Streptococcus pyogenes and Staphylococcus aureus.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Clarithromycin; Disease Models, Animal; Erythromycin; Fasciitis, Necrotizing; Mice; Mice, Hairless; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pyogenes | 1998 |
Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Methicillin Resistance; Microbial Sensitivity Tests; Protein Biosynthesis; Ribosomes; Staphylococcus aureus | 1998 |
Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clarithromycin; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 1998 |
Synthesis of 6-O-methyl-azithromycin and its ketolide analogue via Beckmann rearrangement of 9(E)-6-O-methyl-erythromycin oxime.
Topics: Anti-Bacterial Agents; Azithromycin; Erythromycin; Escherichia coli; Haemophilus influenzae; Ketolides; Macrolides; Microbial Sensitivity Tests; Models, Molecular; Staphylococcus aureus; Streptococcus; Structure-Activity Relationship | 1998 |
Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models.
Topics: Anti-Bacterial Agents; Azithromycin; Cell-Free System; Cells, Cultured; Computer Simulation; Enzyme Inhibitors; Erythromycin; Macrolides; Molecular Conformation; Phospholipases A; Phospholipases A1; Phospholipids; Roxithromycin | 1999 |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents.
Topics: Anti-Bacterial Agents; Azithromycin; Carbon Dioxide; Clarithromycin; Colony Count, Microbial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Hydrogen-Ion Concentration; Lung Diseases, Obstructive; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Sputum; Streptococcus pneumoniae | 1999 |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; beta-Lactamases; Clarithromycin; Clindamycin; Drug Therapy, Combination; Erythromycin; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; Ketolides; Macrolides; Metronidazole; Microbial Sensitivity Tests; Roxithromycin; Virginiamycin | 1999 |
Azithromycin versus erythromycin for community-acquired pneumonia: a cost-minimization analysis.
Topics: Anti-Bacterial Agents; Azithromycin; Community-Acquired Infections; Erythromycin; Humans; Male; Medical Records; Middle Aged; Pneumonia; Retrospective Studies | 1999 |
Influence of increased macrolide consumption on macrolide resistance of common respiratory pathogens.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Prescriptions; Drug Resistance, Microbial; Drug Utilization; Erythromycin; Humans; Moraxella; Respiratory Tract Infections; Streptococcus | 1999 |
[Tissue penetration properties of macrolide antibiotics--comparative tissue distribution of erythromycin-stearate, clarithromycin, roxithromycin and azithromycin in rats].
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Male; Organ Specificity; Rats; Rats, Wistar; Roxithromycin | 1999 |
Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7.
Topics: Animals; Anti-Infective Agents; Azithromycin; Bacterial Toxins; Chlorocebus aethiops; Clarithromycin; Dose-Response Relationship, Drug; Enterotoxins; Erythromycin; Escherichia coli O157; Fluoroquinolones; Humans; Macrolides; Norfloxacin; Piperazines; Quinolones; Shiga Toxin 1; Time Factors; Vero Cells | 1999 |
Anti-inflammatory activity of macrolide antibiotics.
Topics: 6-Ketoprostaglandin F1 alpha; Adrenalectomy; Anesthesia; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Carrageenan; Cell Line; Clarithromycin; Cyclooxygenase 2; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Erythromycin; Inflammation Mediators; Isoenzymes; Leukotriene B4; Macrophages; Mice; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Pleurisy; Prostaglandin-Endoperoxide Synthases; Rats; Roxithromycin; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
National guideline for the management of Chlamydia trachomatis genital tract infection. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Breast Feeding; Chlamydia Infections; Chlamydia trachomatis; Contact Tracing; Contraindications; Doxycycline; Erythromycin; Female; Humans; Male; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious; Urethritis | 1999 |
National guideline for the management of non-gonococcal urethritis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases)
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Chlortetracycline; Contact Tracing; Demeclocycline; Doxycycline; Drug Therapy, Combination; Erythromycin; Humans; Male; Ofloxacin; Recurrence; Tetracycline; Urethritis | 1999 |
National guideline for the management of chancroid. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Azithromycin; Breast Feeding; Ceftriaxone; Chancroid; Ciprofloxacin; Contraindications; Erythromycin; Female; Genital Diseases, Female; Genital Diseases, Male; Haemophilus ducreyi; Humans; Male; Pregnancy; Pregnancy Complications, Infectious; Ulcer | 1999 |
Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Azithromycin; Chloroquine; Doxycycline; Erythromycin; Female; Macaca mulatta; Malaria; Male; Mice; Parasitemia; Plasmodium cynomolgi; Plasmodium yoelii; Primaquine; Pyrimethamine | 2000 |
Association of chronic urinary symptoms in women and Ureaplasma urealyticum.
Topics: Adolescent; Adult; Aged; Azithromycin; Bacteriological Techniques; Bacteriuria; Chronic Disease; Cystitis, Interstitial; Doxycycline; Erythromycin; Female; Humans; Middle Aged; Ofloxacin; Treatment Outcome; Ureaplasma Infections; Ureaplasma urealyticum; Urination Disorders | 2000 |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Cefaclor; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Erythromycin; Fluoroquinolones; Humans; Models, Economic; Outpatients; Pneumonia; Treatment Outcome | 2000 |
The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Chromatography, Liquid; Erythromycin; Female; Humans; Maternal-Fetal Exchange; Pregnancy; Pregnancy Complications, Infectious; Roxithromycin; Treatment Outcome | 2000 |
Treatment of Chlamydia pneumoniae.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibodies, Bacterial; Azithromycin; Child; Child, Preschool; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Erythromycin; Humans; Pneumonia, Bacterial | 2000 |
Is azithromycin monotherapy as efficacious as cefuroxime plus erythromycin for the treatment of community-acquired pneumonia in hospitalized patients?
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefuroxime; Cephalosporins; Community-Acquired Infections; Drug Administration Schedule; Drug Therapy, Combination; Erythromycin; Hospitalization; Humans; Injections, Intravenous; Multicenter Studies as Topic; Pneumonia; Randomized Controlled Trials as Topic | 2000 |
Decreased susceptibility to azithromycin and erythromycin mediated by a novel mtr(R) promoter mutation in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Erythromycin; Ferredoxin-NADP Reductase; Gene Expression; Humans; Male; Mutation; Neisseria gonorrhoeae; Promoter Regions, Genetic; Repressor Proteins | 2001 |
In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Cells, Cultured; Chlamydia trachomatis; Clarithromycin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Roxithromycin; Tetracycline | 2001 |
Postantibiotic suppression effect of macrolides on the expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Administration Schedule; Electrophoresis, Polyacrylamide Gel; Erythromycin; Flagellin; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Time Factors; Virulence | 2001 |
Comparative in vitro activity of ABT-773, a novel antibacterial ketolide.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple; Enterococcus; Erythromycin; Helicobacter pylori; Humans; Ketolides; Microbial Sensitivity Tests; Staphylococcus; Streptococcus; Time Factors | 2001 |
Azithromycin, a lysosomotropic antibiotic, impairs fluid-phase pinocytosis in cultured fibroblasts.
Topics: Adenosine Triphosphate; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Azithromycin; Cell Membrane; Cells, Cultured; Coloring Agents; DNA; Erythromycin; Fetus; Fibroblasts; Horseradish Peroxidase; Humans; Ionophores; Lysosomes; Microscopy, Electron; Monensin; Nocodazole; Phospholipids; Pinocytosis; Protein Binding; Rats; Rats, Wistar; Tolonium Chloride; Transferrin; Transport Vesicles; Vacuoles | 2001 |
In vitro activity of midecamycin diacetate, a 16-membered macrolide, against Streptococcus pyogenes isolated in France, 1995-1999.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Colony Count, Microbial; Drug Resistance, Microbial; Erythromycin; France; Humans; Josamycin; Leucomycins; Microbial Sensitivity Tests; Phenotype; Polymerase Chain Reaction; Roxithromycin; Streptococcus pyogenes | 2001 |
Reversible ototoxic effect of azithromycin and clarithromycin on transiently evoked otoacoustic emissions in guinea pigs.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Guinea Pigs; Injections, Intravenous; Otoacoustic Emissions, Spontaneous | 2001 |
Relative potency of telithromycin, azithromycin and erythromycin against recent clinical isolates of gram-positive cocci.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Resistance, Microbial; Erythromycin; Gram-Positive Cocci; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Probability; Sensitivity and Specificity | 2001 |
Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae an
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance; Erythromycin; Ketolides; Macrolides; Microbial Sensitivity Tests; Streptococcus pneumoniae; Streptococcus pyogenes | 2001 |
Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countries.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Resistance, Bacterial; Erythromycin; Europe, Eastern; Genes, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Streptococcus pyogenes | 2002 |
Single antibiotic therapy as effective as dual in treating patients hospitalized with community acquired pneumonia.
Topics: Azithromycin; Cefuroxime; Cost Savings; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Humans; Outcome and Process Assessment, Health Care; Pneumonia; Practice Guidelines as Topic; Treatment Outcome; United States | 2000 |
Potential of macrolide antibiotics to inhibit protein synthesis of Pseudomonas aeruginosa: suppression of virulence factors and stress response.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Proteins; Ceftazidime; Cephalosporins; Clarithromycin; Clindamycin; Erythromycin; In Vitro Techniques; Josamycin; Microbial Sensitivity Tests; Minocycline; Ofloxacin; Oleandomycin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2000 |
Endothelial cell compatibility of azithromycin and erythromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Cells, Cultured; Drug Evaluation, Preclinical; Endothelium, Vascular; Erythromycin; Humans; Pharmaceutical Solutions; Umbilical Veins | 2002 |
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Pharynx; Polymerase Chain Reaction; Streptococcal Infections; Streptococcus | 2002 |
Inhibition of 50S ribosomal subunit assembly in Haemophilus influenzae cells by azithromycin and erythromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Dose-Response Relationship, Drug; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Ribosomes | 2002 |
Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumophila.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Erythromycin; HL-60 Cells; Humans; Ketolides; Legionella pneumophila; Microbial Sensitivity Tests | 2002 |
In vitro and ex vivo effects of erythromycin A, azithromycin and josamycin on the splenic response to specific antigens and mitogens.
Topics: Animals; Anti-Bacterial Agents; Antigens; Azithromycin; Cell Survival; Erythrocytes; Erythromycin; Injections, Intraperitoneal; Josamycin; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mitogens; Sheep; Spleen | 2002 |
Effects of erythromycin, clarithromycin, roxithromycin and azithromycin on murine gut colonization by Candida albicans.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Azithromycin; Candida albicans; Candidiasis; Clarithromycin; Digestive System; Drug Therapy, Combination; Erythromycin; Mice; Mice, Inbred ICR; Roxithromycin; Tissue Distribution | 2002 |
Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Canada; DNA, Bacterial; Drug Resistance; Erythromycin; Gonorrhea; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Nucleic Acid Conformation; Oligonucleotide Probes; Peptidyl Transferases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Ribosomal, 23S; Transformation, Bacterial | 2002 |
Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Cystic Fibrosis; DNA, Bacterial; Drug Resistance; Erythromycin; Genes, Bacterial; Humans; Membrane Transport Proteins; Methyltransferases; Microbial Sensitivity Tests; Mutation; Oligonucleotide Probes; Reverse Transcriptase Polymerase Chain Reaction; Ribosomes; Staphylococcal Infections; Staphylococcus aureus | 2002 |
Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts.
Topics: Alkaline Phosphatase; Anti-Bacterial Agents; Apoptosis; Azithromycin; Cell Survival; Cells, Cultured; Clarithromycin; Collagen Type I; Dose-Response Relationship, Drug; Erythromycin; Fibroblasts; Gene Expression; Humans; Josamycin; Lethal Dose 50; Leucomycins; Miocamycin; Periodontal Ligament; RNA, Messenger; Roxithromycin; Statistics as Topic; Time Factors | 2002 |
Bactericidal effect and pharmacodynamics of cethromycin (ABT-773) in a murine pneumococcal pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clindamycin; Disease Models, Animal; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Ketolides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2002 |
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
Topics: Animals; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Blood Pressure; Clarithromycin; Electrocardiography; Erythromycin; Heart; Heart Rate; In Vitro Techniques; Long QT Syndrome; Male; Rabbits; Time Factors; Torsades de Pointes | 2002 |
Reoccurrence of culture-positive pertussis in an infant initially treated with azithromycin and steroids.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Dexamethasone; Erythromycin; Humans; Infant; Male; Recurrence; Treatment Failure; Whooping Cough | 2002 |
[Macrolide consumption according to geographic areas in the province of Valladolid].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Utilization Review; Erythromycin; Humans; Leucomycins; Retrospective Studies; Roxithromycin; Spain; Spiramycin | 2002 |
A comparison between disk diffusion and microdilution for susceptibility testing of Mycobacterium fortuitum complex.
Topics: Amikacin; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Erythromycin; Microbial Sensitivity Tests; Mycobacterium fortuitum; Ofloxacin; Tetracycline | 2002 |
[Comparative in vitro activities of several antimicrobial agents against Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Gastric Mucosa; Helicobacter pylori; Humans; Levofloxacin; Microbial Sensitivity Tests; Norfloxacin; Ofloxacin; Penicillins; Stomach Ulcer | 2002 |
Structural basis for the antibiotic activity of ketolides and azalides.
Topics: Anti-Bacterial Agents; Azithromycin; Erythromycin; Ketolides; Ribosomes; RNA, Ribosomal; Structure-Activity Relationship | 2003 |
[Effects of 14-, 15-, and 16-membered ring macrolides on IL-8 gene expression in BET-1A cells].
Topics: Anti-Bacterial Agents; Azithromycin; Bronchi; Cells, Cultured; Clarithromycin; Depression, Chemical; Epithelial Cells; Erythromycin; Gene Expression; Humans; Inflammation Mediators; Interleukin-8; Miocamycin; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2001 |
Correlation between erythromycin and azithromycin resistance in Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Drug Resistance, Multiple, Bacterial; Drug Utilization; Erythromycin; Humans; Microbial Sensitivity Tests; Otitis Media; Pneumococcal Infections; South Africa; Streptococcus pneumoniae; Treatment Outcome | 2003 |
Prediction of the in vivo interaction between midazolam and macrolides based on in vitro studies using human liver microsomes.
Topics: Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Azithromycin; Clarithromycin; Cytochrome P-450 CYP3A; Drug Interactions; Erythromycin; Humans; Hydroxylation; Macrolides; Microsomes, Liver; Midazolam; Models, Biological; Oxidoreductases, N-Demethylating; Time Factors | 2003 |
Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefpodoxime; Ceftizoxime; Ceftriaxone; Child; Drug Resistance, Bacterial; Erythromycin; France; Humans; In Vitro Techniques; Josamycin; Ketolides; Macrolides; Penicillin G; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae | 2003 |
Halting a pneumococcal pneumonia outbreak among United States Marine Corps trainees.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Azithromycin; California; Disease Outbreaks; Erythromycin; Humans; Male; Military Personnel; Penicillin G Benzathine; Pneumococcal Vaccines; Pneumonia, Pneumococcal; Risk Factors; Streptococcus pneumoniae | 2003 |
[Antimicrobial activities of macrolides against recent clinical isolates, and analysis of resistant mechanisms].
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Miocamycin; Moraxella catarrhalis; Staphylococcus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 2003 |
Macrolide antibiotics directly reduce active oxygen generation by neutrophils in human peripheral blood.
Topics: Anti-Bacterial Agents; Azithromycin; Erythromycin; Humans; Neutrophils; Reactive Oxygen Species | 2003 |
Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Adhesion; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Clarithromycin; Enoxacin; Epithelial Cells; Erythromycin; Fibroblast Growth Factors; Gingiva; Humans; Integrins; Keratins; Laminin; Lethal Dose 50; Minocycline; Ofloxacin; Proteins; Roxithromycin; Tetracycline | 2004 |
Antimicrobial susceptibility trends in Campylobacter jejuni and Campylobacter coli isolated from a rural Egyptian pediatric population with diarrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Egypt; Erythromycin; Female; Humans; Incidence; Infant; Male; Microbial Sensitivity Tests; Pediatrics; Probability; Rural Population; Sensitivity and Specificity | 2003 |
Modification of phagocytosis and cytokine production in peritoneal and splenic murine cells by erythromycin A, azithromycin and josamycin.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Candida albicans; Cytokines; Enzyme-Linked Immunosorbent Assay; Erythromycin; In Vitro Techniques; Interleukin-12; Interleukin-18; Interleukin-4; Josamycin; Macrophages, Peritoneal; Male; Mice; Mice, Inbred BALB C; Phagocytosis; Spleen | 2004 |
[Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Pharynx; Phenotype; Streptococcus pyogenes | 2003 |
Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin.
Topics: Animals; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azithromycin; Bile; Cyclosporine; Erythromycin; Hyperbilirubinemia; Immunosuppressive Agents; Intestinal Mucosa; Kidney; Liver; Male; Mitochondrial Proteins; Probenecid; Rats; Rats, Sprague-Dawley; Rats, Wistar; Renal Agents; Ribosomal Proteins; Saccharomyces cerevisiae Proteins; Tissue Distribution | 2004 |
[Equally whether the child's lung or chronically inflamed bronchi. Acute bacterial infections have to be terminated fast].
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchitis, Chronic; Child; Clinical Trials as Topic; Double-Blind Method; Erythromycin; Humans; Middle Aged; Multicenter Studies as Topic; Ofloxacin; Pneumonia, Bacterial; Pulmonary Disease, Chronic Obstructive; Radiography, Thoracic; Randomized Controlled Trials as Topic; Time Factors | 2004 |
Rates of Chlamydia trachomatis testing and chlamydial infection in pregnant women.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Databases as Topic; Erythromycin; Female; Humans; Incidence; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Laboratories; Male; Mass Screening; Middle Aged; New Zealand; Pregnancy; Pregnancy Complications, Infectious | 2004 |
Ophthalmomyiasis caused by the sheep bot fly Oestrus ovis in northern Iraq.
Topics: Adult; Animals; Anti-Bacterial Agents; Azithromycin; Blepharitis; Conjunctivitis; Diptera; Edema; Erythromycin; Eye Infections, Parasitic; Humans; Iraq; Larva; Male; Military Medicine; Military Personnel; Myiasis; Orbital Diseases | 2004 |
Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
Topics: Anti-Bacterial Agents; Austria; Azithromycin; Bacterial Proteins; beta-Lactams; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Hungary; Josamycin; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Pharyngitis; Pharynx; Skin; Streptococcal Infections; Streptococcus pyogenes; Tetracycline Resistance; Tonsillitis; Vagina | 2004 |
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Ketolides; Macrolides; Microbial Sensitivity Tests; Mutation; Streptococcus pneumoniae; Time Factors | 2004 |
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Ketolides; Macrolides; Microbial Sensitivity Tests; Ribosomal Proteins; RNA, Ribosomal, 23S; Time Factors | 2004 |
Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Genotype; Microbial Sensitivity Tests; Phenotype; Phylogeny; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae | 2004 |
In vitro activity of azithromycin and dirithromycin against axenic Entamoeba histolytica.
Topics: Animals; Antiprotozoal Agents; Azithromycin; Entamoeba histolytica; Erythromycin; Parasitic Sensitivity Tests | 2004 |
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Cefotaxime; Ceftriaxone; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Erythromycin; Humans; Pneumonia, Bacterial | 2005 |
An economic and outcomes assessment of first-line monotherapy in the treatment of community-acquired pneumonia within managed care.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Databases as Topic; Erythromycin; Female; Health Care Costs; Humans; Levofloxacin; Male; Managed Care Programs; Middle Aged; Models, Econometric; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Risk Assessment; Treatment Outcome | 2005 |
Macrolides with promotive activity of monocyte to macrophage differentiation.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Erythromycin; Humans; Immunologic Factors; Macrolides; Macrophages; Structure-Activity Relationship | 2005 |
Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Binding Sites; Clindamycin; Crystallography; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Haloarcula marismortui; Ketolides; Mutation; Protein Binding; Ribosomes; RNA, Ribosomal, 23S; Virginiamycin | 2005 |
Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats.
Topics: Acetic Acid; Animals; Azithromycin; Colitis, Ulcerative; Colon; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Erythromycin; Interferon-gamma; Male; Nitric Oxide Synthase; Peroxidase; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2005 |
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cell Line; Clarithromycin; Dogs; Epithelial Cells; Erythromycin; Humans; Ketolides; Macrolides; Mice; Neutrophils; Phagocytes | 2005 |
Accumulation and clearance of orally administered erythromycin and its derivative, azithromycin, in juvenile fall chinook salmon Oncorhynchus tshawytscha.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aquaculture; Azithromycin; Erythromycin; Histological Techniques; Salmon; Tissue Distribution | 2005 |
Characterization of the MacA-MacB efflux system in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Azithromycin; Bacterial Outer Membrane Proteins; Bacterial Proteins; Base Sequence; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Gene Deletion; Gene Expression; Lipoproteins; Macrolides; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Neisseria gonorrhoeae; Open Reading Frames; Operon; Promoter Regions, Genetic; Sequence Analysis, DNA; Transcription, Genetic | 2005 |
Prediction of time-dependent CYP3A4 drug-drug interactions: impact of enzyme degradation, parallel elimination pathways, and intestinal inhibition.
Topics: Algorithms; Area Under Curve; Azithromycin; Biological Transport; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Diltiazem; Drug Interactions; Enzyme Inhibitors; Erythromycin; Humans; Intestinal Mucosa; Intestines; Metabolic Clearance Rate; Models, Biological; Time Factors | 2006 |
Legionella pneumophila pneumonia during pregnancy: a case report.
Topics: Adult; Anti-Bacterial Agents; Antibodies, Bacterial; Azithromycin; Enzyme-Linked Immunosorbent Assay; Erythromycin; Female; Humans; Legionella pneumophila; Legionnaires' Disease; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Respiration, Artificial; Rifampin; Treatment Outcome | 2006 |
Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.
Topics: Azithromycin; Bacterial Proteins; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gene Dosage; Humans; Ketolides; Macrolides; Membrane Proteins; Phenotype; Promoter Regions, Genetic; Streptococcus pneumoniae | 2005 |
Recommended antimicrobial agents for the treatment and postexposure prophylaxis of pertussis: 2005 CDC Guidelines.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Clarithromycin; Erythromycin; Humans; Infant; Whooping Cough | 2005 |
Pharmaceutical prescribing for children. Part 3. Antibiotic prescribing for children with odontogenic infections.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Erythromycin; Focal Infection, Dental; Humans; Metronidazole; Penicillin V | 2006 |
An observational cohort study of Chlamydia trachomatis treatment in pregnancy.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Cohort Studies; Erythromycin; Female; Genital Diseases, Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Retrospective Studies; Treatment Outcome | 2006 |
Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Drug Resistance, Bacterial; Drug Utilization; Erythromycin; Evaluation Studies as Topic; Haemophilus influenzae; Health Policy; Hospitals, Teaching; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; Taiwan | 2006 |
Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Base Sequence; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycoplasma hominis; RNA, Ribosomal, 23S | 2006 |
Macrolide prescriptions and erythromycin resistance of Streptococcus pyogenes.
Topics: Adolescent; Azithromycin; Child; Child, Preschool; Drug Resistance, Bacterial; Erythromycin; Humans; Infant; Italy; Macrolides; Microbial Sensitivity Tests; State Medicine; Streptococcal Infections; Streptococcus pyogenes | 2006 |
Concentrations of erythromycin and azithromycin in mature Chinook salmon Oncorhynchus tshawytscha after intraperitoneal injection, and in their progeny.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Azithromycin; Body Burden; Drug Residues; Embryo, Nonmammalian; Erythromycin; Female; Half-Life; Injections, Intraperitoneal; Kidney; Male; Ovum; Salmon; Time Factors; Vitellins | 2006 |
[Current infection of Mycoplasma pneumoniae in adults: clinical analysis of 13 hospitalized patients].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Erythromycin; Female; Follow-Up Studies; Hospitalization; Humans; Male; Pneumonia, Mycoplasma; Retrospective Studies | 2006 |
Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey.
Topics: Azithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Penicillins; Streptococcal Infections; Streptococcus pyogenes; Turkey | 2006 |
Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cefixime; Cefmenoxime; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Humans; Male; Neisseria gonorrhoeae | 2006 |
Intrinsic and selected resistance to antibiotics binding the ribosome: analyses of Brucella 23S rrn, L4, L22, EF-Tu1, EF-Tu2, efflux and phylogenetic implications.
Topics: Anti-Bacterial Agents; Azithromycin; Binding, Competitive; Brucella; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Microbial Sensitivity Tests; Molecular Sequence Data; Peptide Elongation Factor Tu; Phylogeny; Polymorphism, Genetic; Protein Isoforms; Ribosomal Proteins; Ribosomes; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2006 |
Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells.
Topics: Azithromycin; Cells, Cultured; Dinoprost; Erythromycin; Humans; Immunosuppressive Agents; Interleukin-17; Interleukin-8; Lung Transplantation; Macrolides; Mitogen-Activated Protein Kinases; Myocytes, Smooth Muscle; Oxidative Stress; Respiratory System; Steroids | 2007 |
Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Line; Cephalothin; Clindamycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Epithelial Cells; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillin V; Streptococcus pyogenes | 2006 |
Activity of azithromycin or erythromycin in combination with antimalarial drugs against multidrug-resistant Plasmodium falciparum in vitro.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Azithromycin; Drug Antagonism; Drug Combinations; Drug Resistance, Multiple; Drug Synergism; Erythromycin; Inhibitory Concentration 50; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinine | 2006 |
Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Models, Biological; Moraxella catarrhalis; Moraxellaceae Infections; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 2007 |
Effect of macrolide antibiotics on uptake of digoxin into rat liver.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Biological Transport; Blood Flow Velocity; Cardiotonic Agents; Clarithromycin; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Hepatocytes; Josamycin; Liver; Macrolides; Male; Permeability; Rats; Rats, Sprague-Dawley; Roxithromycin; Tissue Distribution | 2007 |
Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals.
Topics: Administration, Oral; Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Bronchoalveolar Lavage; Clarithromycin; Erythromycin; Female; Horses; Lung; Male | 2007 |
[Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope].
Topics: Azithromycin; Bacterial Proteins; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Membrane Proteins; Methicillin Resistance; Methyltransferases; Microscopy, Electron, Scanning; Miocamycin; Polymerase Chain Reaction; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 2007 |
Streptococcus pneumoniae bacteraemia: pharmacodynamic correlations with outcome and macrolide resistance--a controlled study.
Topics: Anti-Bacterial Agents; Area Under Curve; Azithromycin; Bacteremia; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Microbial Sensitivity Tests; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Failure | 2007 |
Sensitive liquid chromatography/mass spectrometry assay for the quantification of azithromycin in human plasma.
Topics: Acetonitriles; Anti-Bacterial Agents; Azithromycin; Biological Assay; Chemical Precipitation; Chromatography, Liquid; Erythromycin; Humans; Methanol; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solvents; Spectrometry, Mass, Electrospray Ionization; Time Factors; Water | 2007 |
Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Drug Resistance, Bacterial; Erythromycin; Heptavalent Pneumococcal Conjugate Vaccine; Humans; Infant; Infant, Newborn; Macrolides; Meningococcal Vaccines; Middle Aged; Models, Statistical; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Portugal; Serotyping; Streptococcus pneumoniae | 2008 |
Costs and health consequences of chlamydia management strategies among pregnant women in sub-Saharan Africa.
Topics: Africa South of the Sahara; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Costs and Cost Analysis; Erythromycin; Female; Humans; Male; Patient Compliance; Point-of-Care Systems; Pregnancy; Pregnancy Complications, Infectious; Prenatal Care; Treatment Outcome | 2007 |
Case for nonsurgical management not made.
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Erythromycin; Humans; Periodontal Diseases | 2007 |
The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment.
Topics: Anti-Bacterial Agents; Azithromycin; Conjunctivitis, Bacterial; Dose-Response Relationship, Drug; Erythromycin; Haemophilus influenzae; Humans; Kinetics; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 2008 |
Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Azithromycin; Bacterial Outer Membrane Proteins; Bacterial Proteins; Drug Resistance, Bacterial; Erythromycin; Female; Gene Expression Profiling; Gonorrhea; Lipoproteins; Membrane Proteins; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Mutation; Neisseria gonorrhoeae; Progesterone; Promoter Regions, Genetic; Repressor Proteins; RNA Stability; Virulence | 2008 |
Macrolide use shortens fever duration in Mycoplasma pneumoniae infection in children: a 2-year experience.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Erythromycin; Female; Fever; Humans; Infant; Male; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Retrospective Studies | 2008 |
Characterization of Renibacterium salmoninarum with reduced susceptibility to macrolide antibiotics by a standardized antibiotic susceptibility test.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Colony Count, Microbial; DNA, Bacterial; DNA, Ribosomal; Dose-Response Relationship, Drug; Erythromycin; Fish Diseases; Kidney; Kidney Diseases; Macrolides; Microbial Sensitivity Tests; Micrococcaceae; Mutation; Open Reading Frames; RNA, Ribosomal, 23S; Salmon | 2008 |
The effects of antibiotics on in vitro biofilm model of periodontal disease.
Topics: Anti-Bacterial Agents; Azithromycin; Biofilms; Erythromycin; Humans; In Vitro Techniques; Periodontal Diseases; Porphyromonas gingivalis; Streptococcus gordonii | 2008 |
Use of azithromycin ophthalmic solution in the treatment of chronic mixed anterior blepharitis.
Topics: Aged; Anterior Eye Segment; Anti-Bacterial Agents; Azithromycin; Blepharitis; Chronic Disease; Erythromycin; Eye Infections, Bacterial; Female; Humans; Male; Ophthalmic Solutions; Prospective Studies; Treatment Outcome | 2008 |
Characterization of a novel macrolide efflux gene, mef(B), found linked to sul3 in porcine Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Bacterial Typing Techniques; Cloning, Molecular; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Gene Order; Genotype; Integrons; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Random Amplified Polymorphic DNA Technique; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Swine | 2009 |
Total synthesis of azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Catalysis; Copper; Erythromycin; Imines; Stereoisomerism | 2009 |
Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations.
Topics: Abnormalities, Drug-Induced; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bioterrorism; Ciprofloxacin; Doxycycline; Erythromycin; Female; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Primary Prevention; Registries; Retrospective Studies; Risk Assessment; Tennessee; Young Adult | 2009 |
In vitro compared activity of telithromycin and azithromycin against northwest Italian isolates of Streptococcus pyogenes and Streptococcus pneumoniae with different erythromycin susceptibility.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Child; Drug Resistance, Bacterial; Erythromycin; Humans; Italy; Ketolides; Microbial Sensitivity Tests; Streptococcal Infections; Streptococcus pneumoniae; Streptococcus pyogenes | 2008 |
Compliance with azithromycin versus erythromycin in the setting of a pertussis outbreak.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Case-Control Studies; Child; Child, Preschool; Disease Outbreaks; Erythromycin; Female; Humans; Male; Medication Adherence; Whooping Cough | 2009 |
Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Cystic Fibrosis; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus | 2009 |
[Disappearance of Streptococcus pyogenes macrolide resistance in an area of northeastern Italy: a possible link with rational long-acting macrolide consumption].
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Delayed-Action Preparations; Drug Resistance, Multiple, Bacterial; Drug Utilization; Erythromycin; Humans; Italy; Macrolides; Streptococcal Infections; Streptococcus pyogenes | 2009 |
Macrolide-induced digoxin toxicity: a population-based study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azithromycin; Cardiotonic Agents; Case-Control Studies; Clarithromycin; Comorbidity; Digoxin; Drug Interactions; Erythromycin; Female; Humans; Macrolides; Male; Polypharmacy | 2009 |
Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Biological Transport; Chlorocebus aethiops; Clarithromycin; COS Cells; Dogs; Dose-Response Relationship, Drug; Erythromycin; Estrone; Humans; Intestinal Mucosa; Intestines; Kinetics; Macrolides; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Rats; Taurocholic Acid; Transfection | 2009 |
Canadian province-level risk factor analysis of macrolide consumption patterns (2000-2006).
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Clarithromycin; Drug Utilization; Erythromycin; Health Knowledge, Attitudes, Practice; Humans; Influenza, Human; Macrolides; Risk Factors; Seasons; Socioeconomic Factors | 2010 |
Synthesis and antibacterial activity of novel 11,12-cyclic carbonate azithromycin 4''-O-carbamate derivatives.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbamates; Carbonates; Drug Resistance, Bacterial; Erythromycin; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 2010 |
Cost analysis of povidone-iodine for ophthalmia neonatorum prophylaxis.
Topics: Anti-Infective Agents, Local; Azithromycin; Cost-Benefit Analysis; Drug Costs; Erythromycin; Health Care Costs; Humans; Infant; Infant, Newborn; Ophthalmia Neonatorum; Povidone-Iodine | 2010 |
CEM-101 activity against Gram-positive organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia.
Topics: Azithromycin; Bacterial Proteins; Child; Child, Preschool; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; Latvia; Macrolides; Membrane Proteins; Methyltransferases; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes | 2010 |
Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; United Kingdom; Young Adult | 2010 |
Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Child; Child, Preschool; China; Clarithromycin; DNA Fingerprinting; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Point Mutation; Polymorphism, Restriction Fragment Length; RNA, Bacterial; RNA, Ribosomal, 23S; Tetracyclines | 2010 |
Disposition of oral telithromycin in foals and in vitro activity of the drug against macrolide-susceptible and macrolide-resistant Rhodococcus equi isolates.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Azithromycin; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Resistance, Bacterial; Epithelium; Erythromycin; Female; Horses; Ketolides; Linear Models; Lung; Macrolides; Male; Microbial Sensitivity Tests; Rhodococcus equi | 2010 |
Revisiting the structures of several antibiotics bound to the bacterial ribosome.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Binding Sites; Chloramphenicol; Deinococcus; Erythromycin; Haloarcula marismortui; Ketolides; Molecular Structure; Ribosomes; Thermus thermophilus | 2010 |
The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Calcium Channel Blockers; Case-Control Studies; Clarithromycin; Cross-Over Studies; Cytochrome P-450 Enzyme Inhibitors; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Humans; Hypotension; Macrolides; Male; Matched-Pair Analysis; Ontario; Patient Admission | 2011 |
Macrolide antibiotics broadly and distinctively inhibit cytokine and chemokine production by COPD sputum cells in vitro.
Topics: Anti-Bacterial Agents; Azithromycin; Cell Survival; Cells, Cultured; Chemokines; Clarithromycin; Cytokines; Erythromycin; Humans; Macrolides; Pulmonary Disease, Chronic Obstructive; Roxithromycin; Sputum | 2011 |
Maternal-amniotic-fetal distribution of macrolide antibiotics following intravenous, intramuscular, and intraamniotic administration in late pregnant sheep.
Topics: Amnion; Amniotic Fluid; Animals; Anti-Bacterial Agents; Azithromycin; Erythromycin; Female; Fetal Blood; Fetus; Injections; Injections, Intramuscular; Injections, Intravenous; Pregnancy; Sheep; Tissue Distribution | 2011 |
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Reproducibility of Results; Roxithromycin; Tetracycline; Time Factors; Ureaplasma Infections; Ureaplasma urealyticum | 2011 |
A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge.
Topics: Anti-Bacterial Agents; Azithromycin; Bacitracin; Cell Line; Conjunctiva; Epithelial Cells; Erythromycin; Humans; Microbial Sensitivity Tests; Protein Binding; Staphylococcal Infections; Staphylococcus aureus; Tetracycline | 2011 |
Serotype distribution and antibiotic resistance of 140 pneumococcal isolates from pediatric patients with upper respiratory infections in Beijing, 2010.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; China; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Respiratory Tract Infections; Serotyping; Streptococcus pneumoniae | 2011 |
Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis.
Topics: Anti-Bacterial Agents; Azithromycin; Biofilms; Erythromycin; Humans; Microbial Sensitivity Tests; Microscopy, Confocal; Porphyromonas gingivalis | 2011 |
[Detection and the antibiotic susceptibility analysis of mycoplasma and chlamydia in urogenital tract infections of 327 cases patients with tubal infertility].
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Chlamydia; Chlamydia Infections; Clarithromycin; Doxycycline; Erythromycin; Female; Humans; Infertility, Female; Josamycin; Microbial Sensitivity Tests; Minocycline; Mycoplasma; Mycoplasma Infections; Roxithromycin; Spectinomycin; Tetracycline; Ureaplasma urealyticum; Urogenital System; Young Adult | 2011 |
Antimalarial activity of 9a-N substituted 15-membered azalides with improved in vitro and in vivo activity over azithromycin.
Topics: Amides; Amines; Aminoquinolines; Animals; Antimalarials; Azithromycin; Cell Line, Tumor; Drug Resistance; Erythromycin; Humans; Macrolides; Malaria; Male; Mice; Microsomes, Liver; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum; Rats; Structure-Activity Relationship | 2012 |
Effect of azithromycin on small bowel motility in patients with gastrointestinal dysmotility.
Topics: Adult; Aged; Azithromycin; Erythromycin; Female; Gastrointestinal Agents; Gastrointestinal Motility; Gastroparesis; Humans; Intestine, Small; Male; Manometry; Middle Aged; Myoelectric Complex, Migrating; Octreotide; Retrospective Studies; Young Adult | 2012 |
[The effects of macrolides (EM900, clarithromycin and azithromycin) on IL-17-induced IL-8 production by airway epithelial cells].
Topics: Anti-Inflammatory Agents; Azithromycin; Cells, Cultured; Clarithromycin; Erythromycin; Humans; Interleukin-17; Interleukin-8; Recombinant Proteins; Respiratory Mucosa | 2009 |
Macrolides for acute lung injury.
Topics: Acute Lung Injury; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Clarithromycin; Erythromycin; Female; Humans; Macrolides; Male; Pentoxifylline | 2012 |
N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Azithromycin; Bronchiolitis; Bronchoalveolar Lavage Fluid; Cell Line; Clarithromycin; Cystic Fibrosis; Drug Interactions; Drug Resistance, Bacterial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Interleukin-6; Lipopolysaccharides; Lung; Macrolides; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moraxella catarrhalis; Neutrophils; Rats; Rats, Sprague-Dawley; Streptococcus | 2012 |
Campylobacter antimicrobial resistance in Peru: a ten-year observational study.
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Feces; Humans; Microbial Sensitivity Tests; Peru; Prevalence | 2012 |
Appropriate antibiotic therapy improves Ureaplasma sepsis outcome in the neonatal mouse.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Azithromycin; Bacteremia; Disease Models, Animal; Erythromycin; Female; Humans; Mice; Microbial Sensitivity Tests; Pregnancy; Sepsis; Ureaplasma; Ureaplasma Infections; Ureaplasma urealyticum | 2012 |
Novel spectrophotometric method for determination of some macrolide antibiotics in pharmaceutical formulations using 1,2-naphthoquinone-4-sulphonate.
Topics: Anti-Bacterial Agents; Azithromycin; Coloring Agents; Erythromycin; Limit of Detection; Naphthoquinones; Pharmaceutical Preparations; Spectrophotometry; Sulfonic Acids | 2012 |
In vitro activity of Pheroid vesicles containing antibiotics against Plasmodium falciparum.
Topics: Antimalarials; Azithromycin; Chloroquine; Drug Delivery Systems; Drug Resistance; Erythromycin; Inhibitory Concentration 50; Lipids; Particle Size; Plasmodium falciparum; Solubility; Time Factors | 2012 |
Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Attention; Azithromycin; Canada; Clarithromycin; Erythromycin; Humans; Microbial Sensitivity Tests; Mutation; Pneumococcal Infections; Streptococcus pneumoniae | 2013 |
The antibiotic azithromycin is a motilin receptor agonist in human stomach: comparison with erythromycin.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Azithromycin; Calcium; CHO Cells; Cricetulus; Electric Stimulation; Erythromycin; Female; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Male; Middle Aged; Motilin; Obesity; Pyloric Antrum; Receptors, Gastrointestinal Hormone; Receptors, Neuropeptide; Recombinant Proteins | 2013 |
Chemobiosynthesis of new antimalarial macrolides.
Topics: Antimalarials; Azithromycin; Chloroquine; Drug Resistance; Erythromycin; Macrolides; Malaria; Parasitic Sensitivity Tests; Plasmodium berghei; Plasmodium falciparum | 2013 |
Safety of macrolides during pregnancy.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Female; Heart Defects, Congenital; Humans; Logistic Models; Macrolides; Pregnancy; Prenatal Exposure Delayed Effects; Pyloric Stenosis; Risk | 2013 |
Macrolides and bronchiectasis: clinical benefit with a resistance price.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchiectasis; Erythromycin; Female; Humans; Male; Respiratory Tract Infections | 2013 |
Nonantibiotic macrolides prevent human neutrophil elastase-induced mucus stasis and airway surface liquid volume depletion.
Topics: Azithromycin; Epithelial Sodium Channels; Erythromycin; Humans; Leukocyte Elastase; Macrolides; Mucus; Respiratory Mucosa; Respiratory System | 2013 |
Macrolide antibiotics block autophagy flux and sensitize to bortezomib via endoplasmic reticulum stress-mediated CHOP induction in myeloma cells.
Topics: Animals; Apoptosis; Autophagy; Azithromycin; Boronic Acids; Bortezomib; Cell Line, Tumor; Clarithromycin; Endoplasmic Reticulum Stress; Erythromycin; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Macrolides; Mice; Multiple Myeloma; Pyrazines; Transcription Factor CHOP | 2013 |
Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Azithromycin; Cause of Death; Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Erythromycin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Retrospective Studies; Rhabdomyolysis | 2013 |
Use of long-term antibiotic treatment in COPD patients in the UK: a retrospective cohort study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cohort Studies; Disease Progression; Doxycycline; Erythromycin; Female; Humans; Longitudinal Studies; Male; Middle Aged; Oxytetracycline; Penicillins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pulmonary Disease, Chronic Obstructive; Retrospective Studies; Sex Factors; United Kingdom | 2013 |
Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Gentamicins; Horse Diseases; Horses; Macrolides; Microbial Sensitivity Tests; Mutation; Rhodococcus equi; Rifampin; Vancomycin | 2013 |
Effect of magnesium sulfate and nifedipine on the risk of developing pulmonary edema in preterm births.
Topics: Adult; Azithromycin; Case-Control Studies; Drug Synergism; Erythromycin; Female; Humans; Infant, Newborn; Logistic Models; Magnesium Sulfate; Nifedipine; Obstetric Labor, Premature; Pregnancy; Pregnancy Complications; Pregnancy, Multiple; Premature Birth; Pulmonary Edema; Retrospective Studies; Risk Factors; Tocolysis; Tocolytic Agents; Young Adult | 2014 |
Ocular involvement in a patient with Legionella longbeachae 1 infection.
Topics: Administration, Oral; Adult; Azithromycin; Ceftriaxone; Drug Therapy, Combination; Erythromycin; Eye Infections, Bacterial; Humans; Injections, Intravenous; Legionella longbeachae; Legionellosis; Male; Retinitis; Scotoma; Tomography, Optical Coherence; Visual Acuity | 2014 |
Survey of the occurrence of pharmaceuticals in Spanish finished drinking waters.
Topics: Azithromycin; Chromatography, Liquid; Clarithromycin; Drinking Water; Environmental Monitoring; Erythromycin; Ibuprofen; Pharmaceutical Preparations; Spain; Sulfamethoxazole; Tandem Mass Spectrometry; Water Pollutants, Chemical | 2014 |
A retrospective comparison of antibiotic regimens for preterm premature rupture of membranes.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Azithromycin; Cohort Studies; Comparative Effectiveness Research; Delivery, Obstetric; Drug Monitoring; Drug Substitution; Drug Therapy, Combination; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Indiana; Infant, Newborn; Obstetric Labor Complications; Pregnancy; Retrospective Studies; Treatment Outcome | 2014 |
Group determination of 14-membered macrolide antibiotics and azithromycin using antibodies against common epitopes.
Topics: Animals; Anti-Bacterial Agents; Antibodies; Azithromycin; Body Fluids; Cattle; Clarithromycin; Cross Reactions; Enzyme-Linked Immunosorbent Assay; Epitopes; Erythromycin; Food Contamination; Humans; Limit of Detection; Macrolides; Rabbits; Roxithromycin; Water Pollutants, Chemical | 2015 |
[Clinical analysis of scrub typhus-associated hemophagocytic syndrome].
Topics: Anti-Bacterial Agents; Azithromycin; C-Reactive Protein; Clinical Laboratory Techniques; Diagnosis, Differential; Erythromycin; Humans; Imipenem; Lymphohistiocytosis, Hemophagocytic; Pneumonia; Retrospective Studies; Scrub Typhus | 2014 |
Identification of ribosomal RNA methyltransferase gene ermF in Riemerella anatipestifer.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; China; Drug Resistance, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Erythromycin; Escherichia coli; Lincomycin; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Polymerase Chain Reaction; Riemerella; Tylosin | 2015 |
Where macrolide resistance is prevalent.
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Infant; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough | 2015 |
Novel macrolide-resistance genes, mef(C) and mph(G), carried by plasmids from Vibrio and Photobacterium isolated from sediment and seawater of a coastal aquaculture site.
Topics: Animals; Anti-Bacterial Agents; Aquatic Organisms; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Genes, Bacterial; Geologic Sediments; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Phosphotransferases; Photobacterium; Plasmids; Seawater; Vibrio | 2015 |
Enrofloxacin and macrolides alone or in combination with rifampicin as antimicrobial treatment in a bovine model of acute Chlamydia psittaci infection.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cattle; Chlamydophila psittaci; Disease Models, Animal; Enrofloxacin; Erythromycin; Fluoroquinolones; Inflammation; Macrolides; Male; Psittacosis; Rifampin | 2015 |
Prevalence and molecular analysis of macrolide-resistant Moraxella catarrhalis clinical isolates in Japan, following emergence of the highly macrolide-resistant strain NSH1 in 2011.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Japan; Microbial Sensitivity Tests; Moraxella catarrhalis; Moraxellaceae Infections; Mutation; RNA, Ribosomal, 23S | 2015 |
Prevalence and resistance patterns of commensal S. aureus in community-dwelling GP patients and socio-demographic associations. A cross-sectional study in the framework of the APRES-project in Austria.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Austria; Azithromycin; Child; Child, Preschool; Cross-Sectional Studies; Demography; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Odds Ratio; Penicillins; Prevalence; Primary Health Care; Staphylococcal Infections; Staphylococcus aureus; Surveys and Questionnaires; Young Adult | 2015 |
High frequency of the 23S rRNA A2058G mutation of Treponema pallidum in Shanghai is associated with a current strategy for the treatment of syphilis.
Topics: Adult; Azithromycin; China; Drug Resistance, Bacterial; Erythromycin; Ethylenediamines; Female; Humans; Incidence; Macrolides; Male; Mutation; Penicillin G Procaine; RNA, Ribosomal, 23S; Surveys and Questionnaires; Syphilis; Treatment Failure; Treponema pallidum | 2015 |
Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cardiotoxins; Clarithromycin; Cytochromes c; Erythromycin; In Vitro Techniques; Macrolides; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondria, Liver; Mitochondrial Swelling; Myocytes, Cardiac; Rats, Wistar; Reactive Oxygen Species; Succinate Dehydrogenase | 2016 |
Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.
Topics: Animals; Anopheles; Antimalarials; Azithromycin; Erythrocytes; Erythromycin; Host-Parasite Interactions; Humans; Malaria; Mice; Plasmodium berghei; Plasmodium falciparum | 2015 |
Parametrization of macrolide antibiotics using the force field toolkit.
Topics: Algorithms; Amino Sugars; Anti-Bacterial Agents; Azithromycin; Binding Sites; Erythromycin; Escherichia coli; Hexoses; Ketolides; Macrolides; Molecular Dynamics Simulation; Ribosomes; Static Electricity; Thermodynamics; Thermus thermophilus; Water | 2015 |
Teaching old drugs new tricks to stop malaria invasion in its tracks.
Topics: Animals; Antimalarials; Azithromycin; Erythrocytes; Erythromycin; Humans; Malaria; Plasmodium berghei; Plasmodium falciparum | 2015 |
Susceptibility of Group A Streptococcus to Antimicrobial Agents in Northern Israel: A Surveillance Study.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Clindamycin; Drug Resistance, Bacterial; Epidemiological Monitoring; Erythromycin; Female; Humans; Israel; Male; Microbial Sensitivity Tests; Penicillins; Streptococcal Infections; Streptococcus pyogenes; Tetracycline; Tonsillitis; Young Adult | 2015 |
Use of macrolides during pregnancy and the risk of birth defects: a population-based study.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cohort Studies; Erythromycin; Female; Heart Defects, Congenital; Humans; Infant, Newborn; Macrolides; Penicillins; Pregnancy; Pregnancy Trimester, First; Prenatal Exposure Delayed Effects; Quebec; Registries; Risk Factors | 2015 |
A flow cytometry-based reporter assay identifies macrolide antibiotics as nonsense mutation read-through agents.
Topics: Animals; Azithromycin; Cell Line; Codon, Nonsense; Codon, Terminator; Erythromycin; Flow Cytometry; Gene Expression; Gene Expression Regulation; Genes, APC; Genes, Reporter; Humans; Intestinal Polyps; Macrolides; Mice; Mice, Knockout; Protein Biosynthesis; RNA, Messenger | 2016 |
Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines.
Topics: Apoptosis; Autophagy; Azithromycin; Cell Line, Tumor; Clarithromycin; Drug Synergism; ErbB Receptors; Erythromycin; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Macrolides; Pancreatic Neoplasms; Quinazolines | 2016 |
Macrolide antibiotics and the risk of ventricular arrhythmia in older adults.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Cohort Studies; Erythromycin; Female; Humans; Logistic Models; Macrolides; Male; Ontario; Propensity Score; Retrospective Studies; Risk Assessment; Risk Factors | 2016 |
Macrolides use and the risk of sudden cardiac death.
Topics: Anti-Bacterial Agents; Arrhythmias, Cardiac; Azithromycin; Clarithromycin; Coronary Artery Disease; Coronary Disease; Death, Sudden, Cardiac; Erythromycin; Humans; Macrolides; Plaque, Atherosclerotic; Risk Factors; Torsades de Pointes | 2016 |
Reduced persistence of the macrolide antibiotics erythromycin, clarithromycin and azithromycin in agricultural soil following several years of exposure in the field.
Topics: Agriculture; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Environmental Monitoring; Environmental Pollution; Erythromycin; Macrolides; Soil; Soil Pollutants; Waste Disposal, Fluid | 2016 |
Synthesis and antibacterial activity of novel 11-[3-[(arylcarbamoyl)oxy]propylamino]-11-deoxy-6-O-methyl-3-oxoerythromycin A 11-N,12-O-cyclic carbamate derivatives.
Topics: Anti-Bacterial Agents; Azithromycin; Carbamates; Erythromycin; Haemophilus influenzae; Ketolides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes | 2016 |
[Donovanosis (granuloma inguinale)].
Topics: Anti-Bacterial Agents; Azithromycin; Chlamydia trachomatis; Ciprofloxacin; Erythromycin; Granuloma Inguinale; Humans; Ofloxacin | 2016 |
In Vitro Activities of Lefamulin and Other Antimicrobial Agents against Macrolide-Susceptible and Macrolide-Resistant Mycoplasma pneumoniae from the United States, Europe, and China.
Topics: Anti-Bacterial Agents; Azithromycin; China; Diterpenes; Doxycycline; Drug Resistance, Bacterial; Erythromycin; Europe; Fluoroquinolones; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma pneumoniae; Pleuromutilins; Polycyclic Compounds; United States | 2017 |
Ribosomal Mutations Conferring Macrolide Resistance in Legionella pneumophila.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Clone Cells; Drug Resistance, Bacterial; Erythromycin; High-Throughput Nucleotide Sequencing; Legionella pneumophila; Microbial Sensitivity Tests; Mutation; Protein Isoforms; Ribosomal Proteins; RNA, Ribosomal, 23S | 2017 |
Macrolide resistance in Legionella pneumophila: the role of LpeAB efflux pump.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Legionella pneumophila; Macrolides; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Operon; RNA, Ribosomal, 23S | 2017 |
PharmGKB summary: Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Clarithromycin; Erythromycin; Humans; Macrolides; Pharmacogenetics; Signal Transduction | 2017 |
Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Cats; Child, Preschool; Ciprofloxacin; DNA, Bacterial; Dogs; Drug Resistance, Bacterial; Erythromycin; Fresh Water; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Pets; Poland; Poultry; Prevalence; Tetracycline; Water Microbiology | 2017 |
Toward the rational design of macrolide antibiotics to combat resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Design; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Escherichia coli Infections; Humans; Ketolides; Macrolides; Molecular Dynamics Simulation; Point Mutation; Ribosomes | 2017 |
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Atrial Fibrillation; Azithromycin; Cardiotonic Agents; Case-Control Studies; Cefuroxime; Clarithromycin; Death, Sudden; Digoxin; Drug Interactions; Erythromycin; Female; Heart Failure; Humans; Macrolides; Male; Ontario; Risk Factors | 2017 |
Comparison of Azithromycin versus Erythromycin for Prolongation of Latency in Pregnancies Complicated by Preterm Premature Rupture of Membranes.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cost-Benefit Analysis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Logistic Models; Multivariate Analysis; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Proteins; Bulgaria; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Macrolides; Male; Membrane Proteins; Methyltransferases; Microbial Sensitivity Tests; Middle Aged; Multiplex Polymerase Chain Reaction; Streptococcal Infections; Streptococcus pyogenes; Young Adult | 2017 |
Expression of acquired macrolide resistance genes in Haemophilus influenzae.
Topics: Anti-Bacterial Agents; Azithromycin; Cloning, Molecular; Drug Resistance, Bacterial; Electroporation; Erythromycin; Escherichia coli; Gene Expression; Genes, Bacterial; Genetic Vectors; Haemophilus influenzae; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Plasmids; Transformation, Bacterial | 2017 |
Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Czech Republic; Erythromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough; Young Adult | 2017 |
Prevalence and Antibiotic Resistance Profiles of Campylobacter jejuni Isolated from Poultry Meat and Related Samples at Retail Shops in Northern India.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Campylobacter jejuni; Cephalothin; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Food Contamination; Food Microbiology; India; Meat; Microbial Sensitivity Tests; Nalidixic Acid; Poultry; Public Health; Tetracycline | 2018 |
Burden and Risk Factors of Antimicrobial Use in Children Less Than 5 Years of Age with Diarrheal Illness in Rural Bangladesh.
Topics: Anti-Infective Agents; Azithromycin; Bangladesh; Child, Preschool; Cross-Sectional Studies; Diarrhea; Dysentery, Bacillary; Erythromycin; Feces; Female; Humans; Infant; Male; Multivariate Analysis; Prescription Drug Overuse; Risk Factors; Rotavirus Infections; Rural Population; Serotyping; Shigella; Tertiary Care Centers; Time Factors | 2018 |
Macrolide Resistance and Its Molecular Genetic Mechanisms in Streptococcus pyogenes Isolated from Children.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Child; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Ear, Middle; Erythromycin; Female; Gene Expression; Genotype; Humans; Male; Membrane Proteins; Methylation; Microbial Sensitivity Tests; Nasopharynx; Phenotype; Ribosomes; Streptococcal Infections; Streptococcus pyogenes; Vagina | 2016 |
Clinical Inquiries: Does prophylactic azithromycin reduce the number of COPD exacerbations or hospitalizations?
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive | 2018 |
The anti-inflammatory effects of erythromycin, clarithromycin, azithromycin and roxithromycin on histamine-induced otitis media with effusion in guinea pigs.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Clarithromycin; Disease Models, Animal; Ear, Middle; Erythromycin; Guinea Pigs; Histamine; Otitis Media with Effusion; Roxithromycin | 2018 |
Diffuse panbronchiolitis: A fine road from the discovery of a disease to the establishment of treatment.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Erythromycin; Haemophilus Infections; Humans; Japan; Macrolides; Male; Middle Aged; Prognosis; Sputum; Suppuration | 2018 |
Genomic characterisation, detection of genes encoding virulence factors and evaluation of antibiotic resistance of Trueperella pyogenes isolated from cattle with clinical metritis.
Topics: Actinomycetaceae; Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cattle; Clone Cells; Drug Resistance, Multiple, Bacterial; Erythromycin; Escherichia coli; Escherichia coli Infections; Female; Fusobacterium; Fusobacterium Infections; Genes, Bacterial; Iran; Parturition; Puerperal Infection; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination; Uterus; Virulence Factors | 2018 |
Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Equidae; Erythromycin; Feces; Horses; Kentucky; Microbial Sensitivity Tests; Musculoskeletal Diseases; Prevalence; Respiratory System; Rhodococcus equi; Rifampin; Soft Tissue Infections | 2019 |
Cysteine induces resistance of lactobacilli to erythromycin and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Cysteine; Drug Resistance, Bacterial; Erythromycin; Lactobacillus; Microbial Sensitivity Tests; Protein Synthesis Inhibitors; Transcriptional Activation | 2019 |
Antibiotic Resistance of
Topics: Anti-Bacterial Agents; Azithromycin; Campylobacter; Campylobacter jejuni; Ciprofloxacin; Diarrhea; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Tetracycline | 2019 |
Clinical Characteristics and Antibiotic Resistance of Mycoplasma Pneumoniae Pneumonia in Hospitalized Chinese Children.
Topics: Anti-Bacterial Agents; Azithromycin; Child; China; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enzyme-Linked Immunosorbent Assay; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Structure-Activity Relationship | 2018 |
Rapid molecular detection of macrolide resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Resistance, Bacterial; Erythromycin; Genes, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Streptococcus pneumoniae; Streptococcus pyogenes | 2019 |
Azithromycin vs erythromycin for the management of preterm premature rupture of membranes.
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Azithromycin; Chorioamnionitis; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Pregnancy; Respiratory Distress Syndrome, Newborn; Retrospective Studies | 2019 |
Antimicrobial susceptibility and molecular characteristics of
Topics: Azithromycin; China; DNA, Ribosomal; Drug Resistance, Bacterial; Erythromycin; Genotype; Genotyping Techniques; Humans; Microbial Sensitivity Tests; Minisatellite Repeats; Multilocus Sequence Typing; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2019 |
Spread of multidrug resistance among
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Mutation; Phylogeny; Serogroup; Tunisia; Ureaplasma; Ureaplasma Infections | 2020 |
Characterization of four unknown impurities in azithromycin and erythromycin imino ether using two-dimensional liquid chromatography coupled to high-resolution quadrupole time-of-flight mass spectrometry and nuclear magnetic resonance.
Topics: Azithromycin; Chromatography, Liquid; Drug Contamination; Erythromycin; Magnetic Resonance Spectroscopy; Models, Molecular; Spectrometry, Mass, Electrospray Ionization | 2020 |
Antimicrobial susceptibility patterns of Rhodococcus equi from necropsied foals with rhodococcosis.
Topics: Actinomycetales Infections; Animals; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Erythromycin; Horse Diseases; Horses; Microbial Sensitivity Tests; Rhodococcus equi | 2020 |
The First Report of Macrolide-Resistant Bordetella pertussis Isolation in Japan.
Topics: Anti-Bacterial Agents; Azithromycin; Bordetella pertussis; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Infant; Japan; Macrolides; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; RNA, Ribosomal, 23S; Whooping Cough | 2020 |
Changing Susceptibility Pattern of
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bangladesh; Child; Cholera; Ciprofloxacin; Drug Resistance, Bacterial; Erythromycin; Female; Furazolidone; Hospitals, Special; Humans; Male; Microbial Sensitivity Tests; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae O1 | 2020 |
Comparative Study of the Effect of Macrolide Antibiotics Erythromycin, Clarithromycin, and Azithromycin on the ERG1 Gene Expression in H9c2 Cardiomyoblast Cells.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Carrier Proteins; Cell Proliferation; Cell Survival; Clarithromycin; Erythromycin; Gene Expression; Heart; Macrolides; Membrane Proteins; Myoblasts, Cardiac; Rats | 2020 |
Azithromycin in the Treatment of Preterm Prelabor Rupture of Membranes Demonstrates a Lower Risk of Chorioamnionitis and Postpartum Endometritis with an Equivalent Latency Period Compared with Erythromycin Antibiotic Regimens.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Cesarean Section; Chorioamnionitis; Drug Administration Schedule; Endometritis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Middle Aged; Neonatal Sepsis; Postpartum Period; Pregnancy; Prospective Studies; Young Adult | 2020 |
Erythromycin compared to amoxicillin and azithromycin for antimicrobial prophylaxis for preterm premature rupture of the membranes: a retrospective study.
Topics: Adult; Amoxicillin; Antibiotic Prophylaxis; Azithromycin; Delivery, Obstetric; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Streptococcal Infections; Streptococcus agalactiae; Time Factors; Treatment Outcome | 2021 |
Direct anti-biofilm effects of macrolides on Acinetobacter baumannii: comprehensive and comparative demonstration by a simple assay using microtiter plate combined with peg-lid.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acyl-Butyrolactones; Agrobacterium tumefaciens; Anti-Bacterial Agents; Azithromycin; Biofilms; Biological Assay; Clarithromycin; Erythromycin; Fidaxomicin; Humans; Ivermectin; Josamycin; Microbial Sensitivity Tests; Microbial Viability; Quorum Sensing; Spiramycin | 2020 |
Antibiofilm Effects of Macrolide Loaded Microneedle Patches: Prospects in Healing Infected Wounds.
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Erythromycin; Escherichia coli; Humans; Male; Microbial Sensitivity Tests; Rats; Salmonella enterica; Skin; Staphylococcus aureus; Transdermal Patch; Wound Healing; Wound Infection | 2021 |
Application value of erythromycin combined with azithromycin sequential therapy in the treatment of mycoplasma pneumonia in children.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Erythromycin; Humans; Mycoplasma pneumoniae; Pneumonia, Mycoplasma | 2022 |
Comparative Effectiveness of Intravenous Azithromycin Versus Erythromycin Stimulating Antroduodenal Motility in Children.
Topics: Adult; Azithromycin; Child; Erythromycin; Gastrointestinal Motility; Humans; Manometry; Retrospective Studies | 2022 |
A retrospective study of azithromycin and ceftizoxime for the management of children with Mycoplasma pneumoniae pneumonia.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftizoxime; Child; Erythromycin; Female; Fever; Humans; Lactate Dehydrogenases; Male; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Retrospective Studies; Sulbactam; Treatment Outcome | 2021 |
Effects of a combination of erythromycin sequential therapy and azithromycin on lung function and inflammatory factors in children with severe mycoplasma pneumonia.
Topics: Anti-Bacterial Agents; Azithromycin; Biomarkers; C-Reactive Protein; Case-Control Studies; Child; Child, Preschool; China; Drug Therapy, Combination; Erythromycin; Female; Host-Pathogen Interactions; Humans; Inflammation Mediators; Interleukin-6; Interleukin-8; Lung; Male; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Random Allocation; Recovery of Function; Severity of Illness Index; Time Factors; Treatment Outcome | 2021 |
Large-scale characterization of the macrolide resistome reveals high diversity and several new pathogen-associated genes.
Topics: Azithromycin; Bacteria; Bacterial Proteins; Computational Biology; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Evolution, Molecular; Macrolides; Markov Chains; Metagenomics; Methyltransferases; Microbial Sensitivity Tests; Multigene Family; Phosphotransferases; Phylogeny | 2022 |
Comparative Computational Analysis of Dirithromycin and Azithromycin in Search for a Potent Drug against COVID-19 caused by SARS-CoV-2: Evidence from molecular docking and dynamic simulation.
Topics: Antiviral Agents; Azithromycin; COVID-19 Drug Treatment; Erythromycin; Humans; Molecular Docking Simulation; Molecular Dynamics Simulation; Pandemics; SARS-CoV-2; Viral Nonstructural Proteins | 2022 |
Antibiotics in sewage treatment plants, receiving water bodies and groundwater of Chennai city and the suburb, South India: Occurrence, removal efficiencies, and risk assessment.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Environmental Monitoring; Erythromycin; Fluoroquinolones; Groundwater; India; Macrolides; Ofloxacin; Risk Assessment; Sewage; Sulfamethazine; Tetracyclines; Water; Water Pollutants, Chemical | 2022 |
Predicting selection for antimicrobial resistance in UK wastewater and aquatic environments: Ciprofloxacin poses a significant risk.
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; United Kingdom; Wastewater; Water Pollutants, Chemical | 2022 |
Risk ranking of macrolide antibiotics - Release levels, resistance formation potential and ecological risk.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Erythromycin; Humans; Macrolides | 2023 |
Gene network interaction analysis to elucidate the antimicrobial resistance mechanisms in the Clostridiumdifficile.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Clostridioides difficile; Drug Resistance, Bacterial; Erythromycin; Gene Regulatory Networks; Microbial Sensitivity Tests; Rifampin | 2023 |
Alterations of growth, biofilm-forming, and gene expression of Bordetella pertussis by antibiotics at sub-minimum inhibitory concentrations.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Biofilms; Bordetella pertussis; Erythromycin; Gene Expression; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Whooping Cough | 2023 |
Susceptibility antibiotic screening reveals high rates of multidrug resistance of Salmonella, Shigella and Campylobacter in HIV infected and uninfected patients from Mozambique.
Topics: Agar; Animals; Anti-Bacterial Agents; Azithromycin; Bacteria; Campylobacter; Diarrhea; Drug Resistance, Bacterial; Drug Resistance, Multiple; Erythromycin; Gentamicins; HIV Infections; Microbial Sensitivity Tests; Mozambique; Salmonella; Sheep; Shigella; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2023 |
[Pollution Characteristics and Risk Assessment of Antibiotics in Beiyun River Basin in Beijing].
Topics: Anti-Bacterial Agents; Azithromycin; Beijing; Clarithromycin; Erythromycin; Lincomycin; Ofloxacin; Risk Assessment; Rivers; Roxithromycin; Sulfapyridine; Tandem Mass Spectrometry | 2023 |
Immunotechniques for the Group Determination of Macrolide Antibiotics Traces in the Environment Using a Volume-Mediated Sensitivity Enhancement Strategy.
Topics: Anti-Bacterial Agents; Azithromycin; Erythromycin; Haptens; Humans; Macrolides; Tandem Mass Spectrometry; Water | 2023 |
Seasonal Azithromycin Use in Paediatric Protracted Bacterial Bronchitis Does Not Promote Antimicrobial Resistance but Does Modulate the Nasopharyngeal Microbiome.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria; Bacterial Infections; Bronchitis, Chronic; Child; Chronic Disease; Cough; Drug Resistance, Bacterial; Erythromycin; Humans; Microbiota; RNA, Ribosomal, 16S; Seasons; Streptococcus pneumoniae | 2023 |